mitomycin has been researched along with Glaucoma in 689 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This unicentric randomized clinical trial was designed to compare the surgical outcomes of mitomycin C-enhanced trabeculectomy (MMC-TRAB) with and without subtenon triamcinolone acetonide (TAAC) injection in patients with non-inflammatory glaucomas." | 9.51 | Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial. ( Almeida, I; Dias, DT; Gracitelli, CPB; Kanadani, FN; Lopes, FS; Prata, TS; Ushida, M, 2022) |
| "To investigate the outcome of mitomycin C (MMC)-augmented trabeculectomy with subconjunctival bevacizumab in the management of Fuchs heterochromic iridocyclitis (FHI)-related glaucoma in 1-year follow-up period." | 9.34 | The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis. ( Berker, N; Elgin, U; Ozdal, P; Ozdemir, K; Sen, E, 2020) |
| "To determine whether adjunctive mitomycin C (MMC) or amniotic membrane transplantation (AMT) improve the outcomes of Ahmed glaucoma valve (AGV) implantation." | 9.22 | Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial. ( Doozandeh, A; Ghahari, E; Mahboobipour, H; Pakravan, M; Yazdani, S, 2016) |
| "To compare the results of subscleral trabeculectomy (SST) augmented with mitomycin-C (MMC) versus Ologen™ implant regarding intraocular pressure (IOP) control and incidence of complications." | 9.17 | Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma. ( Ellakwa, AF; Mandour, SS; Marey, HM, 2013) |
| "To evaluate the potential usefulness of a freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C (MMC) in the maintenance of functioning glaucoma surgery in cases of pediatric glaucoma." | 9.14 | A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma. ( Almasalamy, SM; Almasary, AM; Anany, HA; Mahdy, RA; Nada, WM, 2010) |
| "To evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in eyes undergoing Ahmed Glaucoma Valve implantation." | 9.11 | Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. ( Arcieri, ES; Azuara-Blanco, A; Costa, VP; Lesk, MR; Netland, PA, 2004) |
| "In one-year-follow up patients after trabeculectomies with or without topical use of mitomycin C were controlled for early and late complications, and levels of intraocular pressure." | 9.11 | [Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications]. ( Szaflik, J; Zaleska-Zmijewska, A, 2004) |
| "To probe the results of trabeculectomy with human amniotic membrane (HAM) or mitomycin(MMC) in the treatment of glaucoma." | 9.11 | [The comparison study of glaucoma trabeculectomy applying amniotic membrane or mitomycin C]. ( Huang, Y; Huang, Z; Li, H; Xie, M; Zheng, K; Zou, H, 2005) |
| "To evaluate subconjunctival mitomycin C (MMC) injection efficacy and safety in patients with failing glaucoma non-penetrating filtering blebs." | 9.10 | Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery. ( Iester, M; Mermoud, A; Ravinet, E, 2002) |
| "To investigate the long-term therapeutic effect of Hunan aqueous drainage (HAD) implantation with and without adjunctive intraoperative mitomycin C (MMC) for refractory glaucoma." | 9.10 | [Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma]. ( Duan, X; Jiang, Y; Qing, G, 2003) |
| "To verify if partial intraoperative Tenon's capsule resection (PTCR) with adjunctive mitomycin C is effective in developing thin, avascular blebs in eyes undergoing Ahmed glaucoma valve insertion, and to assess the efficacy and safety of this procedure." | 9.10 | Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. ( Susanna, R, 2003) |
| "The use of adjunctive intraoperative mitomycin C has considerably improved the success rate of glaucoma filtering surgery." | 9.08 | The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. ( Mégevand, GS; Murray, AD; Salmon, JF; Scholtz, RP, 1995) |
| "Twenty-eight eyes of 28 patients with advanced primary open-angle glaucoma undergoing primary trabeculectomy were randomized to either mitomycin C (0." | 9.08 | Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. ( Comegno, PE; Costa, VP; José, NK; Malta, RF; Vasconcelos, JP, 1996) |
| "To evaluate the adjunctive use of mitomycin-C (MMC) during trabeculotomy and trabeculectomy for eyes with high-risk congenital glaucoma." | 9.08 | Mitomycin-C in congenital glaucoma. ( Agarwal, HC; Honavar, SG; Sanga, L; Sihota, R; Sood, NN, 1997) |
| "Although there is a currently a revolution in angle-based procedures, subconjunctival filtration surgery with mitomycin C (MMC) wound modification remains a vital skill for glaucoma surgeons." | 9.05 | Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions. ( Fellman, RL; Grover, DS; Kornmann, HL, 2020) |
| " We concluded mitomycin C might be more effective in reducing intraocular pressure and increasing qualified success compared to 5-fluorouracil." | 8.98 | Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma? ( Pimentel, E; Schmidt, J, 2018) |
| "To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma." | 8.79 | Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997) |
| "The purpose of the study was to investigate the incidence for endophthalmitis and blebitis after deep sclerectomy (DS) and trabeculectomy with routine use of Mitomycin C (MMC) 0." | 8.31 | Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C. ( Harju, M; Kankainen, T, 2023) |
| "The gold standard for managing postoperative ocular fibrosis in glaucoma surgery is the chemotherapeutic mitomycin C (MMC) despite its association with significant adverse effects." | 8.31 | ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts. ( Armstrong, JJ; Denstedt, J; Hutnik, CML; Liu, H; Teplitsky, JE; Vinokurtseva, A, 2023) |
| "To investigate the efficacy of nintedanib on preventing postoperative scar in formation following glaucoma filtering surgery (GFC) in rabbits in comparison with Mitomycin-C (MMC)." | 8.31 | The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits. ( Demirci Küçük, K; Furat Rençber, S; Öztürk, A; Yazır, Y; Yüksel, N; Yüksel, R, 2023) |
| "To evaluate the effect of intraoperative mitomycin C (MMC) on the surgical outcomes of ciliary sulcus (CS) Ahmed glaucoma valve (AGV) tube placement." | 8.31 | Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement. ( Bae, HW; Choi, W; Kim, CY; Kim, NE; Kim, SS; Lee, JS; Lee, K; Lee, SY, 2023) |
| "To compare the efficacy and safety of primary Ahmed valve implantation (AVI) and primary trabeculectomy with mitomycin C (MMC) in patients with pseudophakic exfoliative glaucoma (XFG)." | 8.31 | Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma. ( Ahn, HB; Hwang, SY; Jin, SW, 2023) |
| "To discuss the first case of mitomycin C (MMC) toxicity after XEN® gel stent implantation in a glaucoma patient, conducted using the XEN "air" technique with an ophthalmic viscosurgical device (OVD)." | 8.31 | A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. ( Baeg, JY; Choi, HS; Lee, SH, 2023) |
| "This study aimed to compare the effectiveness of combination therapy consisting of low-dose mitomycin C (MMC) and valproic acid (VPA) against high-dose MMC for improving the scar phenotype in minimally invasive glaucoma surgery (MIGS)." | 8.12 | Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery. ( Chu, SWL; Ibrahim, FI; Seet, LF; Teng, X; Toh, LZ; Wong, TT; Yap, ZL, 2022) |
| "To determine surgical outcomes and risk factors for failure of trabeculectomy with mitomycin C (TMMC) in pediatric traumatic glaucoma." | 8.12 | Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study. ( Jain, E; Mohan, A; Peeush, P; Prasad, K; Sen, A; Sen, P; Shah, C; Tripathi, S, 2022) |
| "We performed retrospective analysis of 31 eyes with myopia that underwent canaloplasty modified with mitomycin C in a consecutive single-surgeon case series." | 8.12 | Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 8.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "2 mg/mL mitomycin C, either alone or in combination with cataract surgery." | 8.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| ": To evaluate the outcomes of primary trabeculectomy with mitomycin-C (trab MMC) in phakic eyes with post-traumatic angle recession glaucoma with no prior intraocular surgeries." | 8.12 | Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention. ( Battula, M; Dangeti, D; Garudadri, C; Rao, HL; Senthil, S, 2022) |
| "To compare the intraocular pressure-lowering effect and success rate of trabeculectomy with OloGen to that of trabeculectomy with mitomycin C (MMC) in cases of silicone oil-induced glaucoma." | 8.12 | Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma. ( Hashem, NH; Shalaby, HS, 2022) |
| "The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy." | 8.02 | [Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C]. ( Bedar, MS; Kellner, U, 2021) |
| "This paper reports a retrospective consecutive case series investigating the efficacy of Mitomycin C-augmented trabeculectomy in the treatment of primary and secondary pediatric glaucoma in a mixed etiology, multiethnic cohort of patients." | 8.02 | Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort. ( Ahmad, M; Gurney, SP; Makanjuola, T; Parulekar, MV; Ramm, L, 2021) |
| "To investigate the effects of halofuginone and pirfenidone on wound healing in experimental glaucoma filtration surgery (GFS)." | 8.02 | The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery. ( Akin, MM; Demir, T; Gungor Kobat, S; Kasar, K, 2021) |
| "The purpose of this study was to determine the long-term outcomes of Ahmed glaucoma valve (AGV) implantation with intraoperative application of mitomycin-C (MMC) for the treatment of childhood glaucoma." | 8.02 | Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma. ( Lyons, CJ; Promelle, V, 2021) |
| "To examine the efficacy and safety of current trabeculectomy with mitomycin C in Japan for glaucomatous eyes with low intraocular pressure (IOP)." | 7.96 | Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops. ( Higashide, T; Hirooka, K; Kiuchi, Y; Ohkubo, S; Sugimoto, Y; Sugiyama, K; Yuasa, Y, 2020) |
| "The aim of this study is to describe the effectiveness of trabeculectomy with mitomycin C and releasable suture in Posner-Schlossman syndrome (PSS) with secondary glaucoma." | 7.91 | The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series. ( Artini, W; Bani, AP, 2019) |
| "To compare the effect of two exposure durations of mitomycin C in combined angle and filtering surgery for primary congenital glaucoma." | 7.88 | Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations. ( Bayoumi, NH, 2018) |
| " The triamcinolone + mitomycin C acetate group presented better indices as for the maximum bleb height and vascularization of the bleb central area (p=0." | 7.88 | Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study. ( Araújo, ID; Cronemberger, S; Rangel, HMDA; Rolim, HT; Vidigal, P, 2018) |
| "To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients." | 7.85 | Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017) |
| "To examine the effect of mitomycin c and 5-flurouracil on treatment outcomes following Ahmed glaucoma valve implantation." | 7.85 | Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. ( Cui, QN; Han, Y; Hsia, YC; Lin, SC; Mehta, N; Naseri, A; Porco, TC; Rose-Nussbaumer, J; Stamper, RL, 2017) |
| "To compare efficacy and safety of EX-PRESS mini glaucoma shunt (Alcon) and trabeculectomy with mitomycin-C (MMC) in the management of pediatric glaucoma." | 7.85 | Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma. ( Crouch, ER; Nash, DL, 2017) |
| "To evaluate the intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma." | 7.85 | Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017) |
| "To report the outcomes of primary trabeculectomy with mitomycin-C (MMC) in eyes with glaucoma secondary to iridocorneal endothelial (ICE) syndrome." | 7.83 | Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome. ( Chandran, P; Choudhari, NS; Garudadri, CS; Mandal, AK; Rao, HL; Senthil, S, 2016) |
| "To evaluate the short-term outcomes of lensectomy, combined with vitrectomy, scleral-fixated intraocular lens (SFIOL), and trabeculectomy with adjunctive mitomycin C (MMC) in patients with subluxated/dislocated crystalline lenses with associated elevated intraocular pressure (IOP)." | 7.83 | Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens. ( Balekudaru, S; David, RL; George, RJ; Lingam, V; Sen, P, 2016) |
| "To evaluate the outcomes of trabeculectomy with mitomycin-C (MMC) in uveitis associated with Vogt-Koyanagi-Harada disease (VKH)." | 7.83 | Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2016) |
| "To determine if sequential treatment with Bevacizumab (Avastin), a monoclonal, VEGF antibody that blocks angiogenesis; Saratin, a 12 kD polypeptide with anti-inflammatory and anti-thrombotic properties; and Ilomastat, a matrix metalloproteinase (MMP) inhibitor, prolongs bleb life following glaucoma filtration surgery (GFS) in a rabbit model." | 7.81 | Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model. ( Levine, MA; Lukowski, ZL; Martorana, GM; Meyers, CA; Min, J; Schaefer, JL; Schultz, GS; Sherwood, MB, 2015) |
| "To evaluate the long-term success of trabeculectomy with mitomycin C for glaucoma after vitreoretinal surgery with silicone oil insertion." | 7.80 | Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series. ( Chandra, A; Gupta, V; Kumar, S; Sihota, R; Singh, D, 2014) |
| "To compare outcomes between patients undergoing trabeculectomy with an Ex-PRESS mini glaucoma device using mitomycin-C (MMC) to those undergoing the same procedure using a subconjunctival collagen matrix implant (Ologen)." | 7.80 | Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. ( Johnson, MS; Sarkisian, SR, 2014) |
| "To evaluate the surgical outcome of Ahmed glaucoma valve (AGV) implantation with a new technique of mitomycin C (MMC) application." | 7.80 | Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique. ( Huang, W; Wang, W; Zhang, X; Zhou, M, 2014) |
| "To compare the effects of silver nanoparticles (AgNPs) and mitomycin C (MMC) on intraocular pressure (IOP) and external, histologic, and immunohistochemical bleb characteristics in a rabbit model of filtration surgery." | 7.79 | Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery. ( Butler, MR; Chevez-Barrios, P; Frankfort, BJ; Orengo-Nania, S; Prospero Ponce, CM; Weinstock, YE, 2013) |
| "To evaluate the prognostic factors for surgical outcomes of subsequent trabeculectomy with mitomycin C (MMC) after prior incisional glaucoma surgery." | 7.79 | Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2013) |
| "To report outcomes of deep sclerectomy (DS) with intraoperative mitomycin C (MMC) application in eyes with previous failed glaucoma surgery (GS) and/or cataract extraction (CE)." | 7.78 | Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia. ( Anand, N; Wechsler, D, 2012) |
| "The purposes of this study were to investigate the effects of topically administrated Tacrolimus and Octreotide on modulation of postoperative scarring in experimental glaucoma filtration surgery and to compare the antifibrotic properties of these agents with mitomycin-C (MMC)." | 7.78 | Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery. ( Arslan, S; Aydemir, O; Dağlı, AF; Güler, M, 2012) |
| "To compare the histopathologic and morphologic findings of encapsulated blebs following Ahmed glaucoma valve implantation and primary standard trabeculectomy with mitomycin-C." | 7.78 | Comparative study of encapsulated blebs following Ahmed glaucoma valve implantation and trabeculectomy with mitomycin-C. ( Bae, K; Kee, C; Suh, W, 2012) |
| "To determine the medium-term intraocular pressure (IOP) control and visual outcomes for patients with advanced glaucoma undergoing trabeculectomy with mitomycin C." | 7.77 | Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma. ( King, AJ; Stead, RE, 2011) |
| "To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery." | 7.77 | Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. ( Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H, 2011) |
| "To report corneal toxicity of Mitomycin C application during filtering glaucoma surgery in two patients." | 7.76 | Corneal complications of intraoperative Mitomycin C in glaucoma surgery. ( Coppens, G; Maudgal, P, 2010) |
| "To analyse clinical outcomes of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) with inactive uveitis and compare them to those in eyes with primary open-angle glaucoma (POAG)." | 7.75 | Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. ( Araie, M; Kaburaki, T; Kawashima, H; Koshino, T; Numaga, J; Shirato, S; Tomidokoro, A, 2009) |
| "To evaluate the safety and effectiveness of trabeculectomy with mitomycin C in the management of childhood glaucoma." | 7.74 | Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. ( Borges-Giampani, AS; Carani, JC; Giampani, J; Oltrogge, EW; Susanna, R, 2008) |
| "To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period." | 7.74 | Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007) |
| "The purpose of this study was to compare the outcomes of mitomycin C (MMC)-augmented trabeculectomy in glaucoma patients with uveitis to those without uveitis but with other high-risk characteristics." | 7.74 | Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. ( Birt, C; Derzko-Dzulynsky, L; Noble, J; Rabinovitch, T, 2007) |
| "To determine the long-term antiscarring effect of ilomastat treatment after experimental glaucoma filtration surgery (GFS)." | 7.73 | Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. ( Khaw, PT; Mead, AL; Wong, TT, 2005) |
| "To assess intraocular pressure (IOP) changes of the contralateral eyes of eyes undergoing trabeculectomy with mitomycin C (MMC)." | 7.73 | Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C. ( Flammer, J; Haefliger, IO; Shaarawy, T; Vysniauskiene, I, 2005) |
| "To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)." | 7.73 | Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005) |
| "To prospectively study the evolution of possible high risk features of conjunctival filtration blebs like avascularity, transconjunctival oozing (TCO), and leaks after mitomycin C (MMC) enhanced glaucoma surgery." | 7.73 | Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. ( Anand, N; Arora, S; Clowes, M, 2006) |
| "Antimetabolites, especially mitomycin C (MMC), increase the incidence of late bleb-related endophthalmitis in trabeculectomy." | 7.73 | Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C. ( Flesner, P; Jensen, PK; Kessing, SV, 2006) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 7.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery." | 7.72 | Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. ( Bagga, H; Gothwal, VK; Mandal, AK; Nanda, AK; Nutheti, R, 2003) |
| "Comparison of fornix- and limbus-based conjunctival flaps with respect to cystic bleb-related complications of trabeculectomy with high-dose mitomycin C (MMC) in pediatric and young adult glaucoma." | 7.72 | Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. ( Bunce, C; Cordeiro, MF; Khaw, PT; Wells, AP, 2003) |
| "To evaluate the results of trabeculectomy with and without the use of mitomycin C in children with primary congenital glaucoma." | 7.72 | Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C. ( de Arruda Melo, PA; Júnior, AP; Montezano, FT; Prata, J; Rodrigues, AM, 2004) |
| "To assess the outcomes of patients who had late infections after undergoing filtering surgery with mitomycin C with respect to treatment, resultant vision, and maintenance of intraocular pressure." | 7.72 | Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. ( Lehrer, RA; Muckley, ED, 2004) |
| "To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease." | 7.72 | Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004) |
| "To describe the surgical technique and clinical outcomes of a procedure for refractory glaucoma, concurrent Baerveldt glaucoma implant (BGI) and trabeculectomy with mitomycin C." | 7.71 | Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. ( Budenz, DL; Bueche, M; Feuer, W; Nguyen, QH; Nicolela, MT; Palmberg, PF; Scott, IU; Singh, K, 2002) |
| "In medically uncontrolled post-traumatic angle recession glaucoma trabeculectomy with mitomycin C is an effective surgical procedure with an acceptable complication rate." | 7.71 | Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. ( Barron, A; Manners, T; Murray, AD; Salmon, JF; Willies, C, 2001) |
| "To investigate the changes of tear film functions due to the use of postoperative 5-fluourouracil (5-Fu) and intraoperative mitomycin C (MMC) in glaucoma filtration surgery." | 7.71 | [Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery]. ( Li, J; Pang, L, 2001) |
| "The authors determine if the intraoperative placement of paclitaxel powder in the subconjunctival space improves the outcome of glaucoma filtration surgery in rabbits." | 7.70 | The effect of paclitaxel powder on glaucoma filtration surgery in rabbits. ( Jampel, HD; Moon, JI, 1998) |
| "This study aimed to compare the surgical outcomes of mitomycin C trabeculectomy glaucoma drainage device (GDD) surgery and laser neodymium:YAG (Nd:YAG) cyclophotocoagulation (CPC) in the management of intractable glaucoma after penetrating keratoplasty (PKP) in a retrospective study." | 7.70 | Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. ( Ayyala, RS; Cooper, ML; Dreyer, EB; Frangie, JP; Goldstein, MH; Mattox, C; Netland, PA; Pieroth, L; Schuman, JS; Vinals, AF; Wu, HK; Zurakowski, D, 1998) |
| "The purpose of this study was to determine the intraocular pressure (IOP), aqueous humor flow, flare and ocular side effects in eyes with a history of hypotony after trabeculectomy with adjunctive mitomycin C (MMC)." | 7.70 | Effect of mitomycin C on aqueous humor flow, flare and intraocular pressure in eyes with glaucoma 2 years after trabeculectomy. ( Diestelhorst, M; Ustundag, C, 1998) |
| "Retrospective review of consecutive cases of pediatric glaucoma that underwent mitomycin C augmented trabeculectomy between January 1991 and December 1995." | 7.70 | Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. ( Beck, AD; Lynch, MG; Lynn, MJ; Noe, R; Wilson, WR, 1998) |
| "The use of a sponge impregnated with mitomycin-C is an increasingly common practice in glaucoma surgery." | 7.70 | A novel method for controlling the quantity of mitomycin-C applied during filtering surgery for glaucoma. ( Mehel, E; Péchereau, A; Stork, L; Weber, M, 1998) |
| "To present two cases of delayed-onset postoperative endophthalmitis following trabeculectomy combined with mitomycin C for secondary glaucoma after penetrating keratoplasty." | 7.70 | Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Akova, YA; Bulut, S; Dabil, H; Duman, S, 1999) |
| "To evaluate the surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma." | 7.70 | Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. ( Mandal, AK; Naduvilath, TJ; Prasad, K, 1999) |
| "To evaluate the outcome of filtering procedures supplemented with mitomycin C in children with glaucoma." | 7.70 | Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma. ( Augsburger, JJ; Azuara-Blanco, A; Schmidt, CM; Spaeth, GL; Wilson, RP, 1999) |
| "To determine the chemical stability of various mitomycin C (MMC) solutions used in glaucoma filtering surgery." | 7.70 | A comparative study of the chemical stability of various mitomycin C solutions used in glaucoma filtering surgery. ( Assalian, A; Calleja, K; Francoeur, AM; Guttman, A; Lesk, MR; Morin, I; Pan, SS; Rauth, M; Tétreault, F, 1999) |
| "To evaluate the effectiveness and safety of trabeculectomy with mitomycin-C (MMC) in the management of childhood glaucomas." | 7.70 | Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. ( Belmonte, SJ; Liebmann, JM; Ritch, R; Sidoti, PA, 2000) |
| "To investigate the effect of trabeculectomy with and without mitomycin C in post-keratoplasty glaucoma." | 7.70 | Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. ( Fujishima, H; Ishioka, M; Shimazaki, J; Shimmura, S; Tsubota, K; Yamagami, J, 2000) |
| "The effects of mitomycin-C on intraocular pressure (IOP), facility of outflow (C), and Tenon's capsule fibrosis were studied over 60 days in 10 clinically normal dogs." | 7.69 | Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs. ( Davidson, MG; Glover, TL; Nasisse, MP, 1995) |
| "Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation." | 7.69 | One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995) |
| "Twenty-one eyes of 21 patients with refractory glaucoma underwent glaucoma surgery involving placement of a modified Molteno implant and intraoperative application of mitomycin C." | 7.69 | Mitomycin C as adjunctive therapy with glaucoma implant surgery. ( Nicolela, MT; Susanna, R; Takahashi, WY, 1994) |
| "Mitomycin C (MMC) was used as a perioperative adjunct during trabeculectomy for 51 consecutive cases of complicated glaucoma." | 7.69 | Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months. ( Krieglstein, GK; Mietz, H, 1994) |
| "Intraoperative mitomycin-C application has been well accepted recently as a useful adjunctive procedure to enhance the filtering effect in glaucoma surgery." | 7.69 | Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery. ( Hsieh, JW; Hung, PT; Lin, LL; Wang, TH, 1995) |
| "To determine whether filtering blebs resulting from adjunctive use of mitomycin C (MMC) leads to an increased risk of endophthalmitis." | 7.69 | Bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Bergstrom, TJ; Higginbotham, EJ; Karp, KO; Lichter, PR; Musch, DC; Skuta, GL; Stevens, RK, 1996) |
| "To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin." | 7.69 | Endophthalmitis after filtering surgery with mitomycin. ( Flynn, HW; Greenfield, DS; Kangas, TA; Miller, MP; Palmberg, PF; Suñer, IJ, 1996) |
| "To investigate the effects of postoperative mitomycin C (MMC) eyedrop as an adjunct to intraoperative MMC in refractory glaucomas, 15 eyes of 14 glaucoma patients (age; 47." | 7.69 | Effects of postoperative mitomycin C eyedrop on trabeculectomy in refractory glaucoma patients. ( Choi, MY; Hyung, SM, 1996) |
| "The purpose of this study was to assess the effects of intraoperative mitomycin-C (MMC) on the function of Baerveldt glaucoma implants in rabbits." | 7.69 | Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits. ( Baerveldt, G; Mermoud, A; Minckler, DS; Prata, JA, 1996) |
| "An attempt was made to observe the possibility of controlling intraocular pressure (IOP) without hypotony and ocular motility disorder by installing an experimentally designed glaucoma implant through a small conjunctival incision with the aid of a stylet and maintaining the aqueous reservoir using mitomycin C (MMC)." | 7.69 | Experimentally designed glaucoma implant surgery with mitomycin C in rabbit. ( Kee, C; Youn, DH, 1995) |
| "A 91-year-old woman with a complete rupture of her mitomycin-C filtration bleb associated with eye rubbing while crying was examined." | 7.69 | Bleb rupture following filtering surgery with mitomycin-C: clinicopathologic correlations. ( Greenfield, DS; Parrish, RK, 1996) |
| "Combined penetrating keratoplasty and trabeculectomy with mitomycin-C should be considered for selected patients with uncontrolled glaucoma and corneal disease who have sufficient conjunctiva for a filtering procedure." | 7.69 | Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. ( Araujo, SV; Cohen, EJ; Figueiredo, RS; Katz, LJ; Rapuano, CJ; Wilson, RP, 1996) |
| "To inhibit the wound healing process and to achieve a better intraocular pressure lowering effect, we applied mitomycin-C (MMC) topically in trabeculectomy at different time sequences." | 7.69 | Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma. ( Bair, JS; Chen, CW, 1997) |
| "Adjunctive intraoperative mitomycin C increases the success of glaucoma filtering surgery, but also the postoperative complications." | 7.69 | Scleritis after glaucoma filtering surgery with mitomycin C. ( Fourman, S, 1995) |
| "The quantities of mitomycin-C contained in sponges prepared for glaucoma surgery differed for a given surgeon and between surgeons." | 7.69 | [Does the dosage of mitomycin-C applied during filtering surgery of glaucoma vary with the individual surgeon?]. ( Mehel, E; Pechereau, A; Stork Vabres, L; Weber, M, 1997) |
| "The effects of mitomycin C (MMC, 1 microgram/ml for 5 min) on growth and morphology of six MMC 'sensitive' and four MMC 'resistant' human Tenon's capsule fibroblasts grown from 10 patients who had had trabeculectomy for glaucoma were studied." | 7.69 | In vitro effects of mitomycin C on human Tenon's capsule fibroblasts & correlation with surgical outcome in glaucoma patients. ( Madhavan, HN; Vijaya, L, 1997) |
| "The authors studied the efficacy and complications of intraoperative mitomycin-C in glaucoma associated with ocular inflammation." | 7.69 | Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. ( McGehee, RF; Pederson, JE; Wright, MM, 1997) |
| "The purpose of the study is to determine the safety and efficacy of mitomycin C-augmented trabeculectomy in children with developmental glaucoma treated previously by conventional procedures." | 7.69 | Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. ( Jayagandan, A; John, T; Mandal, AK; Walton, DS, 1997) |
| "Subconjunctival mitomycin C has been used in glaucoma filtration surgery with success." | 7.69 | Transconjunctival mitomycin C as an adjunct to conventional glaucoma filtration surgery in rabbits. ( Buffenn, AN; Higginbotham, EJ; Kincaid, MC; Musch, DC; Saetre, SB, 1997) |
| "To evaluate the safety and efficacy of trabeculectomy with mitomycin-C in the management of postkeratoplasty glaucoma." | 7.69 | Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study. ( Gupta, A; Kumar, S; Ram, J; Sharma, A, 1997) |
| "The study was designed to observe the effect of heterogeneous scleral transplantation in treatment of hypotony after filtration surgery of glaucoma with mitomycin C." | 7.69 | [The effect of heterogeneous scleral transplantation on hypotony after filtration surgery of glaucoma with mitomycin C]. ( Dong, Q; Yan, L; Zhang, S, 1997) |
| "We studied the efficacy and safety of using topical mitomycin C (MMC) as an adjunct to glaucoma filtration surgery." | 7.68 | Effects of topical mitomycin C on glaucoma filtration surgery. ( Hong, C; Hyung, SM; Kim, DM; Song, KY; Youn, DH, 1993) |
| "In this study, an experimental model of glaucoma filtration surgery was used to evaluate the clinical and histologic effects of a single intraoperative topical application of mitomycin C." | 7.68 | Effect of topical mitomycin C on glaucoma filtration surgery in monkeys. ( Dorman-Pease, ME; Jampel, HD; Pasquale, LR; Quigley, HA; Thibault, D, 1992) |
| " 1989 trabeculectomy with per-operative topical application of mitomycin C was performed on eyes with refractory glaucoma." | 7.68 | Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. ( Bair, JS; Chen, CW; Huang, HT; Lee, CC, 1990) |
| "Mitomycin C (MMC) is an alkylating agent with extraordinary ability to crosslink DNA, preventing DNA synthesis." | 6.72 | History, presence, and future of mitomycin C in glaucoma filtration surgery. ( Al Majidi, R; Beckers, HJM; Gorgels, TGMF; Pinchuk, L; van Mechelen, RJS; Webers, CAB; Wolters, JEJ, 2021) |
| "To study the clinical effect of trabeculectomy combined with Mitomycin C and removed suture." | 6.71 | [Trabeculectomy combined with mitomycin C and removed suture in glaucoma]. ( Feng, Y, 2003) |
| "To determine the anticicatrization effect of mytomycin C (MMC)." | 6.68 | [The effect of mitomycin C on filtration surgery of glaucoma with poor prognosis]. ( Wu, L; Yin, J, 1996) |
| "Late postoperative complications are similar with the exception of an increased incidence of Tenon cyst formation in the MMC-treated eyes." | 6.68 | Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. ( Bergstrom, TJ; Higginbotham, EJ; Johnson, AT; Katz, GJ; Lichter, PR; Musch, DC; Skuta, GL, 1995) |
| "These include young patients, those with pigmentary glaucoma, secondary glaucoma, angle recession glaucoma, aphakic or pseudophakic glaucoma, and patients requiring reoperation." | 6.67 | Intraoperative mitomycin C in complicated glaucomas. ( Dogra, A; Kaur, J; Singh, G, 1993) |
| "Glaucoma affects more than 70 million people worldwide, with about 10% being bilaterally blind, making it the leading cause of irreversible blindness globally." | 6.61 | Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma. ( Foo, VHX; Htoon, HM; Perera, SA; Welsbie, DS, 2019) |
| "Raised intraocular pressure is a risk factor for glaucoma." | 6.52 | Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. ( Cabourne, E; Clarke, JC; Evans, JR; Schlottmann, PG, 2015) |
| "Mitomycin C (MMC) is an antimetabolite used during the initial stages of a trabeculectomy to prevent excessive postoperative scarring and thus reduce the risk of failure." | 6.43 | Intra-operative mitomycin C for glaucoma surgery. ( Indar, A; Wilkins, M; Wormald, R, 2005) |
| "Mitomycin C is an antimetabolite applied between the sclera and conjunctiva during the initial stages of a trabeculectomy to prevent excessive post-operative scarring and thus reduce the risk of failure." | 6.41 | Intra-operative mitomycin C for glaucoma surgery. ( Indar, A; Wilkins, M; Wormald, R, 2001) |
| "Mitomycin C seems to be a better treatment than 5 fluorouracil." | 6.38 | [Mitomycin C in glaucoma surgery]. ( Collignon-Brach, J, 1993) |
| " Outcome measures included IOP reduction from baseline, mean IOP change from baseline at month 6, medication use at 6 months, complications, adverse events, and need for further procedures." | 5.91 | Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries. ( Burgos-Blasco, B; Fernandez-Vigo, JI; García-Feijóo, J; Gines-Gallego, C; Martinez de la Casa, JM; Mendez-Hernandez, CD; Morales-Fernandez, L; Perucho-Gonzalez, L; Saenz-Frances, F, 2023) |
| "Inflammation-driven scarring is a major contributor to surgical failure after subconjunctival bleb forming glaucoma surgery." | 5.72 | Differential effects of acetylsalicylic acid and mitomycin C on cytokine-induced Tenon's capsule myofibroblast transdifferentiation and activity: Implications for glaucoma surgery. ( Armstrong, JJ; Hutnik, CML; Liu, H; Vinokurtseva, A, 2022) |
| "To evaluate the efficacy and safety of using Mitomycin-C (MMC) or Ologen implant as an adjunct to combined trabeculotomy-trabeculectomy (CTT) surgery relative to non-augmented CTT surgery in achieving higher success rates in patients with primary congenital glaucoma (PCG)." | 5.69 | Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial. ( Al-Nashar, HY; Fawzi, KM; Kenawy, S; Khairy, MA, 2023) |
| "This unicentric randomized clinical trial was designed to compare the surgical outcomes of mitomycin C-enhanced trabeculectomy (MMC-TRAB) with and without subtenon triamcinolone acetonide (TAAC) injection in patients with non-inflammatory glaucomas." | 5.51 | Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial. ( Almeida, I; Dias, DT; Gracitelli, CPB; Kanadani, FN; Lopes, FS; Prata, TS; Ushida, M, 2022) |
| "Excessive fibrosis is the topmost factor for the defeat of surgical glaucoma drainage device (GDD) implantation." | 5.51 | Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis. ( Dong, A; Fan, P; Han, L; Shao, Z; Yuan, H; Zhou, X, 2019) |
| "Both cataract and glaucoma are significant public health problems." | 5.40 | Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy. ( Kunhammad, S; Singh, P, 2014) |
| "To investigate the outcome of mitomycin C (MMC)-augmented trabeculectomy with subconjunctival bevacizumab in the management of Fuchs heterochromic iridocyclitis (FHI)-related glaucoma in 1-year follow-up period." | 5.34 | The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis. ( Berker, N; Elgin, U; Ozdal, P; Ozdemir, K; Sen, E, 2020) |
| " The dosage of mitomycin-C was 0." | 5.31 | Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. ( Aslanides, IM; Augsburger, JJ; Dudley, D; Lanzl, IM; Spaeth, GL; Wilson, RP, 2000) |
| "To compare the efficacy and safety of trabeculectomy with Ologen versus Mitomycin C in primary glaucoma." | 5.30 | Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh. ( Abdullahi, SM; Alam, S; Badmus, S; Hassan, Z; Kabir, J; Mahatma, M; Malek, MI; Rahman, M; Sarker, BK, 2019) |
| "Mitomycin C is a promising substance which improves substantially the prognosis of complicated cases of glaucoma." | 5.29 | [Initial experience with the use of mitomycin C in anti-glaucoma filtering surgery]. ( Liehneová, I; Rozsíval, P, 1994) |
| "While trabeculectomy with mitomycin C has previously been the gold standard in penetrating glaucoma surgery, glaucoma drainage implants used early within glaucoma surgery were examined in the course of the tube versus trabeculectomy (TVT) study." | 5.27 | [Glaucoma Drainage Devices: Tube versus Trabeculectomy Study]. ( Alnawaiseh, M; Bula, AM; Rosentreter, A; Strzalkowski, P, 2018) |
| "This was a prospective, controlled, cohort study that included 64 eyes of 46 children younger than 12 years with uncontrolled glaucoma, who underwent trabeculectomy with mitomycin C in an institutional setting." | 5.22 | Excision of Tenon Capsule in Pediatric Trabeculectomy: A Controlled Study. ( Awadein, A; El Sayed, YM, 2016) |
| "To determine whether adjunctive mitomycin C (MMC) or amniotic membrane transplantation (AMT) improve the outcomes of Ahmed glaucoma valve (AGV) implantation." | 5.22 | Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial. ( Doozandeh, A; Ghahari, E; Mahboobipour, H; Pakravan, M; Yazdani, S, 2016) |
| " The purpose of this study was to compare intraocular pressure (IOP)-lowering efficacy and safety of trabeculectomy or combined phacoemulsification and trabeculectomy with mitomycin-C (MMC) vs." | 5.22 | Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial. ( de Moraes, CG; Godfrey, DG; Rademaker, AW; Ritch, R; Sarkisian, SR; Tanna, AP; Vold, SD, 2016) |
| " A total of 49 eyes of 45 patients with uncontrolled glaucoma were recruited: 22 eyes in the bevacizumab (BVZ) group, and 27 eyes in the mitomycin C (MMC) group." | 5.20 | [Comparison study on the efficacy and safety of bevacizumab versus mitomycin C as adjuvants in trabeculectomy]. ( Martín Giral, E; Perucho Martínez, S; Rivera Zori, M; Toledano Fernández, N, 2015) |
| "This study was a retrospective chart review of 21 children with uveitic glaucoma who underwent TE with administration of mitomycin C including analysis of complications, further interventions, additional surgical procedures to control intraocular pressure (IOP) and of the success rates after a mean follow-up of 5 years." | 5.19 | [Trabeculectomy in uveitis associated with juvenile idiopathic arthritis: long-term results in pediatric secondary glaucoma]. ( Heiligenhaus, A; Heinz, C; Wiese, K, 2014) |
| "The rate of reoperation for glaucoma was higher following trabeculectomy with mitomycin C than tube shunt surgery in the TVT Study." | 5.19 | Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study. ( Feuer, WJ; Gedde, SJ; Saheb, H; Schiffman, JC, 2014) |
| "In this preliminary study, diclofenac sodium is at least as good as topical dexamethasone phosphate for glaucoma patients undergoing two-site combined phacotrabeculectomy with mitomycin C." | 5.17 | Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C. ( Goldenfeld, M; Kalev-Landoi, M; Katz, G; Levkovitch-Verbin, H, 2013) |
| "To compare the results of subscleral trabeculectomy (SST) augmented with mitomycin-C (MMC) versus Ologen™ implant regarding intraocular pressure (IOP) control and incidence of complications." | 5.17 | Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma. ( Ellakwa, AF; Mandour, SS; Marey, HM, 2013) |
| "Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC 0." | 5.16 | Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2012) |
| "Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C ([MMC]; 0." | 5.16 | Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2012) |
| "A 350-mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (MMC 0." | 5.14 | Three-year follow-up of the tube versus trabeculectomy study. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2009) |
| "Between July 2005 and October 2007, 61 consecutive medically uncontrolled glaucoma patients scheduled for first-time trabeculectomy were randomized to 1 of 3 study topical medication groups: nonsteroidal anti-inflammatory drugs (ketorolac), steroids (fluorometholone), or placebo (artificial tears)." | 5.14 | Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. ( Breusegem, C; Fieuws, S; Renier, C; Spielberg, L; Stalmans, I; Van de Veire, S; Van Ginderdeuren, R; Vandewalle, E; Zeyen, T, 2010) |
| "To evaluate the potential usefulness of a freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C (MMC) in the maintenance of functioning glaucoma surgery in cases of pediatric glaucoma." | 5.14 | A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma. ( Almasalamy, SM; Almasary, AM; Anany, HA; Mahdy, RA; Nada, WM, 2010) |
| "The purpose of our study was to assess intraocular pressure control (IOP) and postoperative complications in nonpenetrating very deep sclerectomy (NPVDS) with reticulated hyaluronic acid implant (SKGEL) and Mitomycin C (MMC)." | 5.13 | Nonpenetrating very deep sclerectomy with reticulated hyaluronic acid implant in glaucoma treatment. ( Forminśka-Kapuścik, M; Gierek-Ciaciura, S; Leszczyński, R; Mrukwa-Kominek, E; Rokita-Wala, I, 2008) |
| "350 mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (MMC)." | 5.12 | Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2007) |
| "To evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in eyes undergoing Ahmed Glaucoma Valve implantation." | 5.11 | Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. ( Arcieri, ES; Azuara-Blanco, A; Costa, VP; Lesk, MR; Netland, PA, 2004) |
| "In one-year-follow up patients after trabeculectomies with or without topical use of mitomycin C were controlled for early and late complications, and levels of intraocular pressure." | 5.11 | [Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications]. ( Szaflik, J; Zaleska-Zmijewska, A, 2004) |
| "Study patients were randomized to undergo placement of a 350-mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (0." | 5.11 | The tube versus trabeculectomy study: design and baseline characteristics of study patients. ( Brandt, JD; Feuer, WJ; Gedde, SJ; Heuer, DK; Parrish, RK; Schiffman, JC, 2005) |
| "To evaluate subconjunctival mitomycin C (MMC) injection efficacy and safety in patients with failing glaucoma non-penetrating filtering blebs." | 5.10 | Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery. ( Iester, M; Mermoud, A; Ravinet, E, 2002) |
| "To investigate the long-term therapeutic effect of Hunan aqueous drainage (HAD) implantation with and without adjunctive intraoperative mitomycin C (MMC) for refractory glaucoma." | 5.10 | [Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma]. ( Duan, X; Jiang, Y; Qing, G, 2003) |
| "To verify if partial intraoperative Tenon's capsule resection (PTCR) with adjunctive mitomycin C is effective in developing thin, avascular blebs in eyes undergoing Ahmed glaucoma valve insertion, and to assess the efficacy and safety of this procedure." | 5.10 | Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. ( Susanna, R, 2003) |
| "Trabeculectomy augmented with mitomycin C application at both sites could produce a greater lowering of intraocular pressure with low incidence of postoperative complications, and could provide an increased chance of long-term success." | 5.10 | Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy. ( Fang, CT; Gu, YS; Ma, XQ; You, YA, 2002) |
| "To compare the efficacy and safety of subconjunctival and intrascleral applications of mitomycin C (MMC) in trabeculectomy for high-risk glaucomas." | 5.09 | Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies. ( Agarwal, HC; Saigal, D; Sihota, R, 2001) |
| "The perioperative use of oral prednisone did not alter the surgical outcome of filtering procedures associated with antifibrosis agents in this population of glaucoma patients." | 5.09 | Oral prednisone in guarded filtration procedures supplemented with antimetabolites. ( Augsburger, JJ; Azuara-Blanco, A; Spaeth, GL, 1999) |
| "To evaluate the efficacy and safety of application of mitomycin-C (MMC) in combined and separate trabeculectomy and penetrating keratoplasty for the treatment of coexisting corneal disease and glaucoma." | 5.09 | Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty. ( Chowers, I; Ticho, U, 1999) |
| "The intraoperative application of the antimetabolite mitomycin C has been recommended extensively in the literature for trabeculectomy in eyes with poor prognosis glaucoma." | 5.08 | [Effect of mitomycin C on aqueous humor flow after trabeculectomy]. ( Diestelhorst, M; Krieglstein, GK, 1995) |
| "The use of adjunctive intraoperative mitomycin C has considerably improved the success rate of glaucoma filtering surgery." | 5.08 | The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. ( Mégevand, GS; Murray, AD; Salmon, JF; Scholtz, RP, 1995) |
| "The authors assessed the efficacy of adjunctive intraoperative mitomycin C to produce lower intraocular pressures (IOPs) in patients with complicated glaucoma who underwent double-plate Molteno implantation." | 5.08 | Adjunctive mitomycin C in Molteno implant surgery. ( Cardakli, UF; Eisele, JR; Heatley, GA; Kaufman, PL; Perkins, TW, 1995) |
| "The concentration of the antitumor antibiotic mitomycin (CAS 50-07-7, mitomycin C, MMC), used in ophthalmic surgery for its antiproliferative effects, was measured in the aqueous humor of 7 glaucoma patients undergoing trabeculectomy." | 5.08 | Mitomycin-C concentration in human ocular aqueous humor after topical administration during trabeculectomy. ( Biederbick, W; Botvinik-Helling, S; Conrady, S; Diestelhorst, M; Krieglstein, GK; Matthey, B; Rump, AF; Schierholz, J; Stemmler, M; Theisohn, M, 1995) |
| "Twenty-eight eyes of 28 patients with advanced primary open-angle glaucoma undergoing primary trabeculectomy were randomized to either mitomycin C (0." | 5.08 | Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. ( Comegno, PE; Costa, VP; José, NK; Malta, RF; Vasconcelos, JP, 1996) |
| "The purpose of the study is to determine whether the intraoperative application of subconjunctival mitomycin C (MMC), during combined phacoemulsification and trabeculectomy, is an effective means of improving filtration, defined as overall lower intraocular pressure (IOP) and less antiglaucoma medication use." | 5.08 | A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. ( Alward, WL; Barad, JP; Carlson, DW; Carney, BL; Zimmerman, MB, 1997) |
| "To evaluate the adjunctive use of mitomycin-C (MMC) during trabeculotomy and trabeculectomy for eyes with high-risk congenital glaucoma." | 5.08 | Mitomycin-C in congenital glaucoma. ( Agarwal, HC; Honavar, SG; Sanga, L; Sihota, R; Sood, NN, 1997) |
| "Mitomycin-C (MMC) is a useful adjunct to high risk glaucoma surgery." | 5.08 | Intraoperative mitomycin C and the corneal endothelium. ( Agarwal, HC; Sharma, T; Sihota, R, 1998) |
| "The authors assess whether adjunctive mitomycin C improves Molteno tube shunt surgery in terms of intraocular pressure (IOP), visual acuity, and complication rates." | 5.08 | The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. ( Bhavnani, V; Brizendine, E; Burgoyne, J; Cantor, L; Hoop, J; Sanders, S, 1998) |
| "Although there is a currently a revolution in angle-based procedures, subconjunctival filtration surgery with mitomycin C (MMC) wound modification remains a vital skill for glaucoma surgeons." | 5.05 | Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions. ( Fellman, RL; Grover, DS; Kornmann, HL, 2020) |
| " We concluded mitomycin C might be more effective in reducing intraocular pressure and increasing qualified success compared to 5-fluorouracil." | 4.98 | Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma? ( Pimentel, E; Schmidt, J, 2018) |
| "The Tube Versus Trabeculectomy (TVT) Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube-shunt surgery to trabeculectomy with mitomycin C (MMC) in eyes with previous cataract and/or failed glaucoma surgery." | 4.88 | The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice. ( Feuer, WJ; Gedde, SJ; Schiffman, JC; Singh, K, 2012) |
| "The Tube Versus Trabeculectomy (TVT) Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube-shunt surgery to trabeculectomy with mitomycin (MMC) in eyes with previous cataract and/or unsuccessful glaucoma surgery." | 4.86 | Review of results from the Tube Versus Trabeculectomy Study. ( Gedde, SJ; Heuer, DK; Parrish, RK, 2010) |
| "With the increased use of intraoperative antifibrotic (eg, mitomycin and fluorouracil) as an adjunct to standard trabeculectomy, an increased incidence is seen of late-onset filtering bleb-related infections." | 4.82 | Glaucoma-filtering bleb infections. ( Mac, I; Soltau, JB, 2003) |
| "The use of antifibrotic agents, namely, 5-fluorouracil and mitomycin C, in conjunction with glaucoma surgery has resulted in lower postoperative intraocular pressures after trabeculectomy or combined cataract and glaucoma surgery." | 4.82 | Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. ( Singh, K; Yoon, PS, 2004) |
| "Agents such as the antimetabolites 5-fluorouracil (5FU) and mitomycin-C (MMC) have revolutionised glaucoma surgery in patients with a high risk of surgical failure." | 4.82 | Wound healing after glaucoma surgery: how to manage it? ( Collignon, NJ, 2005) |
| "The preponderance of evidence from the literature suggests a small (2-4 mmHg) benefit from the use of mitomycin-C (MMC), but not 5-fluorouracil (5-FU), in combined cataract and glaucoma surgery (evidence grade B)." | 4.81 | Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. ( Bass, EB; Congdon, N; Friedman, DS; Jampel, HD; Kempen, JH; Levkovitch-Verbin, H; Lubomski, LH; Quigley, H; Robinson, KA, 2002) |
| "To examine why most ophthalmologists routinely use mitomycin C or 5-fluorouracil (antimetabolites) in association with filtering surgery for glaucoma." | 4.81 | The use of antimetabolites with trabeculectomy: a critical appraisal. ( Mutlukan, E; Spaeth, GL, 2001) |
| "Intraoperative Mitomycin C may be a helpful adjunct in achieving low final intraocular pressure after trabeculectomy in high-risk glaucoma filtering surgery, and Mitomycin C may be a viable alternative to postoperative 5-Fluorouracil." | 4.79 | [Trabeculectomy with mitomycin C. Study apropos of 30 cases]. ( Ballion, JC; Bazin, S; Ducousso, F; Poirier, L; Verin, P; Williamson, W, 1995) |
| "To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma." | 4.79 | Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997) |
| "Trabeculectomy (TE) with mitomycin C (MMC) is considered the gold standard in glaucoma surgery." | 4.31 | [Trabeculectomy with mitomycin C and Ologen® implant in comparison to classical trabeculectomy]. ( Helmers, G; Löw, U; Munteanu, C; Seitz, B, 2023) |
| "To compare the surgical outcomes of the Aurolab aqueous drainage implant (AADI) and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to iridocorneal endothelial (ICE) syndrome." | 4.31 | Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome. ( Gedde, SJ; Krishnadas, SR; Mani, I; Nagdev, N; Puthuran, GV; Ramesh, S; Senthilkumar, VA; Tara, TD, 2023) |
| "This was a single-center, nonrandomized retrospective cohort study of 998 eyes from 854 patients with glaucoma who underwent trabeculectomy with mitomycin C." | 4.31 | Trabeculectomy Tenon Advancement Technique May Reduce Bleb-Related Infections. ( Higashide, T; Mambo, Y; Ohkubo, S; Okayama, M; Sugiyama, K; Tsuchiya, S; Udagawa, S; Wajima, R; Yamashita, Y, 2023) |
| "The purpose of the study was to investigate the incidence for endophthalmitis and blebitis after deep sclerectomy (DS) and trabeculectomy with routine use of Mitomycin C (MMC) 0." | 4.31 | Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C. ( Harju, M; Kankainen, T, 2023) |
| "We retrospectively reviewed primary glaucoma patients who underwent mitomycin C-augmented trabeculectomy and completed 2 years of follow-up." | 4.31 | Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma. ( Chansangpetch, S; Itthipanichpong, R; Manassakorn, A; Ratanawongphaibul, K; Rojanapongpun, P; Tantisevi, V; Winuntamalakul, Y, 2023) |
| "To evaluate the efficacy and safety of the Preserflo MicroShunt with mitomycin C in patients with complicated glaucoma." | 4.31 | One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma. ( Erokhina, M; Haus, A; Seuthe, AM; Szurman, P, 2023) |
| " Mitomycin C has been used adjunctively in various procedures, including pterygium excision." | 4.31 | Inadvertent filtering bleb due to extracapsular cataract extraction wound reopening after mitomycin C use: a case report. ( Chaidaroon, W; Pathanapitoon, K; Upaphong, P, 2023) |
| "The gold standard for managing postoperative ocular fibrosis in glaucoma surgery is the chemotherapeutic mitomycin C (MMC) despite its association with significant adverse effects." | 4.31 | ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts. ( Armstrong, JJ; Denstedt, J; Hutnik, CML; Liu, H; Teplitsky, JE; Vinokurtseva, A, 2023) |
| "To investigate the efficacy of nintedanib on preventing postoperative scar in formation following glaucoma filtering surgery (GFC) in rabbits in comparison with Mitomycin-C (MMC)." | 4.31 | The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits. ( Demirci Küçük, K; Furat Rençber, S; Öztürk, A; Yazır, Y; Yüksel, N; Yüksel, R, 2023) |
| "In this 4-year retrospective cohort study, medical records of glaucoma patients older than 18 who underwent primary trabeculectomy with Mitomycin-C between 2012 and 2020 were reviewed." | 4.31 | Impact of postoperative choroidal detachment on trabeculectomy outcomes: a four-year comparative study. ( Ghanbarnia, MJ; Yadgari, M, 2023) |
| "To evaluate the effect of intraoperative mitomycin C (MMC) on the surgical outcomes of ciliary sulcus (CS) Ahmed glaucoma valve (AGV) tube placement." | 4.31 | Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement. ( Bae, HW; Choi, W; Kim, CY; Kim, NE; Kim, SS; Lee, JS; Lee, K; Lee, SY, 2023) |
| "The purpose of this study was to evaluate the effectiveness and safety of an open bleb revision with mitomycin- C (MMC) for bleb fibrosis after PreserFlo MicroShunt implantation." | 4.31 | Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma. ( Hoffmann, EM; Pfeiffer, N; Schuster, AK; Strzalkowska, A; Strzalkowski, P, 2023) |
| "Trabeculectomy with mitomycin C was the most common primary surgery performed in Thai patients with JOAG, and successfully reduced intraocular pressure without significant complications." | 4.31 | Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand. ( Annopawong, K; Friedman, DS; Seresirikachorn, K; Thiamthat, W; Vu, DM; Wanichwecharungruang, B, 2023) |
| "To compare the efficacy and safety of primary Ahmed valve implantation (AVI) and primary trabeculectomy with mitomycin C (MMC) in patients with pseudophakic exfoliative glaucoma (XFG)." | 4.31 | Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma. ( Ahn, HB; Hwang, SY; Jin, SW, 2023) |
| "To discuss the first case of mitomycin C (MMC) toxicity after XEN® gel stent implantation in a glaucoma patient, conducted using the XEN "air" technique with an ophthalmic viscosurgical device (OVD)." | 4.31 | A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. ( Baeg, JY; Choi, HS; Lee, SH, 2023) |
| "Although mitomycin C is commonly used in glaucoma filtering surgeries, reports of postoperative posterior segment toxicity are rare." | 4.31 | RETINAL TOXICITY FOLLOWING PRESUMED INADVERTENT INTRAOCULAR INJECTION OF MITOMYCIN C DURING TRABECULECTOMY. ( Desai, R; Jampol, LM, 2023) |
| "This study aimed to compare the effectiveness of combination therapy consisting of low-dose mitomycin C (MMC) and valproic acid (VPA) against high-dose MMC for improving the scar phenotype in minimally invasive glaucoma surgery (MIGS)." | 4.12 | Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery. ( Chu, SWL; Ibrahim, FI; Seet, LF; Teng, X; Toh, LZ; Wong, TT; Yap, ZL, 2022) |
| "To determine surgical outcomes and risk factors for failure of trabeculectomy with mitomycin C (TMMC) in pediatric traumatic glaucoma." | 4.12 | Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study. ( Jain, E; Mohan, A; Peeush, P; Prasad, K; Sen, A; Sen, P; Shah, C; Tripathi, S, 2022) |
| " Trabeculectomy with or without augmentation with Mitomycin C(MMC) was the first-choice glaucoma incisional surgery for 96." | 4.12 | Surgical trends in glaucoma management: The current Indian scenario. ( Bhartiya, S; Ichhpujani, P; Kalra, G; Kumar, S; Singla, E, 2022) |
| "To report outcomes and assess the risk factors for failure of trabeculectomy (trab), trabeculectomy with mitomycin-C (trabMMC), and combined trabeculectomy with cataract extraction (CT) in vernal keratoconjunctivitis (VKC) eyes with steroid-induced glaucoma (SIG)." | 4.12 | Long-term outcomes and risk factors for failure of glaucoma filtering surgery in eyes with vernal keratoconjunctivitis and steroid-induced glaucoma. ( Ali, MH; Choudhari, N; Dikshit, S; Garudadri, C; Krishnamurthy, R; Rao, HL; Sastry, R; Senthil, S, 2022) |
| "We performed retrospective analysis of 31 eyes with myopia that underwent canaloplasty modified with mitomycin C in a consecutive single-surgeon case series." | 4.12 | Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 4.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "2 mg/mL mitomycin C, either alone or in combination with cataract surgery." | 4.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| "Cytotoxic agents such as mitomycin C (MMC) are part of the mainstay treatment for limiting subconjunctival scarring following glaucoma filtration surgery (GFS)." | 4.12 | Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Mouse Model of Glaucoma Filtration Surgery and TGFβ1-Induced Responses in Human Tenon's Fibroblasts. ( Chan, EC; Edgley, AJ; Fan Gaskin, JC; Kong, RCK; Peshavariya, HM; Shah, MH, 2022) |
| " We included 27 eyes of 27 patients with glaucoma who underwent needling procedure using mitomycin C and were subsequently treated with ripasudil-a rho-associated protein kinase inhibitor (ripasudil group)-or without ripasudil (control group)." | 4.12 | Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study. ( Hirooka, K; Kiuchi, Y; Mizuno, Y; Okada, N; Okumichi, H; Onoe, H; Tokumo, K, 2022) |
| "We aim to compare the outcomes of trabeculectomy with mitomycin-C by a fellowship-trained glaucoma surgeon in the first hundred compared to second hundred surgeries." | 4.12 | Augmented trabeculectomy-outcomes of first hundred versus second hundred surgeries of a fellowship-trained glaucoma surgeon. ( Ali, ZC; Khoo, DI; Rattanasirivilai, P; Shankar, V, 2022) |
| ": To evaluate the outcomes of primary trabeculectomy with mitomycin-C (trab MMC) in phakic eyes with post-traumatic angle recession glaucoma with no prior intraocular surgeries." | 4.12 | Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention. ( Battula, M; Dangeti, D; Garudadri, C; Rao, HL; Senthil, S, 2022) |
| "To compare the intraocular pressure-lowering effect and success rate of trabeculectomy with OloGen to that of trabeculectomy with mitomycin C (MMC) in cases of silicone oil-induced glaucoma." | 4.12 | Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma. ( Hashem, NH; Shalaby, HS, 2022) |
| "The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy." | 4.02 | [Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C]. ( Bedar, MS; Kellner, U, 2021) |
| "This paper reports a retrospective consecutive case series investigating the efficacy of Mitomycin C-augmented trabeculectomy in the treatment of primary and secondary pediatric glaucoma in a mixed etiology, multiethnic cohort of patients." | 4.02 | Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort. ( Ahmad, M; Gurney, SP; Makanjuola, T; Parulekar, MV; Ramm, L, 2021) |
| "To determine the incidence of postoperative complications following combined trabeculotomy trabeculectomy with mitomycin C (CTTM) for congenital glaucoma (CG), in addition to documentation of some unusual complications and possible ways to manage these complications safely with minimal morbidity." | 4.02 | Common and rare complications following filtering surgery for children with congenital glaucoma; a5 years study. ( Sayed, KM, 2021) |
| "To investigate the effects of halofuginone and pirfenidone on wound healing in experimental glaucoma filtration surgery (GFS)." | 4.02 | The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery. ( Akin, MM; Demir, T; Gungor Kobat, S; Kasar, K, 2021) |
| "The purpose of this study was to determine the long-term outcomes of Ahmed glaucoma valve (AGV) implantation with intraoperative application of mitomycin-C (MMC) for the treatment of childhood glaucoma." | 4.02 | Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma. ( Lyons, CJ; Promelle, V, 2021) |
| "Aniridic glaucoma can be managed efficiently by medications in early glaucomatous neuropathy, and with trabeculectomy augmented with mitomycin-C and releasable sutures for more advanced glaucomas, offering favourable long-term IOP control, visual stability and safety." | 4.02 | Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma. ( Azmira, K; Dada, T; Gupta, A; Selvan, H; Sharma, A; Sihota, R; Upadhyay, A, 2021) |
| "A prospective, noncomparative case series of 30 eyes of 30 Chinese patients with mixed types of glaucoma who underwent fornix-based trabeculectomy combined with intraoperative mitomycin C application." | 3.96 | The Tenons' Layer Reposition Approach of Trabeculectomy: A Longitudinal Case Series of a Mixed Group of Glaucoma Patients. ( Baig, N; Chan, PP; Chan, TCY; Lai, G; Wong, LYN, 2020) |
| "Adult patients who have undergone glaucoma surgery including a tube shunt, trabeculectomy with mitomycin C, trabectome, or transcleral cyclophotocoagulation from June 1, 2015 to August 30, 2017 at a single institution." | 3.96 | Reoperations for Complications Within 90 Days After Glaucoma Surgery. ( Al-Aswad, LA; Blumberg, DM; Chu, CK; Cioffi, GA; Liebmann, JM, 2020) |
| "PRéCIS:: Glaucoma drainage devices (GDD) by Australian and New Zealand glaucomatologists are implanted superotemporally under a peribulbar anesthesia without the use of mitomycin C." | 3.96 | Glaucoma Drainage Device Technique in a Cohort of Experienced Glaucoma Surgeons in Australia and New Zealand. ( Craig, JE; Danesh-Meyer, HV; Lee, GA; Liu, L, 2020) |
| " The greatest absolute success rate (= IOD ≤ 15 mmHg without antiglaucoma medication) was in the group with exclusive goniotrepanation + mitomycin C (MMC; 72." | 3.96 | [Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety]. ( Heinz, C; Koch, JM; Lommatzsch, C; Rothaus, K, 2020) |
| "To examine the efficacy and safety of current trabeculectomy with mitomycin C in Japan for glaucomatous eyes with low intraocular pressure (IOP)." | 3.96 | Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops. ( Higashide, T; Hirooka, K; Kiuchi, Y; Ohkubo, S; Sugimoto, Y; Sugiyama, K; Yuasa, Y, 2020) |
| "A total of 1,098 eyes of patients with glaucoma who underwent trabeculectomy with mitomycin C at 34 clinical centers included in CBIITS were analyzed." | 3.91 | Trabeculectomy followed by phacoemulsification versus trabeculectomy alone: The Collaborative Bleb-Related Infection Incidence and Treatment Study. ( Arimura, S; Gozawa, M; Inatani, M; Iwasaki, K; Takamura, Y, 2019) |
| "In a retrospective clinical study, 806 patients with advanced glaucoma were treated with trabeculectomy combined with mitomycin C0." | 3.91 | [Long-Term Results after Trabeculectomy Combined with Mitomycin C and Ologen Implant]. ( Fili, S; Kohlhaas, M; Seddig, S, 2019) |
| "To report a new approach for the treatment of severe ocular hypotony secondary to glaucoma filtering surgery with mitomycin C by injecting autologous eye platelet-rich plasma (E-PRP) in the anterior chamber to block excessive diffuse filtration through an abnormally thinned sclera." | 3.91 | Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: A case report. ( Abdalrahman, O; Alio Del Barrio, JL; Alio, JL; Rodriguez, AE, 2019) |
| "To report on the frequency, efficacy, and safety of laser goniopuncture (LGP) in lowering intraocular pressure (IOP) following mitomycin-C-augmented nonpenetrating deep sclerectomy (NPDS) in a large cohort of eyes." | 3.91 | Outcomes of Laser Goniopuncture Following Nonpenetrating Deep Sclerectomy With Mitomycin C: A Large Retrospective Cohort Study. ( Akesbi, J; Blumen-Ohana, E; Laplace, O; Leleu, I; Nordmann, JP; Penaud, B, 2019) |
| "The aim of this study is to describe the effectiveness of trabeculectomy with mitomycin C and releasable suture in Posner-Schlossman syndrome (PSS) with secondary glaucoma." | 3.91 | The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series. ( Artini, W; Bani, AP, 2019) |
| "Rabbit model studies suggested better morphology blebs with equal intraocular pressure (IOP) efficacy as a standard mitomycin C (MMC) trabeculectomy using a novel slow-release drug delivery antifibrotic system delivering small quantities of MMC and 5-fluorouracil (5-FU)." | 3.91 | Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model. ( Ayyala, RS; Blake, D; Fullerton, M; Greenberg, E; John, V; Le, C; Mancera, N; Margo, C; Muddasani, N; Satija, C; Singh, S; Swann, FB; Wall, J; Zhang, Z; Zurakowski, D, 2019) |
| "Phacotrabeculectomy with adjunctive mitomycin C is a good option for the management of coexisting cataract and glaucoma." | 3.91 | Phacotrabeculectomy in Eyes With Uveitic Glaucoma: A Retrospective Case-Control Study. ( Balekudaru, S; Biswas, J; Ganesh, SK; George, AE; George, R; Lingam, V; Wadke, V, 2019) |
| "Wider area bleb revision using bleb knife with adjunctive mitomycin C (MMC) had a good success rate, according to strict success criteria, except in patients with neovascular glaucoma (NVG)." | 3.91 | Outcomes of Wider Area Bleb Revision Using Bleb Knife With Adjunctive Mitomycin C. ( Asaoka, R; Kiuchi, Y; Nakakura, S; Noguchi, A; Tabuchi, H; Tanabe, H, 2019) |
| "The purpose of this article is to analyze the results achieved in lowering intraocular pressure (IOP) after trabeculectomy or combined surgery (phacotrabeculectomy) with low-dose mitomycin C (MMC) using the Ologen Collagen Matrix (Ologen CM) implant." | 3.88 | Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up. ( Bolivar, G; Castaño, B; Castejón, MA; Paz-Moreno-Arrones, J; Teus, MA, 2018) |
| "To evaluate outcomes of trabeculectomy with adjunctive mitomycin C in patients with uncontrolled intraocular pressure (IOP) after glaucoma drainage device implantation." | 3.88 | Trabeculectomy Outcomes After Glaucoma Drainage Device Surgery. ( Akil, H; Alizadeh, R; Caprioli, J; Law, SK; Tan, J, 2018) |
| "To compare the effect of two exposure durations of mitomycin C in combined angle and filtering surgery for primary congenital glaucoma." | 3.88 | Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations. ( Bayoumi, NH, 2018) |
| "We report a case of a rare complication after trabeculotomy combined with a small trabeculectomy with mitomycin C in a young patient with juvenile glaucoma." | 3.88 | Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery. ( Gericke, A; Hoffmann, EM; Klezlova, A; Liebezeit, S; Pfeiffer, N; Prokosch-Willing, V, 2018) |
| "The objective of this study is to investigate the results of an adaptive approach of bleb revision surgery for late onset hypotony after trabeculectomy with mitomycin C because of bleb leakage and/or scleral melting." | 3.88 | Results of an Adaptive Surgical Approach for Managing Late Onset Hypotony After Trabeculectomy With Mitomycin C. ( Hoffmann, EM; Lamparter, J; Pfeiffer, N; Prokosch-Willing, V; Toshev, AP; Ul Hassan, SN, 2018) |
| " The triamcinolone + mitomycin C acetate group presented better indices as for the maximum bleb height and vascularization of the bleb central area (p=0." | 3.88 | Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study. ( Araújo, ID; Cronemberger, S; Rangel, HMDA; Rolim, HT; Vidigal, P, 2018) |
| "To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients." | 3.85 | Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017) |
| "After a failed filtration surgery, a low-diffuse bleb was reestablished by pretreating with subconjunctival mitomycin C followed by ab interno bleb revision with the Grover-Fellman biplanar sclerostomy spatula, decreasing further more invasive glaucoma procedures." | 3.85 | Outcomes for Ab Interno Bleb Revision With a Novel Translimbal Sclerostomy Spatula. ( Fellman, RL; Grover, DS, 2017) |
| "A prospective study was conducted on 39 eyes (26 right eyes) of 39 children (20 boys; 19 girls) who had primary congenital glaucoma treated with combined trabeculotomy-trabeculectomy with mitomycin C and scleral flap closure with regular or releasable sutures." | 3.85 | Regular Versus Releasable Sutures in Surgery for Primary Congenital Glaucoma. ( Bayoumi, NH, 2017) |
| "To examine outcomes of trabeculectomy with mitomycin C for uncontrolled glaucoma when performed by glaucoma trainee surgeons." | 3.85 | Primary Trabeculectomy Outcomes by Glaucoma Fellows in a Tertiary Hospital in Brazil. ( Abe, RY; Costa, VP; Shigueoka, LS; Vasconcellos, JPC, 2017) |
| "To examine the effect of mitomycin c and 5-flurouracil on treatment outcomes following Ahmed glaucoma valve implantation." | 3.85 | Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. ( Cui, QN; Han, Y; Hsia, YC; Lin, SC; Mehta, N; Naseri, A; Porco, TC; Rose-Nussbaumer, J; Stamper, RL, 2017) |
| "To compare efficacy and safety of EX-PRESS mini glaucoma shunt (Alcon) and trabeculectomy with mitomycin-C (MMC) in the management of pediatric glaucoma." | 3.85 | Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma. ( Crouch, ER; Nash, DL, 2017) |
| "To evaluate the intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma." | 3.85 | Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017) |
| "To report the outcomes of primary trabeculectomy with mitomycin-C (MMC) in eyes with glaucoma secondary to iridocorneal endothelial (ICE) syndrome." | 3.83 | Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome. ( Chandran, P; Choudhari, NS; Garudadri, CS; Mandal, AK; Rao, HL; Senthil, S, 2016) |
| "To evaluate the short-term outcomes of lensectomy, combined with vitrectomy, scleral-fixated intraocular lens (SFIOL), and trabeculectomy with adjunctive mitomycin C (MMC) in patients with subluxated/dislocated crystalline lenses with associated elevated intraocular pressure (IOP)." | 3.83 | Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens. ( Balekudaru, S; David, RL; George, RJ; Lingam, V; Sen, P, 2016) |
| " Antimetabolites, such as mitomycin C and 5-fluorouracil, have been used for many years to increase survival time of filtration surgeries by preventing bleb fibrosis and scarring." | 3.83 | A role for antimetabolites in glaucoma tube surgery: current evidence and future directions. ( Amoozgar, B; Han, Y; Kuo, J; Lin, SC, 2016) |
| "To evaluate the outcomes of trabeculectomy with mitomycin-C (MMC) in uveitis associated with Vogt-Koyanagi-Harada disease (VKH)." | 3.83 | Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2016) |
| " In total, 120 eyes included in this study had a glaucoma diagnosis and undergone to Trab with mitomycin." | 3.83 | Additive Effect of Risk Factors for Trabeculectomy Failure in Glaucoma Patients: A Risk-group From a Cohort Study. ( Bigheti Pereira, C; Cena de Oliveira, T; Issa de Fendi, L; Pereira Bigheti, C; Viani, GA, 2016) |
| "To compare the complication rate and effectiveness of mitomycin C (MMC), Ologen alone, and Ologen with 5-fluorouracil (5-FU) as adjunctives with Ex-PRESS mini shunt for medically uncontrolled glaucoma." | 3.81 | Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil. ( Han, Y; Lowry, EA; Menda, SA; Porco, TC; Rubin, MR; Stamper, RL, 2015) |
| "A retrospective comparative case series review was performed on 31 eye surgeries in 20 patients with primary congenital glaucoma who underwent trabeculectomy or Ahmed glaucoma valve implantation after a previous failed trabeculectomy with mitomycin C." | 3.81 | Surgical results of trabeculectomy and Ahmed valve implantation following a previous failed trabeculectomy in primary congenital glaucoma patients. ( Bae, HW; Hong, S; Hong, YJ; Kim, CY; Lee, N; Ma, KT; Seong, GJ, 2015) |
| "To determine the optimum administration route of bevacizumab after glaucoma filtering surgery (GFS) and to investigate whether a reduced dose of mitomycin-C (MMC) in combination with bevacizumab could improve surgical outcome with a reduced incidence of side-effects." | 3.81 | Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery. ( Moons, L; Stalmans, I; Van Bergen, T; Vandewalle, E, 2015) |
| "To evaluate the long-term effectiveness and safety of mitomycin C (MMC)-augmented trabeculectomy undertaken within the first 2 years of life for the surgical management of glaucoma." | 3.81 | Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life. ( Bunce, C; Chiang, M; Jayaram, H; Khaw, PT; Papadopoulos, M; Pooley, F; Scawn, R; Strouthidis, NG, 2015) |
| " Data included patient demographics, pre- and postoperative intraocular pressure (IOP), use of mitomycin C (MMC), spacer device implantation, and follow-up details including surgical success rates." | 3.81 | Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. ( Anand, N; Mercieca, K; Shevade, B, 2015) |
| "To compare intraocular pressure (IOP) at one year with the InnFocus MicroShunt(®) with or without cataract surgery with according to placement and concentration of mitomycin C (MMC) DESIGN: A retrospective two-center, two-surgeon study (France and Dominican Republic)." | 3.81 | [One-year results on the safety and efficacy of the InnFocus MicroShunt™ depending on placement and concentration of mitomycin C]. ( Batlle, J; Kato, YP; Parel, JM; Pinchuk, L; Riss, I; Weber, BA, 2015) |
| "To determine if sequential treatment with Bevacizumab (Avastin), a monoclonal, VEGF antibody that blocks angiogenesis; Saratin, a 12 kD polypeptide with anti-inflammatory and anti-thrombotic properties; and Ilomastat, a matrix metalloproteinase (MMP) inhibitor, prolongs bleb life following glaucoma filtration surgery (GFS) in a rabbit model." | 3.81 | Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model. ( Levine, MA; Lukowski, ZL; Martorana, GM; Meyers, CA; Min, J; Schaefer, JL; Schultz, GS; Sherwood, MB, 2015) |
| "To compare the incidence of upper eyelid blepharoptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification surgeries and the relationship of bleb morphology to the incidence of ptosis." | 3.81 | Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification. ( Amrith, S; Chew, PT; Koh, V; Tatsios, J, 2015) |
| "To evaluate the long-term success of trabeculectomy with mitomycin C for glaucoma after vitreoretinal surgery with silicone oil insertion." | 3.80 | Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series. ( Chandra, A; Gupta, V; Kumar, S; Sihota, R; Singh, D, 2014) |
| "To compare outcomes between patients undergoing trabeculectomy with an Ex-PRESS mini glaucoma device using mitomycin-C (MMC) to those undergoing the same procedure using a subconjunctival collagen matrix implant (Ologen)." | 3.80 | Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. ( Johnson, MS; Sarkisian, SR, 2014) |
| "NPDS without implant placement and with intraoperative mitomycin C application seems to be an effective and well-tolerated method to reduce IOP with long-term effectiveness, casting doubt on the mandatory use of intrascleral implants in nonpenetrating glaucoma surgery." | 3.80 | Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use. ( González-Mesa, A; Gutiérrez-Ortíz, C; Moreno-Salgueiro, A; Pérez-Rico, C; Teus, MA, 2014) |
| "To investigate the safety and efficacy of Nd:YAG laser goniopuncture (LGP) in lowering intraocular pressure (IOP) in eyes having late bleb failure following trabeculectomy with mitomycin C administration." | 3.80 | Nd:YAG laser goniopuncture for late bleb failure after trabeculectomy with adjunctive mitomycin C. ( Alencar, LM; De Moraes, CG; Ritch, R; Susanna, R, 2014) |
| "To report the 5-year incidence of bleb-related infection after mitomycin C-augmented glaucoma filtering surgery and to investigate the risk factors for infections." | 3.80 | The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. ( Araie, M; Kuwayama, Y; Mayama, C; Ohkubo, S; Sawada, A; Sugiyama, K; Yamamoto, T, 2014) |
| "The purpose of this work was to look into the effects of infliximab on wound healing in experimental glaucoma filtration surgery and to compare the antifibrotic effects of this agent to that of mitomycin-C (MMC)." | 3.80 | Topical infliximab for the suppression of wound healing following experimental glaucoma filtration surgery. ( Akın, MM; Demir, T; Eren, K; Kobat, S; Turgut, B, 2014) |
| "To evaluate the surgical outcome of Ahmed glaucoma valve (AGV) implantation with a new technique of mitomycin C (MMC) application." | 3.80 | Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique. ( Huang, W; Wang, W; Zhang, X; Zhou, M, 2014) |
| "This retrospective case series noncomparative study included 9 eyes of 6 consecutive patients with coexistence of corneal edema resulting from Fuchs dystrophy or pseudoexfoliation keratopathy and medically uncompensated glaucoma; these patients underwent combined DSAEK and DS with mitomycin C and an absorbable collagen implant." | 3.80 | Combined deep sclerectomy and descemet stripping automated endothelial keratoplasty. ( Caramello, G; Giudiceandrea, A; Riso, M; Salgarello, T; Sammarco, MG; Vaiano, AS, 2014) |
| "To compare the effects of silver nanoparticles (AgNPs) and mitomycin C (MMC) on intraocular pressure (IOP) and external, histologic, and immunohistochemical bleb characteristics in a rabbit model of filtration surgery." | 3.79 | Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery. ( Butler, MR; Chevez-Barrios, P; Frankfort, BJ; Orengo-Nania, S; Prospero Ponce, CM; Weinstock, YE, 2013) |
| "The aim of this study is to demonstrate a drug delivery system with the capacity to adjust the release of mitomycin C (MMC), based on polymer composition, and inhibit fibroblast proliferation to a better effect than is currently used in glaucoma filtration surgery." | 3.79 | Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery. ( Merritt, SR; Velasquez, G; von Recum, HA, 2013) |
| "To evaluate the prognostic factors for surgical outcomes of subsequent trabeculectomy with mitomycin C (MMC) after prior incisional glaucoma surgery." | 3.79 | Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2013) |
| "To compare intraocular pressure (IOP) reduction after trabeculectomy with mitomycin C (MMC) in eyes that had prior clear-corneal phacoemulsification to those in a control group of phakic eyes." | 3.79 | Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes. ( Caprioli, J; Law, SK; Nouri-Mahdavi, K; Supawavej, C, 2013) |
| "To report outcomes of deep sclerectomy (DS) with intraoperative mitomycin C (MMC) application in eyes with previous failed glaucoma surgery (GS) and/or cataract extraction (CE)." | 3.78 | Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia. ( Anand, N; Wechsler, D, 2012) |
| "The purposes of this study were to investigate the effects of topically administrated Tacrolimus and Octreotide on modulation of postoperative scarring in experimental glaucoma filtration surgery and to compare the antifibrotic properties of these agents with mitomycin-C (MMC)." | 3.78 | Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery. ( Arslan, S; Aydemir, O; Dağlı, AF; Güler, M, 2012) |
| "Patients within an institutional setting who underwent trabeculectomy with mitomycin C (MMC) for uncontrolled elevated intraocular pressure (IOP) after corneal graft surgery were included." | 3.78 | Outcomes of trabeculectomy after descemet stripping automated endothelial keratoplasty: a comparison with penetrating keratoplasty. ( Boey, PY; Ho, CL; Mehta, JS; Tan, DT; Wong, TT, 2012) |
| "A total of 908 eyes of 908 glaucoma patients who had undergone mitomycin C-augmented trabeculectomy or trabeculectomy combined with phacoemulsification and intraocular lens implantation performed at 34 clinical centers." | 3.77 | Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study. ( Kuwayama, Y; Yamamoto, T, 2011) |
| "To determine the medium-term intraocular pressure (IOP) control and visual outcomes for patients with advanced glaucoma undergoing trabeculectomy with mitomycin C." | 3.77 | Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma. ( King, AJ; Stead, RE, 2011) |
| "To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery." | 3.77 | Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. ( Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H, 2011) |
| "To evaluate the efficacy of cyclodialysis-enhanced Mitomycin c (MMC) trabeculectomy in post-keratoplasty glaucoma." | 3.76 | Ab-externo cyclodialysis enhanced trabeculectomy for intractable post-penetrating keratoplasty glaucoma. ( Gupta, V; Sihota, R; Srinivasan, G, 2010) |
| "To report corneal toxicity of Mitomycin C application during filtering glaucoma surgery in two patients." | 3.76 | Corneal complications of intraoperative Mitomycin C in glaucoma surgery. ( Coppens, G; Maudgal, P, 2010) |
| "To examine the rates of intermediate-term intraocular pressure (IOP) control after trabeculectomy with adjunctive mitomycin C (MMC) and assess for associated complications." | 3.76 | Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years. ( Booth, F; Karim, R; Kubay, O; Lusthaus, JA; Wechsler, D, 2010) |
| "This study was conducted to evaluate cytotoxicity due to co-treatment with low-dose Mitomycin-C (MMC) and the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA) for glaucoma filtration surgery." | 3.76 | An experimental study of rabbit conjunctival epithelial toxicity using co-treatment with mitomycin-C and a histone deacetylase inhibitor. ( Ahn, HB; Jeung, WJ; Kim, TH; Oh, HC; Park, WC; Rho, JH; Rho, SH; Yoo, YH, 2010) |
| "The authors report two cases of mid- to long-term reversal of optic disc cupping after trabeculectomy with mitomycine-C in young adult patients suffering from secondary glaucoma." | 3.76 | Reversal of optic disc cupping with improvement of visual field and stereometric parameters after trabeculectomy in young adult patients (two case reports). ( Stalmans, A; Stalmans, I; Swinnen, S; Zeyen, T, 2010) |
| "To evaluate the safety and efficacy of deep sclerectomy with implant and mitomycin C in uveitic glaucoma." | 3.75 | Efficacy and safety of deep sclerectomy in uveitic glaucoma. ( Abu El-Asrar, AM; Al Obeidan, SA; Al-Muammar, AM; Osman, EA, 2009) |
| "Retinal hemorrhages secondary to decompression retinopathy occurred following combined trabeculotomy-trabeculectomy with mitomycine-C (MMC) in one eye of a case of congenital glaucoma and pars plana vitrectomy-lensectomy in a case of vitreous condensation secondary to pars planitis." | 3.75 | Decompression retinopathy and possible risk factors. ( Guven, D; Hasiripi, H; Kalayci, D; Karakurt, A; Saricaoglu, MS, 2009) |
| " We compare and contrast the histopathology of a normally functioning mitomycin-C trabeculectomy site obtained from an eye enucleated for iris melanoma with abnormal blebs discussed in the literature." | 3.75 | Histopathology of a functioning mitomycin-C trabeculectomy. ( Lee, GA; Liang, SY; Whitehead, K, 2009) |
| "To analyse clinical outcomes of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) with inactive uveitis and compare them to those in eyes with primary open-angle glaucoma (POAG)." | 3.75 | Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. ( Araie, M; Kaburaki, T; Kawashima, H; Koshino, T; Numaga, J; Shirato, S; Tomidokoro, A, 2009) |
| "To evaluate the effect of intraoperative mitomycin-C (MMC) on polypropylene Ahmed glaucoma valve (AGV) survival 2 years after implantation during the first 2 years of life." | 3.75 | Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C. ( Al-Mobarak, F; Khan, AO, 2009) |
| "To evaluate long-term outcomes after Ahmed valve implantation in patients with glaucoma when using adjunctive intraoperative mitomycin C (MMC) and postoperative 5-fluorouracil (5-FU)." | 3.74 | Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. ( Alvarado, JA; Hollander, DA; Juster, RP; Lee, LC, 2008) |
| "To compare the effects of variable mitomycin-C (MMC) applications during trabeculectomy on target intraocular pressure (IOP), number of antiglaucomatous therapy, bleb morphology and surgical complications." | 3.74 | Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application. ( Aktaş, Z; Hasanreisoğlu, B; Onol, M, 2008) |
| "To evaluate the safety and effectiveness of trabeculectomy with mitomycin C in the management of childhood glaucoma." | 3.74 | Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. ( Borges-Giampani, AS; Carani, JC; Giampani, J; Oltrogge, EW; Susanna, R, 2008) |
| "To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period." | 3.74 | Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007) |
| "The purpose of this study was to compare the outcomes of mitomycin C (MMC)-augmented trabeculectomy in glaucoma patients with uveitis to those without uveitis but with other high-risk characteristics." | 3.74 | Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. ( Birt, C; Derzko-Dzulynsky, L; Noble, J; Rabinovitch, T, 2007) |
| "The objective of this study was to look at the long-term safety, and the effectiveness on intraocular pressure, of trabeculectomy and mitomycin C (MMC) applied under the scleral flap." | 3.74 | Long-term results of trabeculectomy with mitomycin C applied under the scleral flap. ( Kumar, V; Kyprianou, I; Nessim, M; O'Neill, E, 2007) |
| "The aim of the study was to assess the outcomes of surgical revision with reopening of the scleral flap in eyes with failed glaucoma surgery and adjunctive mitomycin C (MMC)." | 3.74 | Surgical revision of failed filtration surgery with mitomycin C augmentation. ( Anand, N; Arora, S, 2007) |
| "To report the experience with trabeculectomy augmented with mitomycin C and 5-fluorouracil for the treatment of paediatric glaucoma." | 3.73 | Augmented trabeculectomy in paediatric glaucoma. ( Ehrlich, R; Friling, R; Gaton, DD; Lusky, M; Snir, M; Weinberger, D, 2005) |
| "To determine the preference of members of the American Glaucoma Society for the use of antifibrotic agents (mitomycin C or 5-fluorouracil or both) and glaucoma drainage devices in ten clinical settings." | 3.73 | 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. ( Feuer, WF; Joshi, AB; Parrish, RK, 2005) |
| "To investigate the comparative efficacy and safety of deep sclerectomy with and without intraoperative mitomycin C (MMC) application for lowering the intraocular pressure (IOP)." | 3.73 | Deep sclerectomy augmented with mitomycin C. ( Anand, N; Atherley, C, 2005) |
| " Eyes classified with moderate glaucoma had a 13%, 40%, and 80% success rate respectively for goniotomy, trabeculotomy, and combined trabeculotomy-trabeculectomy with mitomycin C." | 3.73 | Correlation between surgical success rate and severity of congenital glaucoma. ( Al-Hazmi, A; Al-Jadaan, I; Al-Mesfer, SA; Al-Mohammed, A; Awad, A; Zwaan, J, 2005) |
| "Combined trabeculotomy and trabeculectomy with mitomycin C was performed in the left eye for primary congenital glaucoma." | 3.73 | Macular hole and sub-hyaloid hemorrhage following filtering surgery with mitomycin C. ( Gupta, V; Sihota, R; Sony, P, 2005) |
| "To determine the long-term antiscarring effect of ilomastat treatment after experimental glaucoma filtration surgery (GFS)." | 3.73 | Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. ( Khaw, PT; Mead, AL; Wong, TT, 2005) |
| "The routine use of mitomycin C to enhance glaucomatous filtering surgery has found wide acceptance." | 3.73 | Bullous keratopathy as a complication of trabeculectomy with mitomycin C. ( Krieglstein, GK; Mietz, H; Roters, S, 2005) |
| "We studied 119 eyes of 149 patients who had undergone fornix-based trabeculectomy with mitomycin C as their primary surgery between 2000 and 2002 and in whom we could evaluate the characteristics of filtering blebs after a follow-up period of 6 months or more, and whose intraocular pressure at the evaluation time was 18 mmHg or less." | 3.73 | [Characteristics of filtering blebs after fornix-based trabeculectomy with a scleral tunnel]. ( Kano, K; Kuwayama, Y, 2005) |
| "To assess intraocular pressure (IOP) changes of the contralateral eyes of eyes undergoing trabeculectomy with mitomycin C (MMC)." | 3.73 | Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C. ( Flammer, J; Haefliger, IO; Shaarawy, T; Vysniauskiene, I, 2005) |
| "To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)." | 3.73 | Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005) |
| "Inflammation was controlled with topical steroids and the patient underwent a combined phacoemulsification and trabeculectomy with mitomycin-C for uncontrolled glaucoma." | 3.73 | Corneal honeybee sting. ( Fam, HB; Lee, JJ; Teoh, SC, 2005) |
| "In comparison with mitomycin C, neither intraoperative nor postoperative treatment with cyclosporin was associated with a decrease in intraocular pressure or prolonged bleb survival." | 3.73 | Cyclosporin as an adjunct to glaucoma filtration surgery. ( Allen, RC; Crouch, ER; Lattanzio, FA; Mitrev, PV; Williams, PB, 2005) |
| "To prospectively study the evolution of possible high risk features of conjunctival filtration blebs like avascularity, transconjunctival oozing (TCO), and leaks after mitomycin C (MMC) enhanced glaucoma surgery." | 3.73 | Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. ( Anand, N; Arora, S; Clowes, M, 2006) |
| "To determine the efficacy and safety of trabeculectomy with mitomycin-C (trabMMC) compared with that of single-site phacotrabeculectomy with mitomycin-C (phacotrabMMC) in glaucoma patients at increased risk for filtering surgery failure." | 3.73 | Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. ( Damji, KF; Hodge, WG; Murthy, SK; Pan, Y, 2006) |
| "Antimetabolites, especially mitomycin C (MMC), increase the incidence of late bleb-related endophthalmitis in trabeculectomy." | 3.73 | Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C. ( Flesner, P; Jensen, PK; Kessing, SV, 2006) |
| "The technique of mitomycin C (MMC) drug delivery and its application in glaucoma surgery are not standardized with resultant inconsistencies in the results." | 3.73 | Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels. ( Arosemena, A; Ayyala, RS; Blake, DA; Clinton, AD; Galler, KE; John, VT; Johnson, PY; Sahiner, N; Walsh, M, 2006) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 3.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery." | 3.72 | Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. ( Bagga, H; Gothwal, VK; Mandal, AK; Nanda, AK; Nutheti, R, 2003) |
| "The present findings indicate that the additional use of mitomycin C may be justified in trabeculectomies in patients with severe glaucoma." | 3.72 | Five-year results of trabeculectomy with mitomycin C. ( Beckers, HJ; Kinders, KC; Webers, CA, 2003) |
| "In this prospective interventional case series of 45 consecutive uncomplicated glaucoma patients, 45 eyes with thick Tenon's capsule underwent primary trabeculectomy with intraoperative mitomycin-C (0." | 3.72 | Effects of thick Tenon's capsule on primary trabeculectomy with mitomycin-C. ( Akarsu, C; Hasanreisoglu, B; Onol, M, 2003) |
| "Mitomycin C (MMC) used as an additive agent in glaucoma surgery has been shown to improve the postoperative results of intraocular pressure (IOP), but may also lead to higher incidences of postoperative wound healing disorders and of hypotonia with choroidal detachment." | 3.72 | [Clinical experiences and results of application of mitomycin C in trabeculectomy]. ( Hudde, T; Laube, T; Ritters, B; Selbach, M, 2003) |
| "Comparison of fornix- and limbus-based conjunctival flaps with respect to cystic bleb-related complications of trabeculectomy with high-dose mitomycin C (MMC) in pediatric and young adult glaucoma." | 3.72 | Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. ( Bunce, C; Cordeiro, MF; Khaw, PT; Wells, AP, 2003) |
| "To evaluate the results of trabeculectomy with and without the use of mitomycin C in children with primary congenital glaucoma." | 3.72 | Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C. ( de Arruda Melo, PA; Júnior, AP; Montezano, FT; Prata, J; Rodrigues, AM, 2004) |
| "To assess the outcomes of patients who had late infections after undergoing filtering surgery with mitomycin C with respect to treatment, resultant vision, and maintenance of intraocular pressure." | 3.72 | Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. ( Lehrer, RA; Muckley, ED, 2004) |
| "To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease." | 3.72 | Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004) |
| "A retrospective chart review of 44 eyes of 44 patients with uveitic glaucoma who underwent trabeculectomy with mitomycin C or 5-fluorouracil." | 3.71 | Trabeculectomy with antiproliferative agents in uveitic glaucoma. ( Beck, AD; Ceballos, EM; Lynn, MJ, 2002) |
| "The authors performed a nonrandomized retrospective review of patients who received the Molteno implant (n = 27), Krupin Eye Valve with Disc (n = 13), or Ahmed Glaucoma Valve (n = 13), with adjunctive mitomycin C." | 3.71 | Comparison of the Ahmed Glaucoma Valve, the Krupin Eye Valve with Disk, and the double-plate Molteno implant. ( Gangnon, R; Heatley, GA; Kaufman, PL; Perkins, TW; Taglia, DP, 2002) |
| "To describe the surgical technique and clinical outcomes of a procedure for refractory glaucoma, concurrent Baerveldt glaucoma implant (BGI) and trabeculectomy with mitomycin C." | 3.71 | Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. ( Budenz, DL; Bueche, M; Feuer, W; Nguyen, QH; Nicolela, MT; Palmberg, PF; Scott, IU; Singh, K, 2002) |
| "Episcleral application of mitomycin-C (MMC) during glaucoma surgery hinders the post-operative wound healing but may lead to side effects to the ciliary body." | 3.71 | Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application. ( Georgopoulos, M; Vass, C; Vatanparast, Z, 2002) |
| "To determine and compare the effectiveness of octreotide, mitomycine-C and corticosteroids on wound-healing reaction after glaucoma surgery." | 3.71 | Effects of systemic octreotide, local mytomycine-C and local corticosteroids on wound-healing reaction after glaucoma surgery. ( Akyol, N; Colakoğlu, N; Demir, T; Kükner, A, 2001) |
| "In medically uncontrolled post-traumatic angle recession glaucoma trabeculectomy with mitomycin C is an effective surgical procedure with an acceptable complication rate." | 3.71 | Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. ( Barron, A; Manners, T; Murray, AD; Salmon, JF; Willies, C, 2001) |
| "02% mitomycin C (MMC) in glaucoma patients at risk for failure of filtration surgery." | 3.71 | Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. ( Casson, R; Rahman, R; Salmon, JF, 2001) |
| "A chromatographic method, which can quantitate mitomycin C (MMC) along with two antiglaucoma drugs, is described." | 3.71 | Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography-photo-diode array detection. ( Chew, P; Lat-Luna, M; Lim, BA; Tan, D; Xiong, X, 2001) |
| "To investigate the changes of tear film functions due to the use of postoperative 5-fluourouracil (5-Fu) and intraoperative mitomycin C (MMC) in glaucoma filtration surgery." | 3.71 | [Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery]. ( Li, J; Pang, L, 2001) |
| " Trabeculectomy with mitomycin C controlled IOP on last visit in 8 of 13 eyes with aphakic glaucoma." | 3.70 | Surgical results of secondary glaucomas in childhood. ( Ellis, FD; Helveston, EM; Plager, DA; Raiesdana, A; Snyder, SK; Wallace, DK, 1998) |
| "The authors develop a simple and economical method of applying reproducible intraoperative doses of mitomycin C for glaucoma filtering surgery." | 3.70 | Half corneal light shield as a delivery system for standardized application of mitomycin C. ( Davis, D; Joos, KM; Khoury, JM; O'Day, DM; Shen, JH, 1998) |
| "Primary trabeculectomy with the use of intraoperative mitomycin lowered the IOP by 30% or more in 78% (at 2 years) to 86% (at 1 year) of the cases and is associated with a marked reduction in the percentage of patients who require glaucoma medication." | 3.70 | Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. ( Greenfield, DS; Nicolela, MT; Palmberg, PF; Rueda, JC; Schiffman, J; Scott, IU; Tsai, JC, 1998) |
| "The authors examine the intermediate-term effects of adjunctive intraoperative mitomycin C (MMC) in a cohort of patients who received double-plate Molteno implants for complicated glaucomas." | 3.70 | Molteno implant with mitomycin C: intermediate-term results. ( Gangnon, R; Kaufman, PL; Ladd, W; Libby, CM; Perkins, TW, 1998) |
| "Bleb leakage occurred in 14 eyes following trabeculectomy (mitomycin C treatment, 10 eyes; 5-fluorouracil treatment, 3 eyes; no antifibrosis agent, 1 eye) and in 1 eye following combined cataract and glaucoma surgery with adjunctive mitomycin C therapy." | 3.70 | Late-onset bleb leaks after glaucoma filtering surgery. ( Greenfield, DS; Jee, J; Liebmann, JM; Ritch, R, 1998) |
| "The authors determine if the intraoperative placement of paclitaxel powder in the subconjunctival space improves the outcome of glaucoma filtration surgery in rabbits." | 3.70 | The effect of paclitaxel powder on glaucoma filtration surgery in rabbits. ( Jampel, HD; Moon, JI, 1998) |
| "The authors investigated the safety and intraocular pressure (IOP) lowering effectiveness of trabeculectomy augmented with mitomycin C application beneath the scleral flap, and assessed the influence of preoperative risk factors on the surgical outcome." | 3.70 | Trabeculectomy augmented with mitomycin C application under the scleral flap. ( Beatty, S; Kheterpal, S; O'Neill, EC; Potamitis, T, 1998) |
| "This study aimed to compare the surgical outcomes of mitomycin C trabeculectomy glaucoma drainage device (GDD) surgery and laser neodymium:YAG (Nd:YAG) cyclophotocoagulation (CPC) in the management of intractable glaucoma after penetrating keratoplasty (PKP) in a retrospective study." | 3.70 | Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. ( Ayyala, RS; Cooper, ML; Dreyer, EB; Frangie, JP; Goldstein, MH; Mattox, C; Netland, PA; Pieroth, L; Schuman, JS; Vinals, AF; Wu, HK; Zurakowski, D, 1998) |
| "To determine whether intrascleral exposure to mitomycin-C (MMC) improves the control of intraocular pressure (IOP), increases the incidence of complications, or both." | 3.70 | Episcleral versus combined episcleral and intrascleral application of mitomycin-C in trabeculectomy. ( Menapace, R; Rainer, G; Strenn, K; Vass, C, 1998) |
| "The purpose of this study was to determine the efficacy of initial mitomycin C (MMC)-augmented trabeculectomy for uncomplicated glaucoma in young patients." | 3.70 | Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of case-matched young patients. ( Dietlein, TS; Jacobi, PC; Krieglstein, GK, 1998) |
| "The results of primary trabeculectomy with and without mitomycin C (MMC) were evaluated in young glaucoma patients." | 3.70 | The results of trabeculectomy with and without mitomycin C in young patients. ( Duman, S; Kahraman, C; Kasim, R; Nurözler, A; Yalvac, IS, 1998) |
| "Retrospective review of consecutive cases of pediatric glaucoma that underwent mitomycin C augmented trabeculectomy between January 1991 and December 1995." | 3.70 | Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. ( Beck, AD; Lynch, MG; Lynn, MJ; Noe, R; Wilson, WR, 1998) |
| "Mitomycin C trabeculectomy after dissection of conjunctival scar tissue may be useful for treating refractory glaucoma." | 3.70 | Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva. ( Honda, Y; Honjo, M; Inatani, M; Tanihara, H, 1998) |
| " Procedures for the control of glaucoma were silicone oil removal (SOR), trabeculectomy with mitomycin C, cyclocryotherapy, semiconductor diode laser contact transscleral cyclophotocoagulation (TSCPC) and anterior chamber tube shunt to encircling band (ACTSEB)." | 3.70 | Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments. ( Dandona, L; Goyal, M; Honavar, SG; Majji, AB; Naduvilath, T; Sen, PK, 1999) |
| "To evaluate corneal graft survival and intraocular pressure control in eyes that have undergone combined penetrating keratoplasty and trabeculectomy with mitomycin C (MMC)." | 3.70 | Combined penetrating keratoplasty and trabeculectomy with mitomycin C. ( Alfonso, E; Palmberg, PF; WuDunn, D, 1999) |
| "To present two cases of delayed-onset postoperative endophthalmitis following trabeculectomy combined with mitomycin C for secondary glaucoma after penetrating keratoplasty." | 3.70 | Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Akova, YA; Bulut, S; Dabil, H; Duman, S, 1999) |
| "Trabeculectomy with mitomycin C might be effective in Cogan-Reese cases with glaucoma resistant to medical treatment." | 3.70 | Clinical and histopathologic findings of iris nevus (Cogan-Reese) syndrome. ( Coşar, CB; Kural, G; Onder, F; Ozdemir, Y; Usubütün, A, 1999) |
| "To evaluate the surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma." | 3.70 | Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. ( Mandal, AK; Naduvilath, TJ; Prasad, K, 1999) |
| "The use of adjunctive antimetabolites such as 5-fluorouracil (5-FU) and mitomycin C (MMC) in trabeculectomy has caused an increased concern as to the risk of bleb-associated endophthalmitis." | 3.70 | Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents. ( Frucht-Pery, J; Solomon, A; Ticho, U, 1999) |
| "To evaluate the effectiveness and safety of trabeculectomy with mitomycin-C (MMC) in the management of childhood glaucomas." | 3.70 | Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. ( Belmonte, SJ; Liebmann, JM; Ritch, R; Sidoti, PA, 2000) |
| "Mitomycin C has improved the success rate of glaucoma filtering surgery in patients at high risk for surgical failure." | 3.70 | Midterm follow-up of necrotic bleb excision and advancement of the fornical conjunctiva. ( Ahn, DG; Hyung, SM, 1999) |
| "Retrospective analysis of all eyes that underwent phacoemulsification surgery for symptomatic cataracts and had a preoperative diagnosis of chronic hypotony (intraocular pressure [IOP] mitomycin C." | 3.70 | Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery. ( Doyle, JW; Smith, MF, 2000) |
| "To investigate the effect of trabeculectomy with and without mitomycin C in post-keratoplasty glaucoma." | 3.70 | Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. ( Fujishima, H; Ishioka, M; Shimazaki, J; Shimmura, S; Tsubota, K; Yamagami, J, 2000) |
| " Visually significant cataract developed in 5/15 re-examined eyes that underwent trabeculectomy alone (33%), possibly associated with pre-existing cataract and diagnosis of angle closure glaucoma, but not with mitomycin C use." | 3.70 | Long term results of glaucoma surgery among participants in an east African population survey. ( Buhrmann, RR; Isseme, I; Oliva, MS; Quigley, HA; Scudder, M; West, SK, 2000) |
| "A concurrent series (from January 1, 1987, to October 1, 1997) of one surgeon's consecutive 585 (456 patients) combined cataract extraction, intraocular lens implantation, and trabeculectomy surgeries, some with intraoperative mitomycin C and/or postoperative subconjunctival 5-fluorouracil." | 3.70 | Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries. ( Hahn, J; Larive, B; Rockwood, EJ, 2000) |
| "Adjunctive chemotherapy with Mitomycin C (MMC) has been used in an attempt to modulate the wound healing response in glaucoma filtration surgery." | 3.69 | Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. ( Chawla, HB; O'Brien, C; Singh, J, 1995) |
| "The effects of mitomycin-C on intraocular pressure (IOP), facility of outflow (C), and Tenon's capsule fibrosis were studied over 60 days in 10 clinically normal dogs." | 3.69 | Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs. ( Davidson, MG; Glover, TL; Nasisse, MP, 1995) |
| " In patients with lower risk for failure a reduction of concentration and application time of Mitomycin C should minimise side effects while maintaining the beneficial effect of lower intraocular pressure." | 3.69 | [Follow-up of a pilot study of trabeculectomy with low dosage mitomycin C (0.2 mg/ml for 1 minute). Independent evaluation of a retrospective nonrandomized study]. ( Annen, DJ; Stürmer, J, 1995) |
| "To determine whether there is increased risk to the corneal endothelium when mitomycin C is used in trabeculectomy surgery instead of fluorouracil, and whether these agents play a role in accelerating cataract formation." | 3.69 | Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment. ( Chaturvedi, N; Dreyer, EB; Zurakowski, D, 1995) |
| "We evaluated the effectiveness of combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C in patients with coexisting cataract and glaucoma." | 3.69 | Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C. ( Alward, WL; Munden, PM, 1995) |
| "Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation." | 3.69 | One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995) |
| "A 45-year-old male underwent a trabeculectomy with mitomycin C for a secondary glaucoma after complicated cataract surgery." | 3.69 | Occlusion of the retinal vasculature after trabeculectomy with mitomycin C. ( Greve, EL; Nuyts, RM; Van Diemen, HA, 1994) |
| "Twenty-one eyes of 21 patients with refractory glaucoma underwent glaucoma surgery involving placement of a modified Molteno implant and intraoperative application of mitomycin C." | 3.69 | Mitomycin C as adjunctive therapy with glaucoma implant surgery. ( Nicolela, MT; Susanna, R; Takahashi, WY, 1994) |
| "We prospectively investigated the postoperative intraocular pressure (IOP) level, visual prognosis, and complications of trabeculectomy with adjunctive mitomycin C in normal-tension glaucoma." | 3.69 | [Trabeculectomy for normal-tension glaucoma]. ( Ichien, M; Kitazawa, Y; Suemori-Matsushita, H; Yamamoto, T, 1994) |
| "Mitomycin C (MMC) was used as a perioperative adjunct during trabeculectomy for 51 consecutive cases of complicated glaucoma." | 3.69 | Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months. ( Krieglstein, GK; Mietz, H, 1994) |
| "In patients with uncertain prognosis for the intraocular pressure after trabeculectomy, the intraoperative application of Mitomycin C seems to improve considerably the operative success rate." | 3.69 | [Experiences with mitomycin C]. ( Flammer, J; Gaspar, AZ; Orgül, S, 1994) |
| "Intraoperative mitomycin-C application has been well accepted recently as a useful adjunctive procedure to enhance the filtering effect in glaucoma surgery." | 3.69 | Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery. ( Hsieh, JW; Hung, PT; Lin, LL; Wang, TH, 1995) |
| "To evaluate the timing, efficacy, and complications of laser suture lysis (LSL) after mitomycin C trabeculectomy in patients with glaucoma at high risk for failure of filtering surgery." | 3.69 | Laser suture lysis after mitomycin C trabeculectomy. ( Baerveldt, G; Heuer, DK; LaBree, L; Lee, PP; Minckler, DS; Morinelli, EN; Sidoti, PA, 1996) |
| "To evaluate intraocular pressure (IOP) control and surgical complications following trabeculectomy with 5-fluorouracil (5-FU) or mitomycin at the inferior limbus." | 3.69 | Trabeculectomy at the inferior limbus. ( Caronia, RM; Cohen, H; Friedman, R; Liebmann, JM; Ritch, R, 1996) |
| "To determine whether filtering blebs resulting from adjunctive use of mitomycin C (MMC) leads to an increased risk of endophthalmitis." | 3.69 | Bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Bergstrom, TJ; Higginbotham, EJ; Karp, KO; Lichter, PR; Musch, DC; Skuta, GL; Stevens, RK, 1996) |
| "To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin." | 3.69 | Endophthalmitis after filtering surgery with mitomycin. ( Flynn, HW; Greenfield, DS; Kangas, TA; Miller, MP; Palmberg, PF; Suñer, IJ, 1996) |
| "The purpose of this study was to assess the effects of intraoperative mitomycin-C (MMC) on the function of Baerveldt glaucoma implants in rabbits." | 3.69 | Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits. ( Baerveldt, G; Mermoud, A; Minckler, DS; Prata, JA, 1996) |
| "Thirteen patients with normal-tension glaucoma with a cystic filtering bleb who had undergone unilateral trabeculectomy with mitomycin C only once at least 1 year previously were subjected to the study." | 3.69 | Epithelial barrier function of the filtering bleb conjunctiva and the cornea after trabeculectomy with mitomycin C. ( Haque, MS; Kinoshita, S; Kitazawa, Y; Komuro, A; Mochizuki, K; Taniguchi, T; Yamamoto, T; Yokoi, N, 1996) |
| "An attempt was made to observe the possibility of controlling intraocular pressure (IOP) without hypotony and ocular motility disorder by installing an experimentally designed glaucoma implant through a small conjunctival incision with the aid of a stylet and maintaining the aqueous reservoir using mitomycin C (MMC)." | 3.69 | Experimentally designed glaucoma implant surgery with mitomycin C in rabbit. ( Kee, C; Youn, DH, 1995) |
| "Administration of subconjunctival 5-fluorouracil (5-FU) and topical mitomycin-C (MMC) has been shown to improve the success rate of glaucoma-filtering surgery." | 3.69 | A novel MMC-loaded pHEMA drainage device for the treatment of glaucoma: in vitro and in vivo studies. ( Akata, RF; Gökçe, M; Kiremitçi-Gümüşderelioglu, M, 1996) |
| "A 91-year-old woman with a complete rupture of her mitomycin-C filtration bleb associated with eye rubbing while crying was examined." | 3.69 | Bleb rupture following filtering surgery with mitomycin-C: clinicopathologic correlations. ( Greenfield, DS; Parrish, RK, 1996) |
| "Both large- and small-incision phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative Mitomycin-C provide good intermediate range (1 year) postoperative IOP in eyes with coexisting cataract and glaucoma." | 3.69 | Combined phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative mitomycin-C: comparison between 3.2- and 6.0-mm incisions. ( Wand, M, 1996) |
| "Combined penetrating keratoplasty and trabeculectomy with mitomycin-C should be considered for selected patients with uncontrolled glaucoma and corneal disease who have sufficient conjunctiva for a filtering procedure." | 3.69 | Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. ( Araujo, SV; Cohen, EJ; Figueiredo, RS; Katz, LJ; Rapuano, CJ; Wilson, RP, 1996) |
| "To determine the surgical outcome of mitomycin trabeculectomy in patients with refractory glaucoma." | 3.69 | Surgery for refractory glaucoma. ( Hagiwara, Y; Kitazawa, Y; Sawada, A; Yamamoto, T, 1996) |
| "The records of 157 eyes of 157 consecutive patients, aged 18 or older, who underwent mitomycin C trabeculectomies for uncontrolled glaucoma of various causes were reviewed." | 3.69 | Intermediate-term outcome of variable dose mitomycin C filtering surgery. ( Cheung, JC; Murali, S; Pederson, JE; Wright, MM, 1997) |
| " Combined phacoemulsification and mitomycin C trabeculectomy appears to be safe and effective for treating selected patients with coexisting glaucoma and cataract." | 3.69 | Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery. ( Berestka, JS; Brown, SV, 1997) |
| "Hypotony maculopathy after glaucoma filtering surgery with adjunctive mitomycin C has been reported to occur in 3% to 14% of cases." | 3.69 | Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. ( Greenfield, DS; Miller, MP; Nicolela, MT; Palmberg, PF; Suñer, IJ, 1997) |
| "To inhibit the wound healing process and to achieve a better intraocular pressure lowering effect, we applied mitomycin-C (MMC) topically in trabeculectomy at different time sequences." | 3.69 | Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma. ( Bair, JS; Chen, CW, 1997) |
| "Adjunctive intraoperative mitomycin C increases the success of glaucoma filtering surgery, but also the postoperative complications." | 3.69 | Scleritis after glaucoma filtering surgery with mitomycin C. ( Fourman, S, 1995) |
| "After trabeculectomy with mitomycin C, the filtering blebs of 117 eyes from 117 patients with various types of glaucoma were examined using ultrasound biomicroscopy." | 3.69 | An ultrasound biomicroscopic study of filtering blebs after mitomycin C trabeculectomy. ( Kitazawa, Y; Sakuma, T; Yamamoto, T, 1995) |
| "Twenty-nine consecutive eyes of 26 patients with cataract and glaucoma that had undergone combined phacoemulsification, posterior chamber lens implantation, and limbus-based trabeculectomy with mitomycin-C applied after the cataract removal and trabeculectomy had a minimal follow-up time of 12 months (mean follow-up 20 +/- 6." | 3.69 | Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure. ( Belyea, DA; Dan, JA; Lieberman, MF; Stamper, RL, 1997) |
| "The effects of mitomycin C (MMC, 1 microgram/ml for 5 min) on growth and morphology of six MMC 'sensitive' and four MMC 'resistant' human Tenon's capsule fibroblasts grown from 10 patients who had had trabeculectomy for glaucoma were studied." | 3.69 | In vitro effects of mitomycin C on human Tenon's capsule fibroblasts & correlation with surgical outcome in glaucoma patients. ( Madhavan, HN; Vijaya, L, 1997) |
| " Also, to elucidate time-dependent changes in corneal epithelium barrier function, we measured fluorescein uptake before and after trabeculectomy prospectively in the central and peripheral cornea of six glaucomatous eyes in six patients." | 3.69 | Prolonged impairment of peripheral corneal epithelium barrier function after successful trabeculectomy. ( Honda, Y; Kinoshita, S; Komuro, A; Tanihara, H; Yokoi, N, 1997) |
| "The authors studied the efficacy and complications of intraoperative mitomycin-C in glaucoma associated with ocular inflammation." | 3.69 | Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. ( McGehee, RF; Pederson, JE; Wright, MM, 1997) |
| "The purpose of the study is to determine the safety and efficacy of mitomycin C-augmented trabeculectomy in children with developmental glaucoma treated previously by conventional procedures." | 3.69 | Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. ( Jayagandan, A; John, T; Mandal, AK; Walton, DS, 1997) |
| "The precise mechanism whereby mitomycin C enhances IOP reduction in glaucoma filtering surgery still eludes us." | 3.69 | Transconjunctival application of mitomycin C in combination with laser sclerostomy ab interno: a long-term morphological study of the postoperative healing process. ( England, C; Frankhauser, F; Iliev, ME; van der Zypen, E, 1997) |
| "To evaluate the effectiveness of combined phacoemulsification and trabeculectomy with mitomycin-C with respect to visual rehabilitation and control of intraocular pressure in patients with coexisting cataract and glaucoma." | 3.69 | Combined phacoemulsification and trabeculectomy with mitomycin-C. ( Schuman, JS; Zacharia, PT, 1997) |
| "Subconjunctival mitomycin C has been used in glaucoma filtration surgery with success." | 3.69 | Transconjunctival mitomycin C as an adjunct to conventional glaucoma filtration surgery in rabbits. ( Buffenn, AN; Higginbotham, EJ; Kincaid, MC; Musch, DC; Saetre, SB, 1997) |
| "To evaluate the safety and efficacy of trabeculectomy with mitomycin-C in the management of postkeratoplasty glaucoma." | 3.69 | Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study. ( Gupta, A; Kumar, S; Ram, J; Sharma, A, 1997) |
| "The clinical appearance of cystic blebs and the incidence of bleb infection were retrospectively evaluated in 215 trabeculectomies with mitomycin C." | 3.69 | [The long-term cystic bleb appearance and safety after trabeculectomy with mitomycin C]. ( Kadowaki, H; Kuroda, S; Matsumura, M; Mizoguchi, T; Nagata, M; Terauchi, H, 1997) |
| "The purpose of the study is to assess the effect of adjunctive intraoperative mitomycin C (MMC) in Molteno drainage device implantation for patients with recalcitrant glaucomas." | 3.69 | The effect of adjunctive mitomycin C in Molteno implant surgery. ( Birt, CM; Khatana, AK; Kim, C; Kupin, TH; Lee, D; Olivier, MM; Reed, SY; Shin, DH, 1997) |
| "To evaluate the outcome of Baerveldt implantation with adjunctive mitomycin-C in cases of complicated glaucoma." | 3.69 | Simultaneous use of mitomycin-C with Baerveldt implantation. ( Azuara-Blanco, A; Moster, MR; Schmidt, CM; Wilson, RP, 1997) |
| "The study was designed to observe the effect of heterogeneous scleral transplantation in treatment of hypotony after filtration surgery of glaucoma with mitomycin C." | 3.69 | [The effect of heterogeneous scleral transplantation on hypotony after filtration surgery of glaucoma with mitomycin C]. ( Dong, Q; Yan, L; Zhang, S, 1997) |
| "We studied the efficacy and safety of using topical mitomycin C (MMC) as an adjunct to glaucoma filtration surgery." | 3.68 | Effects of topical mitomycin C on glaucoma filtration surgery. ( Hong, C; Hyung, SM; Kim, DM; Song, KY; Youn, DH, 1993) |
| "A short-term pilot study used mitomycin C at the time of trabeculectomy in a population of southern Indians with various forms of glaucoma." | 3.68 | Safety and efficacy of mitomycin C trabeculectomy in southern India. A short-term pilot study. ( Krishnadas, R; Michon, J; Ramakrishnan, R; Robin, AL, 1993) |
| "Rabbits undergoing full-thickness glaucoma filtering surgery were exposed for 5 minutes to one of three intraoperative treatments: (1) distilled water; (2) fluorouracil, 50 mg/mL; or (3) mitomycin C, 0." | 3.68 | Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. ( Doyle, JW; Grierson, I; Khaw, PT; McGorray, S; Schultz, G; Sherwood, MB, 1993) |
| "We measured aqueous flare in 16 glaucomatous eyes after trabeculectomy in which 5-fluorouracil (5-FU) or mitomycin C (MMC) had been used as an adjunctive therapy." | 3.68 | Anterior chamber reaction after mitomycin and 5-fluorouracil trabeculectomy: a comparative study. ( Jikihara, S; Kawase, K; Kitazawa, Y; Nishimura, K; Yamamoto, T, 1993) |
| "In this study, an experimental model of glaucoma filtration surgery was used to evaluate the clinical and histologic effects of a single intraoperative topical application of mitomycin C." | 3.68 | Effect of topical mitomycin C on glaucoma filtration surgery in monkeys. ( Dorman-Pease, ME; Jampel, HD; Pasquale, LR; Quigley, HA; Thibault, D, 1992) |
| " 1989 trabeculectomy with per-operative topical application of mitomycin C was performed on eyes with refractory glaucoma." | 3.68 | Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. ( Bair, JS; Chen, CW; Huang, HT; Lee, CC, 1990) |
| "Mean intraocular pressure was significantly reduced compared with baseline in both groups (P < 0." | 2.79 | Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study). ( Ahmed, II; Condon, G; Moster, MR; Netland, PA; Salim, S; Sarkisian, SR; Sherwood, MB; Siegfried, CJ, 2014) |
| "New-onset persistent diplopia was reported in 5 patients (5%) in the tube group and no patients in the trabeculectomy group at 1 year (P = ." | 2.74 | Motility disturbances in the tube versus trabeculectomy study during the first year of follow-up. ( Barton, K; Feuer, WJ; Gedde, SJ; Lee, RK; Rauscher, FM; Schiffman, JC, 2009) |
| "Mitomycin C (MMC) is an alkylating agent with extraordinary ability to crosslink DNA, preventing DNA synthesis." | 2.72 | History, presence, and future of mitomycin C in glaucoma filtration surgery. ( Al Majidi, R; Beckers, HJM; Gorgels, TGMF; Pinchuk, L; van Mechelen, RJS; Webers, CAB; Wolters, JEJ, 2021) |
| "To study the clinical effect of trabeculectomy combined with Mitomycin C and removed suture." | 2.71 | [Trabeculectomy combined with mitomycin C and removed suture in glaucoma]. ( Feng, Y, 2003) |
| "5-Fluorouracil and MMC were found to be equally safe and effective adjuncts to primary trabeculectomy in the short- and medium-term postoperative periods." | 2.69 | Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. ( Baerveldt, GS; Budenz, DL; Chen, PP; Cohen, JS; Greenfield, DS; Mehta, K; Moster, MR; Shaikh, NM; Shaikh, S; Singh, K; Tsai, JC, 2000) |
| "To determine the anticicatrization effect of mytomycin C (MMC)." | 2.68 | [The effect of mitomycin C on filtration surgery of glaucoma with poor prognosis]. ( Wu, L; Yin, J, 1996) |
| "Late postoperative complications are similar with the exception of an increased incidence of Tenon cyst formation in the MMC-treated eyes." | 2.68 | Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. ( Bergstrom, TJ; Higginbotham, EJ; Johnson, AT; Katz, GJ; Lichter, PR; Musch, DC; Skuta, GL, 1995) |
| "These include young patients, those with pigmentary glaucoma, secondary glaucoma, angle recession glaucoma, aphakic or pseudophakic glaucoma, and patients requiring reoperation." | 2.67 | Intraoperative mitomycin C in complicated glaucomas. ( Dogra, A; Kaur, J; Singh, G, 1993) |
| "The objective of this study was to evaluate the efficacy and safety of bevacizumab combined with antimetabolite as an adjunctive therapy in primary trabeculectomy for glaucoma." | 2.58 | Efficacy and Safety of Bevacizumab Combined with Mitomycin C or 5-Fluorouracil in Primary Trabeculectomy: A Meta-Analysis of Randomized Clinical Trials. ( Chen, HJ; Chen, YH; Lee, CH; Lin, C, 2018) |
| "Trabeculectomy is performed as a treatment for glaucoma to lower intraocular pressure (IOP)." | 2.53 | Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery. ( Cheng, JW; Cheng, SW; Lu, GC; Wei, RL, 2016) |
| "Raised intraocular pressure is a risk factor for glaucoma." | 2.52 | Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. ( Cabourne, E; Clarke, JC; Evans, JR; Schlottmann, PG, 2015) |
| "In cases where such treatment fails, glaucoma-filtering surgery is considered, most commonly trabeculectomy surgery with variations in technique, for example, the type of conjunctival flap (fornix- or limbal-based)." | 2.52 | Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma. ( Abdulaal, M; Al-Haddad, C; Al-Moujahed, A; Ervin, AM, 2015) |
| "The healing and scarring determine the percentage of patients achieving low final intraocular pressures (IOPs) that are associated with virtually no glaucoma progression." | 2.44 | Modulation of wound healing during and after glaucoma surgery. ( Brocchini, S; Dahlmann-Noor, A; Georgoulas, S; Khaw, PT, 2008) |
| " These specific ocular side effects are described, caution being taken to precise the strength of the association between each side effect and the related drug by using the classification of World Health Organisation (WHO) (certain, probable, possible or unlikely)." | 2.44 | [Ocular side effects of glaucoma treatment agents]. ( Bremer, F; Ehongo, A, 2007) |
| "Mitomycin C (MMC) is an antimetabolite used during the initial stages of a trabeculectomy to prevent excessive postoperative scarring and thus reduce the risk of failure." | 2.43 | Intra-operative mitomycin C for glaucoma surgery. ( Indar, A; Wilkins, M; Wormald, R, 2005) |
| "Mitomycin C is an antimetabolite applied between the sclera and conjunctiva during the initial stages of a trabeculectomy to prevent excessive post-operative scarring and thus reduce the risk of failure." | 2.41 | Intra-operative mitomycin C for glaucoma surgery. ( Indar, A; Wilkins, M; Wormald, R, 2001) |
| "The mean follow-up time after treatment for endophthalmitis was 6." | 2.41 | Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. ( Budenz, DL; Flynn, HW; Scott, IU; Song, A, 2002) |
| " New anti-glaucoma drugs, latanoprost and nipradilol, have been shown to effect a reduction in IOP equal to that achieved with the equivalent dosage of timolol, with no adverse systemic side effects." | 2.39 | [Current topics in glaucoma]. ( Masuda, K, 1996) |
| "Cataract and glaucoma are two very common conditions that frequently are coincident within the same patient." | 2.39 | Management of coincident glaucoma and cataract. ( Samuelson, TW, 1996) |
| "The use of antiscarring agents, particularly the antimetabolites 5-fluorouracil and mitomycin C, have revolutionized glaucoma surgery over the past decade." | 2.39 | Current techniques in wound healing modulation in glaucoma surgery. ( Khaw, PT; Migdal, CS, 1996) |
| "Mitomycin C seems to be a better treatment than 5 fluorouracil." | 2.38 | [Mitomycin C in glaucoma surgery]. ( Collignon-Brach, J, 1993) |
| " Outcome measures included IOP reduction from baseline, mean IOP change from baseline at month 6, medication use at 6 months, complications, adverse events, and need for further procedures." | 1.91 | Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries. ( Burgos-Blasco, B; Fernandez-Vigo, JI; García-Feijóo, J; Gines-Gallego, C; Martinez de la Casa, JM; Mendez-Hernandez, CD; Morales-Fernandez, L; Perucho-Gonzalez, L; Saenz-Frances, F, 2023) |
| "Mitomycin C (MMC) was used in 54,8% of the cases, collagen matrix (Ologen®, Aeon Astron Corporation, Taipei, Taiwan) was used alone in 8." | 1.72 | Survey of glaucoma surgical preferences among glaucoma specialists in Spain. ( Balboa Miró, M; Botella García, J; Duch, S; Loscos Arenas, J; Moreno-Montañés, J; Romera Romero, P, 2022) |
| "Inflammation-driven scarring is a major contributor to surgical failure after subconjunctival bleb forming glaucoma surgery." | 1.72 | Differential effects of acetylsalicylic acid and mitomycin C on cytokine-induced Tenon's capsule myofibroblast transdifferentiation and activity: Implications for glaucoma surgery. ( Armstrong, JJ; Hutnik, CML; Liu, H; Vinokurtseva, A, 2022) |
| "Eyes with primary open angle glaucoma (OAG), secondary OAG or pseudophakic primary angle closure glaucoma (PACG) were included." | 1.72 | Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique. ( Ang, GS; Chung, IY; Kong, YXG, 2022) |
| "Mitomycin C is a routinely used antimetabolite which effectively limits the scarring process." | 1.62 | National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK. ( Arain, UR; Khan, SA; Razzaq, MA; Whittaker, K, 2021) |
| "Choroidal detachment is a major postoperative complication of trabeculectomy." | 1.56 | Chronic chorioretinal detachment under normal intraocular pressure in eye with uveitic glaucoma after trabeculectomy: A case report. ( Abe, T; Sakurai, Y; Takayama, K; Takeuchi, M, 2020) |
| "Excessive fibrosis is the topmost factor for the defeat of surgical glaucoma drainage device (GDD) implantation." | 1.51 | Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis. ( Dong, A; Fan, P; Han, L; Shao, Z; Yuan, H; Zhou, X, 2019) |
| "For Taiwanese children, the combined trabeculotomy-trabeculectomy using the modified Safer Surgery System offered an efficient and safe surgical option for treating glaucoma with long-term satisfactory control of IOP." | 1.48 | Combined trabeculotomy-trabeculectomy using the modified Safer Surgery System augmented with MMC: its long-term outcomes of glaucoma treatment in Asian children. ( Chen, YH; Hsu, CR; Lu, DW; Tai, MC, 2018) |
| "Mitomycin C was used in 15/19 eyes." | 1.46 | Intermediate Term Outcomes of Early Posttrabeculectomy Bleb Leaks Managed by Large Diameter Soft Bandage Contact Lens. ( Garudadri, CS; Gollakota, S; Mohamed, A; Senthil, S, 2017) |
| " A single subconjunctival injection of MMP inhibitor during the experimental trabeculectomy showed a less toxic affect in the rabbit cornea, conjunctiva, and ciliary body compared to MMC." | 1.46 | Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery. ( Han, JR; Han, KE; Suh, W, 2017) |
| "Mitomycin-C was used in most cases." | 1.43 | The Long-term Outcomes of Glaucoma Drainage Device in Pediatric Glaucoma. ( Mandalos, A; Parmar, T; Sung, V; Tailor, R, 2016) |
| "Three procedures (6%) had intraoperative complications (2 iris prolapses, 1 subconjunctival hemorrhage)." | 1.43 | Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies. ( Ang, GS; Meagher, P; Wang, BZ, 2016) |
| "To report the 5-year incidence of visual impairment after mitomycin C-augmented trabeculectomy (MMC trabeculectomy) and the risk factors for visual impairment." | 1.43 | Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C. ( Araie, M; Chiba, T; Kashiwagi, K; Kogure, S; Kuwayama, Y; Mabuchi, F; Yamamoto, T, 2016) |
| "Secondary glaucoma is a serious complication in patients with transthyretin (TTR)-related familial amyloidotic polyneuropathy (FAP)." | 1.40 | Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy. ( Ando, Y; Eiki, D; Hara, R; Inoue, T; Kawaji, T; Tanihara, H, 2014) |
| "The meiboscores of the bleb-contacting upper eyelid areas were significantly higher than those for the bleb-noncontacting upper eyelid areas (P < 0." | 1.40 | Meibomian gland loss due to trabeculectomy. ( Horikiri, H; Noji, H; Ogasawara, M; Sagara, H; Sekiryu, T; Sugano, Y, 2014) |
| "Mitomycin C (MMC) was loaded into this hydrogel for controlled released to prolong the efficacy and to reduce the long-term toxicity." | 1.40 | Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery. ( Ge, J; Li, X; Liu, J; Luo, J; Quan, D; Wang, T; Xi, L; Zhao, F; Zheng, Q, 2014) |
| "Both cataract and glaucoma are significant public health problems." | 1.40 | Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy. ( Kunhammad, S; Singh, P, 2014) |
| "MMC-augmented revision appears to be a safe and useful tool in reducing intraocular pressure after trabeculectomy failure." | 1.39 | Efficacy and safety of mitomycin C--augmented revisions of non-functioning filtering blebs after trabeculectomy--7 year results. ( Kosior-Jarecka, E; Tomaszewska, J; Tulidowicz-Bielak, M; Zarnowski, T, 2013) |
| "The frequency of LT1009 dosage was determined initially using an enzyme-linked immunosorbent assay assay measuring LT1009 eye tissue retention in 6 New Zealand White rabbits." | 1.39 | Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model. ( Beattie, AR; Levine, MA; Lukowski, ZL; Meyers, CA; Min, J; Samuelson, DA; Schultz, GS; Sherwood, MB; Stoller, G, 2013) |
| " Additional postoperative treatments, such as bleb needling, and adverse events were secondary outcomes." | 1.39 | Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year. ( Aung, T; Hoh, ST; Htoon, HM; Narayanaswamy, A; Perera, SA; Seah, SK; Wong, TT, 2013) |
| "Needling revision with adjunctive MMC is effective for reviving flat filtering blebs and controlling IOP, even several years after the original trabeculectomy, and seems to be safe for the corneal endothelium." | 1.37 | Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium. ( Cronemberger, S; Diniz, AF; Ferreira, GA; Filho, AD; Maestrini, HA; Matoso, HD; Mérula, RV; Reis, JR; Sakurai, E, 2011) |
| "Congenital glaucoma is a global problem and poses a diagnostic and therapeutic challenge to the ophthalmologist." | 1.37 | Update on congenital glaucoma. ( Chakrabarti, D; Mandal, AK, 2011) |
| "In newborns with unilateral buphthalmos and presumed congenital glaucoma, the differential diagnosis should include the rare condition of orbitotemporal neurofibromatosis." | 1.37 | Childhood orbitotemporal neurofibromatosis masked by congenital glaucoma and buphthalmos. ( Boboridis, KG; Kanonidou, ED; Ziakas, NG, 2011) |
| "Filtering blebs with various types of glaucoma were examined using Stratus OCT." | 1.36 | Stratus optical coherence tomography study of filtering blebs after primary trabeculectomy with a fornix-based conjunctival flap. ( Baba, T; Hirooka, K; Shiraga, F; Takagishi, M; Takenaka, H, 2010) |
| "Bleb wall reflectivity of developing blebs on AS-OCT 2 weeks postoperatively was correlated with mature bleb function at 6-month postoperative visit." | 1.36 | Early trabeculectomy bleb walls on anterior-segment optical coherence tomography. ( Hangai, M; Hirose, F; Inoue, R; Nakanishi, H; Nakano, N; Ojima, T; Unoki, N; Yoshimura, N, 2010) |
| "Mitomycin C(MMC) was administered to 15 patients (58%) with needling being performed on 10 (38%) of these patients." | 1.36 | Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma. ( Bissig, A; Feusier, M; Mermoud, A; Roy, S, 2010) |
| "Mitomycin C was used in 12% and 0." | 1.35 | Australia and New Zealand survey of antimetabolite and steroid use in trabeculectomy surgery. ( Khaw, PT; Liu, L; Siriwardena, D, 2008) |
| "SDOCT showed the bleb cavity (23." | 1.35 | High-definition imaging of trabeculectomy blebs using spectral domain optical coherence tomography adapted for the anterior segment. ( Aquino, MC; Chew, PT; See, JL; Singh, M; Thean, LS, 2009) |
| "Thirty-one blebs of 24 patients underwent noncontact in vivo confocal microscopy using the Rostock Cornea Module of the Heidelberg Retina Tomograph II (50x noncontact Nikon lens, 1-2 mum resolution, field of view: 500x500 mum)." | 1.35 | Noncontact in vivo scanning laser microscopy of filtering blebs. ( Liebmann, JM; Palmiero, PM; Ritch, R; Sbeity, Z; Tello, C, 2009) |
| "We report a case of suprachoroidal hemorrhage following removal of a releasable suture after combined phacoemulsification-trabeculectomy." | 1.34 | Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy. ( Eong, KG; Prashanth, S; Raman, GV; Sathyan, P; Singh, G, 2007) |
| "The mean intraocular pressure was significantly decreased from 22." | 1.33 | [Clinical results of fornix-based trabeculectomy with a scleral tunnel]. ( Kano, K; Kuwayama, Y; Mizunoya, H, 2005) |
| "Twenty-four glaucoma filtering blebs in 24 eyes of 17 patients." | 1.33 | Comparison of two clinical Bleb grading systems. ( Ashraff, NN; Hall, RC; Purdie, G; Wells, AP, 2006) |
| "Each bleb was incised segmentally and the cut edges of the conjunctiva and Tenon capsule were sutured to the underlying sclera." | 1.33 | Surgical reduction of symptomatic, circumferential, filtering blebs. ( Anis, S; Liebmann, J; Ritch, R; Shihadeh, W, 2006) |
| "Mitomycin-C release was measured in vitro using spectrophotometry." | 1.33 | [Dosage and kinetics of MMC release of a collagen implant used as a delivery device in glaucoma surgery in the rabbit eye]. ( Adjadj, E; Drewe, J; Flammer, J; Mermoud, A; Roy, S; Shaarawy, T; Zimmermann, C, 2006) |
| "Two additional filtering blebs were treated with balanced saline solution (BSS), two received mitomycin-C (MMC) (0." | 1.33 | A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). ( Sherwood, MB, 2006) |
| "Mitomycin C treatment over the secondary plate alone permits removal of this plate if MMC-related complications occur without requiring removal of the whole implant." | 1.32 | Mitomycin C eliminates the short-term intraocular pressure rise found following Molteno tube implantation. ( Ellingham, RB; House, PH; Morgan, WH; Westlake, W, 2003) |
| "Glaucoma is a common eye disease associated with elevated intraocular pressure (IOP)." | 1.32 | Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension. ( Dawson, DG; Faha, B; Gleiser, J; Heatley, G; Kaufman, PL; Kiland, J; Maneval, D; Nickells, RW; Schlamp, CL; Seeman, J, 2004) |
| " The consultants were asked to estimate the number of trabeculectomies they performed per year, how often they used 5-fluorouracil (5-FU) in primary and redo surgery, their usual method of administration of 5-FU, how often they used mitomycin (MMC) in primary and redo surgery, and their usual dosage regimen of MMC." | 1.32 | National survey of antimetabolite use in glaucoma surgery in the United Kingdom. ( Edmunds, B; Khaw, PT; Siriwardena, D; Wormald, RP, 2004) |
| "In the study 6 patients with cystic blebs after trabeculectomy with mitomycin C was presented." | 1.32 | [Surgical management of pathologic filtering blebs in pediatric glaucoma]. ( Chipczyńska, B; Grałek, M; Kanigowska, K; Klimczak-Slaczka, D, 2004) |
| "We study the efficacy of treating ocular cicatricial pemphigoid (OCP) with subconjuctival mitomycin C (MMC)." | 1.31 | [Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid]. ( Celis Sánchez, J; García Largacha, M; González del Valle, F; López Ferrando, N; Ortiz de la Torre, MJ, 2002) |
| " The dosage of mitomycin-C was 0." | 1.31 | Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. ( Aslanides, IM; Augsburger, JJ; Dudley, D; Lanzl, IM; Spaeth, GL; Wilson, RP, 2000) |
| "Mitomycin C was administered intraoperatively in the dose of 0." | 1.31 | [Antimetabolites in glaucoma surgery--long-term results]. ( Ferková, S; Jakabovicová, E; Michalíková, L; Strmen, P, 2002) |
| "Mitomycin-C (MMC) has been shown to improve the surgical success of trabeculectomy; however, the advantages of MMC have been evaluated almost entirely as an adjunct to limbal-based trabeculectomy." | 1.30 | Fornix-based trabeculectomy with mitomycin-C. ( Goldenfeld, M; Levkovitch-verbin, H; Melamed, S, 1997) |
| " A dose-response effect of the concentration of MMC and IOP levels is present, suggesting that the higher concentration leads to lower IOP values." | 1.30 | Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. ( Krieglstein, GK; Mietz, H, 1998) |
| "Intraocular pressures were lower in the group that received MMC compared to the 5-FU group, but not in the group that did not receive antimetabolites, at all time intervals measured (P < ." | 1.30 | Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. ( Budenz, DL; Gordon, J; Keates, EU; Piltz-Seymour, J; Pyfer, M; Singh, K, 1999) |
| " The dose-response to 5-fluorouracil (5FU) and mitomycin C (MMC) was determined." | 1.30 | Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid. ( Gross, RL, 1999) |
| "In these eyes, intraocular pressure is between 8 and 12 mmHg." | 1.29 | Treatment of postfiltration bleb leaks with autologous blood. ( Betchkal, J; Doyle, JW; Magauran, RG; Smith, MF, 1995) |
| "Mitomycin C is a promising substance which improves substantially the prognosis of complicated cases of glaucoma." | 1.29 | [Initial experience with the use of mitomycin C in anti-glaucoma filtering surgery]. ( Liehneová, I; Rozsíval, P, 1994) |
| "Intraocular pressure was controlled successfully in 97." | 1.29 | Effects of topical mitomycin C on primary trabeculectomies and combined procedures. ( Costa, VP; Gandham, S; Moster, MR; Schmidt, CM; Smith, M; Wilson, RP, 1993) |
| "Mitomycin (0." | 1.29 | Intraoperative use of mitomycin in trabeculectomy. ( Fan, Z; Hu, Y; Mai, C; Wei, H; Zeng, S; Zhang, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 189 (27.43) | 18.2507 |
| 2000's | 194 (28.16) | 29.6817 |
| 2010's | 205 (29.75) | 24.3611 |
| 2020's | 101 (14.66) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, YL | 1 |
| Walkden, A | 1 |
| Mercieca, K | 6 |
| Kido, A | 1 |
| Akagi, T | 1 |
| Ikeda, HO | 1 |
| Kameda, T | 1 |
| Suda, K | 1 |
| Miyake, M | 1 |
| Hasegawa, T | 1 |
| Numa, S | 1 |
| Tsujikawa, A | 1 |
| Seet, LF | 1 |
| Yap, ZL | 1 |
| Chu, SWL | 2 |
| Toh, LZ | 2 |
| Ibrahim, FI | 1 |
| Teng, X | 1 |
| Wong, TT | 4 |
| Shah, C | 1 |
| Sen, P | 2 |
| Mohan, A | 1 |
| Peeush, P | 1 |
| Jain, E | 1 |
| Prasad, K | 2 |
| Sen, A | 1 |
| Tripathi, S | 1 |
| Ichhpujani, P | 1 |
| Singla, E | 1 |
| Kalra, G | 1 |
| Bhartiya, S | 1 |
| Kumar, S | 3 |
| van Mechelen, RJS | 2 |
| Wolters, JE | 1 |
| Bertens, CJF | 1 |
| Webers, CAB | 2 |
| van den Biggelaar, FJHM | 1 |
| Gorgels, TGMF | 2 |
| Beckers, HJM | 2 |
| Senthil, S | 6 |
| Rao, HL | 4 |
| Ali, MH | 1 |
| Krishnamurthy, R | 1 |
| Dikshit, S | 1 |
| Choudhari, N | 1 |
| Sastry, R | 1 |
| Garudadri, C | 2 |
| Romera Romero, P | 1 |
| Duch, S | 1 |
| Moreno-Montañés, J | 1 |
| Botella García, J | 1 |
| Balboa Miró, M | 1 |
| Loscos Arenas, J | 1 |
| Szigiato, AA | 1 |
| Touma, S | 1 |
| Jabbour, S | 1 |
| Lord, F | 1 |
| Agoumi, Y | 1 |
| Singh, H | 1 |
| Tanner, A | 1 |
| Haddad, F | 1 |
| Fajardo-Sanchez, J | 1 |
| Nguyen, E | 1 |
| Thong, KX | 1 |
| Ah-Moye, S | 1 |
| Perl, N | 1 |
| Abu-Bakra, M | 1 |
| Kulkarni, A | 1 |
| Trikha, S | 1 |
| Lascaratos, G | 1 |
| Parnell, M | 1 |
| Kailani, O | 1 |
| King, AJ | 3 |
| Agrawal, P | 1 |
| Stead, R | 1 |
| Giannouladis, K | 1 |
| Rodrigues, I | 1 |
| Goyal, S | 6 |
| Hysi, PG | 1 |
| Lim, S | 1 |
| Yu-Wai-Man, C | 1 |
| Dooling, V | 1 |
| Lappas, A | 1 |
| Dietlein, TS | 3 |
| Lee, GA | 3 |
| Liu, L | 3 |
| Casson, RJ | 2 |
| Danesh-Meyer, HV | 2 |
| Shah, P | 1 |
| Tekcan, H | 1 |
| Mangan, MS | 1 |
| Alpogan, O | 1 |
| Imamoglu, S | 1 |
| Kose, AO | 1 |
| Ercalık, NY | 1 |
| Ibarz Barberá, M | 1 |
| Martínez-Galdón, F | 1 |
| Caballero-Magro, E | 1 |
| Rodríguez-Piñero, M | 1 |
| Tañá-Rivero, P | 1 |
| Dias, DT | 1 |
| Almeida, I | 1 |
| Ushida, M | 1 |
| Lopes, FS | 1 |
| Kanadani, FN | 1 |
| Gracitelli, CPB | 1 |
| Prata, TS | 4 |
| Al-Mugheiry, TS | 1 |
| Clark, A | 1 |
| Broadway, DC | 1 |
| Mandal, AK | 7 |
| Gothwal, VK | 2 |
| Gedde, SJ | 20 |
| Feuer, WJ | 15 |
| Lim, KS | 4 |
| Barton, K | 9 |
| Ahmed, II | 3 |
| Brandt, JD | 10 |
| Saeed, E | 1 |
| Zalewska, R | 1 |
| Konopińska, J | 1 |
| Wong, MOM | 1 |
| Yu, AHY | 1 |
| Chan, CKM | 1 |
| Carré, C | 1 |
| Baudin, F | 1 |
| Buteau, B | 1 |
| Martine, L | 1 |
| Grégoire, S | 1 |
| Vasku, G | 1 |
| Berdeaux, O | 1 |
| Béduneau, A | 1 |
| Pellequer, Y | 1 |
| Jamoussi, J | 1 |
| Desrumeaux, C | 1 |
| Aho, S | 1 |
| Bron, AM | 1 |
| Acar, N | 1 |
| Creuzot-Garcher, C | 1 |
| Gabrielle, PH | 1 |
| Muñoz-Negrete, FJ | 3 |
| Aguado-Casanova, V | 1 |
| Huelin, FJ | 1 |
| Rebolleda, G | 3 |
| Helmers, G | 1 |
| Munteanu, C | 1 |
| Löw, U | 1 |
| Seitz, B | 1 |
| Fan Gaskin, JC | 1 |
| Kong, RCK | 1 |
| Shah, MH | 1 |
| Edgley, AJ | 1 |
| Peshavariya, HM | 1 |
| Chan, EC | 1 |
| Malyugin, BE | 1 |
| Sidorova, AV | 1 |
| Starostina, AV | 1 |
| Zhuravlev, AS | 1 |
| Khaletskaya, AA | 1 |
| Eliseeva, MA | 1 |
| Smirnova, EA | 1 |
| Senthilkumar, VA | 1 |
| Puthuran, GV | 1 |
| Tara, TD | 1 |
| Nagdev, N | 1 |
| Ramesh, S | 1 |
| Mani, I | 1 |
| Krishnadas, SR | 2 |
| Lee, JY | 1 |
| Wu, J | 1 |
| Liu, Y | 1 |
| Saraswathy, S | 1 |
| Zhou, L | 2 |
| Bu, Q | 1 |
| Su, Y | 1 |
| Choi, D | 1 |
| Park, E | 1 |
| Strohmaier, CA | 1 |
| Weinreb, RN | 2 |
| Hong, YK | 1 |
| Pan, X | 1 |
| Huang, AS | 1 |
| Mambo, Y | 1 |
| Higashide, T | 5 |
| Ohkubo, S | 4 |
| Udagawa, S | 1 |
| Yamashita, Y | 1 |
| Tsuchiya, S | 1 |
| Okayama, M | 1 |
| Wajima, R | 1 |
| Sugiyama, K | 6 |
| Khairy, MA | 1 |
| Kenawy, S | 1 |
| Fawzi, KM | 1 |
| Al-Nashar, HY | 1 |
| Vinokurtseva, A | 2 |
| Armstrong, JJ | 2 |
| Liu, H | 2 |
| Hutnik, CML | 2 |
| Kankainen, T | 1 |
| Harju, M | 1 |
| Mizuno, Y | 1 |
| Okada, N | 1 |
| Onoe, H | 1 |
| Tokumo, K | 1 |
| Okumichi, H | 1 |
| Hirooka, K | 3 |
| Kiuchi, Y | 4 |
| Weber, C | 3 |
| Brinken, R | 3 |
| Holz, FG | 3 |
| Cutolo, CA | 3 |
| Bonzano, C | 3 |
| Catti, C | 3 |
| Pizzorno, C | 3 |
| Bagnis, A | 3 |
| Traverso, CE | 3 |
| Iester, M | 4 |
| Gupta, VP | 3 |
| Beri, N | 3 |
| Rohatgi, J | 3 |
| Balekudaru, S | 5 |
| Shah, D | 3 |
| Lingam, V | 5 |
| George, R | 4 |
| George, AE | 4 |
| Ganesh, SK | 4 |
| Biswas, J | 5 |
| Dutta Majumder, P | 3 |
| Baskaran, M | 3 |
| Burgos-Blasco, B | 1 |
| García-Feijóo, J | 1 |
| Gines-Gallego, C | 1 |
| Perucho-Gonzalez, L | 1 |
| Fernandez-Vigo, JI | 1 |
| Martinez de la Casa, JM | 1 |
| Saenz-Frances, F | 1 |
| Morales-Fernandez, L | 1 |
| Mendez-Hernandez, CD | 1 |
| Sharma, R | 1 |
| Nappi, V | 1 |
| Empeslidis, T | 1 |
| Winuntamalakul, Y | 1 |
| Chansangpetch, S | 2 |
| Ratanawongphaibul, K | 1 |
| Itthipanichpong, R | 1 |
| Manassakorn, A | 2 |
| Tantisevi, V | 2 |
| Rojanapongpun, P | 2 |
| Vinod, K | 3 |
| Prum, BE | 2 |
| Seuthe, AM | 1 |
| Erokhina, M | 1 |
| Szurman, P | 1 |
| Haus, A | 1 |
| Lüke, JN | 1 |
| Enders, P | 1 |
| Lappa, A | 1 |
| Upaphong, P | 1 |
| Pathanapitoon, K | 1 |
| Chaidaroon, W | 1 |
| Teplitsky, JE | 1 |
| Denstedt, J | 1 |
| Yüksel, R | 1 |
| Yüksel, N | 1 |
| Yazır, Y | 1 |
| Öztürk, A | 2 |
| Furat Rençber, S | 1 |
| Demirci Küçük, K | 1 |
| Angmo, D | 1 |
| Mahalingam, K | 1 |
| Gowtham, L | 1 |
| Elancheliyan, P | 1 |
| Velpandian, T | 1 |
| Sihota, R | 9 |
| Dada, T | 3 |
| Yadgari, M | 1 |
| Ghanbarnia, MJ | 1 |
| Lee, YJ | 1 |
| Ha, A | 1 |
| Kang, D | 1 |
| Shim, SR | 1 |
| Jeoung, JW | 1 |
| Park, KH | 3 |
| Kim, YK | 1 |
| de Waard, P | 1 |
| Wubbels, RJ | 1 |
| Fang, CEH | 1 |
| Hakim, MT | 1 |
| Siddiqui, MM | 1 |
| Armstrong, D | 1 |
| Shankar, V | 2 |
| Kim, NE | 1 |
| Kim, SS | 1 |
| Lee, JS | 1 |
| Lee, K | 1 |
| Bae, HW | 2 |
| Lee, SY | 1 |
| Choi, W | 1 |
| Kim, CY | 2 |
| Ramesh, PV | 1 |
| Ramesh, SV | 1 |
| Kodnani, A | 1 |
| Velumani, V | 1 |
| Sainath, D | 1 |
| Pannerselvam, P | 1 |
| Strzalkowska, A | 1 |
| Strzalkowski, P | 2 |
| Hoffmann, EM | 5 |
| Pfeiffer, N | 4 |
| Schuster, AK | 1 |
| Sun, CQ | 1 |
| McSoley, MJ | 1 |
| Lum, F | 1 |
| Chang, TC | 1 |
| Vanner, EA | 1 |
| Seresirikachorn, K | 1 |
| Thiamthat, W | 1 |
| Annopawong, K | 1 |
| Wanichwecharungruang, B | 1 |
| Friedman, DS | 2 |
| Vu, DM | 1 |
| Hwang, SY | 1 |
| Ahn, HB | 2 |
| Jin, SW | 1 |
| Baeg, JY | 1 |
| Choi, HS | 1 |
| Lee, SH | 1 |
| Majtanova, N | 1 |
| Keri, P | 1 |
| Kriskova, P | 1 |
| Kurilova, V | 1 |
| Cholevik, D | 1 |
| Majtan, J | 1 |
| Kolar, P | 1 |
| Lenzhofer, M | 2 |
| Strohmaier, C | 1 |
| Hohensinn, M | 1 |
| Hitzl, W | 1 |
| Steiner, V | 1 |
| Baca, B | 1 |
| Moussa, S | 1 |
| Motloch, K | 1 |
| Reitsamer, HA | 1 |
| Salimi, A | 1 |
| Kovalyuk, N | 1 |
| Harasymowycz, PJ | 2 |
| Arimura, S | 1 |
| Iwasaki, K | 1 |
| Gozawa, M | 1 |
| Takamura, Y | 1 |
| Inatani, M | 4 |
| Ahmed, IIK | 3 |
| Elgin, U | 3 |
| Sen, E | 2 |
| Ozdemir, K | 1 |
| Ozdal, P | 1 |
| Berker, N | 2 |
| Nemoto, E | 1 |
| Kojima, S | 2 |
| Sugiyama, T | 1 |
| Jin, D | 1 |
| Takai, S | 1 |
| Maeda, M | 1 |
| Kohmoto, R | 1 |
| Ueki, M | 1 |
| Oku, H | 1 |
| Ikeda, T | 1 |
| Grover, DS | 4 |
| Kornmann, HL | 3 |
| Fellman, RL | 4 |
| Sakurai, Y | 1 |
| Takayama, K | 1 |
| Abe, T | 2 |
| Takeuchi, M | 1 |
| Chan, PP | 1 |
| Wong, LYN | 1 |
| Chan, TCY | 1 |
| Lai, G | 1 |
| Baig, N | 1 |
| Chu, CK | 1 |
| Liebmann, JM | 7 |
| Cioffi, GA | 2 |
| Blumberg, DM | 1 |
| Al-Aswad, LA | 1 |
| Lim, MC | 1 |
| Hom, B | 1 |
| Watnik, MR | 1 |
| Altman, AR | 1 |
| Paul, T | 1 |
| Tong, MG | 1 |
| Seth, PK | 1 |
| Sharma, S | 2 |
| Martins, TGDS | 1 |
| Halili, A | 1 |
| Kessel, L | 1 |
| Subhi, Y | 1 |
| Bach-Holm, D | 1 |
| Venkataraman, P | 1 |
| Manapakkam, M | 1 |
| Mohan, N | 1 |
| Rolim-de-Moura, C | 1 |
| Esporcatte, BLB | 1 |
| F Netto, C | 1 |
| Paranhos, A | 1 |
| de Oliveira, CM | 1 |
| Ferreira, JLM | 1 |
| Hengerer, F | 1 |
| Klabe, K | 1 |
| Schargus, M | 1 |
| Thieme, H | 1 |
| Voykov, B | 1 |
| Gagrani, M | 1 |
| Garg, I | 1 |
| Ghate, D | 2 |
| Craig, JE | 1 |
| Adachi, K | 1 |
| Asada, Y | 1 |
| Hirakata, T | 1 |
| Onoue, M | 1 |
| Iwamoto, S | 1 |
| Kasuga, T | 1 |
| Matsuda, A | 1 |
| El Maamoun, TA | 1 |
| Shalaby, HS | 2 |
| Chiu, HI | 1 |
| Su, HI | 1 |
| Ko, YC | 1 |
| Liu, CJ | 1 |
| Bedar, MS | 1 |
| Kellner, U | 1 |
| Wolters, JEJ | 1 |
| Al Majidi, R | 1 |
| Pinchuk, L | 2 |
| Klapstova, A | 1 |
| Horakova, J | 1 |
| Tunak, M | 1 |
| Shynkarenko, A | 1 |
| Erben, J | 1 |
| Hlavata, J | 1 |
| Bulir, P | 1 |
| Chvojka, J | 1 |
| Gurney, SP | 1 |
| Ahmad, M | 1 |
| Makanjuola, T | 1 |
| Ramm, L | 1 |
| Parulekar, MV | 1 |
| Khan, SA | 1 |
| Whittaker, K | 1 |
| Razzaq, MA | 1 |
| Arain, UR | 1 |
| Swogger, J | 1 |
| Conner, IP | 1 |
| Happ-Smith, C | 1 |
| Kemmerer, MC | 1 |
| Julian, DR | 1 |
| Davis, R | 1 |
| Wells, A | 1 |
| Schuman, JS | 5 |
| Yates, CC | 1 |
| Sayed, KM | 1 |
| Inobhas, A | 1 |
| Ho, DCW | 1 |
| Perera, SA | 3 |
| Hla, MH | 1 |
| Ho, CL | 3 |
| Kasar, K | 1 |
| Demir, T | 3 |
| Akin, MM | 2 |
| Gungor Kobat, S | 1 |
| Lim, FPM | 1 |
| Rattanasirivilai, P | 1 |
| Ali, ZC | 1 |
| Khoo, DI | 1 |
| Promelle, V | 1 |
| Lyons, CJ | 1 |
| Almobarak, FA | 3 |
| Alharbi, AH | 3 |
| Aljadaan, I | 3 |
| Aldhibi, H | 1 |
| Dangeti, D | 1 |
| Battula, M | 1 |
| Hashem, NH | 1 |
| Kong, YXG | 1 |
| Chung, IY | 1 |
| Ang, GS | 3 |
| Desai, R | 1 |
| Jampol, LM | 1 |
| Selvan, H | 1 |
| Azmira, K | 1 |
| Sharma, A | 2 |
| Gupta, A | 3 |
| Upadhyay, A | 1 |
| Komae, K | 1 |
| Takamoto, M | 1 |
| Tanaka, R | 1 |
| Aihara, M | 1 |
| Ohtomo, K | 1 |
| Okinaga, K | 1 |
| Matsuda, J | 1 |
| Nakahara, H | 1 |
| Fujino, Y | 1 |
| Kaburaki, T | 2 |
| Schlenker, MB | 1 |
| Gulamhusein, H | 1 |
| Conrad-Hengerer, I | 1 |
| Somers, A | 1 |
| Stalmans, I | 5 |
| Reitsamer, H | 1 |
| Hengerer, FH | 1 |
| Bayoumi, NH | 2 |
| Chong, RS | 1 |
| Lee, YS | 1 |
| Wong, TTL | 1 |
| Gollakota, S | 1 |
| Garudadri, CS | 3 |
| Mohamed, A | 1 |
| Sobeih, DH | 1 |
| Cotran, PR | 1 |
| Abe, RY | 1 |
| Shigueoka, LS | 1 |
| Vasconcellos, JPC | 1 |
| Costa, VP | 5 |
| Nikita, E | 1 |
| Murdoch, I | 1 |
| Wasielica-Poslednik, J | 1 |
| Schmeisser, J | 1 |
| Weyer-Elberich, V | 1 |
| Bell, K | 1 |
| Lorenz, K | 1 |
| Castejón, MA | 1 |
| Teus, MA | 4 |
| Bolivar, G | 1 |
| Paz-Moreno-Arrones, J | 1 |
| Castaño, B | 1 |
| Quist, MS | 1 |
| Brown, N | 1 |
| Bicket, AK | 1 |
| Herndon, LW | 6 |
| Drury, B | 1 |
| Bhargava, A | 1 |
| Fenerty, C | 1 |
| Alizadeh, R | 1 |
| Akil, H | 1 |
| Tan, J | 1 |
| Law, SK | 7 |
| Caprioli, J | 6 |
| Pimentel, E | 1 |
| Schmidt, J | 1 |
| Klezlova, A | 1 |
| Liebezeit, S | 1 |
| Prokosch-Willing, V | 2 |
| Gericke, A | 1 |
| Lamparter, J | 1 |
| Ul Hassan, SN | 1 |
| Toshev, AP | 1 |
| Shi, W | 3 |
| Brandt, J | 1 |
| Kerr, NM | 1 |
| Wang, J | 1 |
| Sandhu, A | 1 |
| Hsu, CR | 1 |
| Chen, YH | 2 |
| Tai, MC | 1 |
| Lu, DW | 1 |
| Chen, HJ | 1 |
| Lin, C | 1 |
| Lee, CH | 1 |
| Thakur, SKD | 1 |
| Fili, S | 1 |
| Seddig, S | 1 |
| Kohlhaas, M | 1 |
| Sarker, BK | 1 |
| Abdullahi, SM | 1 |
| Hassan, Z | 1 |
| Kabir, J | 1 |
| Badmus, S | 1 |
| Alam, S | 1 |
| Rahman, M | 1 |
| Malek, MI | 1 |
| Mahatma, M | 1 |
| Koike, KJ | 1 |
| Chang, PT | 1 |
| Nguyen, AH | 1 |
| Fatehi, N | 1 |
| Romero, P | 1 |
| Miraftabi, A | 1 |
| Kim, E | 1 |
| Morales, E | 1 |
| Giaconi, J | 1 |
| Coleman, AL | 2 |
| Nouri-Mahdavi, K | 3 |
| Palmberg, P | 1 |
| Rangel, HMDA | 1 |
| Rolim, HT | 1 |
| Vidigal, P | 1 |
| Araújo, ID | 1 |
| Cronemberger, S | 2 |
| Lin, S | 1 |
| Byles, D | 1 |
| Smith, M | 2 |
| Abdalrahman, O | 1 |
| Rodriguez, AE | 1 |
| Alio Del Barrio, JL | 1 |
| Alio, JL | 1 |
| Penaud, B | 1 |
| Leleu, I | 1 |
| Laplace, O | 1 |
| Akesbi, J | 1 |
| Blumen-Ohana, E | 1 |
| Nordmann, JP | 1 |
| Nishino, T | 1 |
| Sakaguchi, K | 1 |
| Yamada, Y | 1 |
| Esfandiari, H | 2 |
| Loewen, NA | 2 |
| Hassanpour, K | 2 |
| Fatourechi, A | 2 |
| Yazdani, S | 4 |
| Wang, C | 2 |
| Yaseri, M | 3 |
| Pakravan, M | 4 |
| Fang, C | 1 |
| Ma, N | 1 |
| Qian, L | 1 |
| Rajendrababu, S | 1 |
| Shroff, S | 1 |
| Patil, SV | 1 |
| Uduman, MS | 1 |
| Vardhan, A | 1 |
| Artini, W | 1 |
| Bani, AP | 1 |
| Dong, A | 1 |
| Han, L | 1 |
| Shao, Z | 1 |
| Fan, P | 1 |
| Zhou, X | 1 |
| Yuan, H | 1 |
| Waibel, S | 1 |
| Spoerl, E | 1 |
| Furashova, O | 1 |
| Pillunat, LE | 1 |
| Pillunat, KR | 1 |
| Lommatzsch, C | 1 |
| Heinz, C | 2 |
| Rothaus, K | 1 |
| Koch, JM | 1 |
| Swann, FB | 1 |
| Singh, S | 1 |
| Blake, D | 1 |
| John, V | 1 |
| Le, C | 1 |
| Fullerton, M | 1 |
| Margo, C | 1 |
| Zhang, Z | 2 |
| Muddasani, N | 1 |
| Wall, J | 1 |
| Satija, C | 1 |
| Greenberg, E | 1 |
| Mancera, N | 1 |
| Zurakowski, D | 3 |
| Ayyala, RS | 4 |
| Wlaź, A | 1 |
| Wilkos-Kuc, A | 1 |
| Rozegnał-Madej, A | 1 |
| Żarnowski, T | 3 |
| El Mazar, HM | 1 |
| Mandour, SS | 2 |
| Mostafa, MI | 1 |
| Elmorsy, OA | 1 |
| Foo, VHX | 1 |
| Htoon, HM | 2 |
| Welsbie, DS | 1 |
| Wadke, V | 1 |
| E Graf, N | 1 |
| Müller, M | 1 |
| Gerlach, F | 1 |
| M Meyer, L | 1 |
| Philipp, S | 1 |
| Distelmaier, P | 1 |
| Klink, T | 1 |
| Schönfeld, CL | 1 |
| Nakakura, S | 1 |
| Noguchi, A | 1 |
| Tanabe, H | 1 |
| Tabuchi, H | 1 |
| Asaoka, R | 1 |
| Chan, G | 1 |
| Coste-Verdier, V | 1 |
| Chan, H | 1 |
| Schweitzer, C | 1 |
| Delyfer, MN | 1 |
| Korobelnik, JF | 1 |
| Yuasa, Y | 1 |
| Sugimoto, Y | 2 |
| Anand, N | 11 |
| Bong, C | 1 |
| El Sayed, Y | 1 |
| Awadein, A | 2 |
| Singh, D | 1 |
| Chandra, A | 1 |
| Gupta, V | 3 |
| Khan, N | 1 |
| Khaleque, MA | 1 |
| Hossain, MS | 1 |
| Islam, MS | 1 |
| Uddin, MS | 1 |
| Butler, MR | 1 |
| Prospero Ponce, CM | 1 |
| Weinstock, YE | 1 |
| Orengo-Nania, S | 2 |
| Chevez-Barrios, P | 1 |
| Frankfort, BJ | 1 |
| Ono, T | 2 |
| Yuki, K | 2 |
| Ozeki, N | 1 |
| Shiba, D | 2 |
| Tsubota, K | 3 |
| Zarbin, MA | 1 |
| Liu, W | 1 |
| Xing, X | 1 |
| Liu, A | 1 |
| Ji, J | 1 |
| Merritt, SR | 1 |
| Velasquez, G | 1 |
| von Recum, HA | 1 |
| Awai-Kasaoka, N | 2 |
| Inoue, T | 5 |
| Takihara, Y | 2 |
| Ogata-Iwao, M | 2 |
| Tanihara, H | 8 |
| Eslami, Y | 1 |
| Samarai, V | 1 |
| Mohammadi, M | 1 |
| Fakhraie, G | 1 |
| Zarei, R | 1 |
| Eslami, S | 1 |
| Moghimi, S | 1 |
| Wiese, K | 1 |
| Heiligenhaus, A | 1 |
| Rao, A | 1 |
| Chatterjee, S | 1 |
| Kouyama, K | 1 |
| Netland, PA | 3 |
| Sarkisian, SR | 3 |
| Moster, MR | 7 |
| Condon, G | 1 |
| Salim, S | 2 |
| Sherwood, MB | 9 |
| Siegfried, CJ | 1 |
| Olawoye, O | 1 |
| Lee, M | 1 |
| Kuwayama, Y | 6 |
| Kee, C | 4 |
| Johnson, MS | 1 |
| De Fendi, LI | 1 |
| Arruda, GV | 1 |
| Scott, IU | 4 |
| Paula, JS | 1 |
| Pérez-Rico, C | 2 |
| Gutiérrez-Ortíz, C | 2 |
| Moreno-Salgueiro, A | 2 |
| González-Mesa, A | 2 |
| Susanna, R | 4 |
| De Moraes, CG | 4 |
| Alencar, LM | 1 |
| Ritch, R | 11 |
| Dulku, S | 2 |
| Kivelä, T | 1 |
| Kujala, E | 1 |
| Forsman, E | 1 |
| Vesti, E | 1 |
| Yamamoto, T | 11 |
| Sawada, A | 3 |
| Mayama, C | 1 |
| Araie, M | 4 |
| He, M | 1 |
| Wang, W | 2 |
| Zhang, X | 3 |
| Huang, W | 2 |
| Kwong, A | 1 |
| Kule, RR | 1 |
| Giaconi, JA | 1 |
| Saheb, H | 1 |
| Schiffman, JC | 9 |
| Leahy, K | 1 |
| Whittles, W | 1 |
| White, A | 1 |
| Yip, KP | 1 |
| Ngai, LY | 1 |
| Kumarasamy, M | 1 |
| Tulidowicz-Bielak, M | 2 |
| Tomaszewska, J | 1 |
| Kosior-Jarecka, E | 2 |
| Napoli, PE | 1 |
| Zucca, I | 1 |
| Fossarello, M | 1 |
| Ma, J | 1 |
| Li, X | 3 |
| Zhang, W | 1 |
| Huang, L | 1 |
| Chen, M | 1 |
| Xi, L | 2 |
| Duan, L | 1 |
| Quan, D | 2 |
| Ge, J | 3 |
| Kawaji, T | 1 |
| Hara, R | 1 |
| Eiki, D | 1 |
| Ando, Y | 1 |
| Turgut, B | 1 |
| Eren, K | 1 |
| Kobat, S | 1 |
| Sagara, H | 1 |
| Sekiryu, T | 1 |
| Noji, H | 1 |
| Ogasawara, M | 1 |
| Sugano, Y | 1 |
| Horikiri, H | 1 |
| Menda, SA | 1 |
| Lowry, EA | 1 |
| Porco, TC | 2 |
| Stamper, RL | 4 |
| Rubin, MR | 1 |
| Han, Y | 3 |
| Wang, T | 1 |
| Zhao, F | 1 |
| Zheng, Q | 1 |
| Luo, J | 1 |
| Liu, J | 1 |
| Zhou, M | 1 |
| Sethi, P | 1 |
| Patel, RN | 1 |
| Goldhardt, R | 1 |
| Koukkoulli, A | 1 |
| Musa, F | 1 |
| Naruo-Tsuchisaka, A | 1 |
| Maruyama, K | 1 |
| Arimoto, G | 1 |
| Goto, H | 1 |
| Mandalos, A | 1 |
| Tailor, R | 1 |
| Parmar, T | 1 |
| Sung, V | 1 |
| Gutierrez Ortiz, C | 1 |
| Vaiano, AS | 1 |
| Salgarello, T | 2 |
| Giudiceandrea, A | 1 |
| Riso, M | 1 |
| Sammarco, MG | 1 |
| Caramello, G | 1 |
| Sangtam, T | 1 |
| Mermoud, A | 8 |
| Karolina, C | 1 |
| Baril, C | 1 |
| Bourret-Massicotte, D | 1 |
| Anctil, JL | 1 |
| Caron, L | 1 |
| Goyette, A | 1 |
| Des Marchais, B | 1 |
| Rafuse, PE | 1 |
| Martín Giral, E | 1 |
| Rivera Zori, M | 1 |
| Perucho Martínez, S | 1 |
| Toledano Fernández, N | 1 |
| Nakashima, K | 1 |
| Fukushima, A | 1 |
| Hirakawa, S | 1 |
| Yun, ST | 1 |
| Chua, B | 1 |
| Clement, CI | 1 |
| Wang, X | 1 |
| El Sayed, YM | 1 |
| Arnalich-Montiel, F | 1 |
| Casado, A | 1 |
| Olayanju, JA | 1 |
| Hassan, MB | 1 |
| Hodge, DO | 1 |
| Khanna, CL | 1 |
| Lee, N | 1 |
| Ma, KT | 1 |
| Hong, S | 1 |
| Seong, GJ | 1 |
| Hong, YJ | 1 |
| Chandran, P | 1 |
| Choudhari, NS | 1 |
| Mahboobipour, H | 1 |
| Doozandeh, A | 1 |
| Ghahari, E | 1 |
| Van Bergen, T | 2 |
| Vandewalle, E | 2 |
| Moons, L | 2 |
| Kaplan, A | 1 |
| Kocatürk, T | 1 |
| Dayanır, V | 1 |
| Takahashi, N | 1 |
| Mochizuki, K | 2 |
| Katada, T | 1 |
| Jayaram, H | 1 |
| Scawn, R | 1 |
| Pooley, F | 1 |
| Chiang, M | 1 |
| Bunce, C | 4 |
| Strouthidis, NG | 1 |
| Khaw, PT | 15 |
| Papadopoulos, M | 1 |
| Shevade, B | 1 |
| Riss, I | 1 |
| Batlle, J | 1 |
| Kato, YP | 1 |
| Weber, BA | 1 |
| Parel, JM | 1 |
| Michael, KB | 1 |
| Montgomery, DM | 2 |
| Li Yim, JF | 1 |
| Martorana, GM | 1 |
| Schaefer, JL | 1 |
| Levine, MA | 3 |
| Lukowski, ZL | 3 |
| Min, J | 3 |
| Meyers, CA | 3 |
| Schultz, GS | 4 |
| Mochizuki, H | 1 |
| Scuderi, G | 1 |
| Iacovello, D | 1 |
| Pranno, F | 1 |
| Plateroti, P | 1 |
| Scuderi, L | 1 |
| Cabourne, E | 1 |
| Clarke, JC | 1 |
| Schlottmann, PG | 1 |
| Evans, JR | 1 |
| David, RL | 1 |
| George, RJ | 1 |
| Al-Haddad, C | 1 |
| Abdulaal, M | 1 |
| Al-Moujahed, A | 1 |
| Ervin, AM | 1 |
| Kinast, RM | 1 |
| Akula, KK | 1 |
| Mansberger, SL | 1 |
| Barker, GT | 1 |
| Gardiner, SK | 1 |
| Whitson, E | 1 |
| DeBarber, AE | 1 |
| Amoozgar, B | 1 |
| Lin, SC | 3 |
| Kuo, J | 1 |
| Panarelli, JF | 2 |
| Banitt, MR | 1 |
| Cheng, JW | 1 |
| Cheng, SW | 1 |
| Wei, RL | 1 |
| Lu, GC | 1 |
| Koh, V | 1 |
| Tatsios, J | 1 |
| Chew, PT | 3 |
| Amrith, S | 1 |
| Dunn, HP | 1 |
| Zheng, L | 1 |
| White, AJ | 1 |
| Healey, PR | 2 |
| Morales, J | 3 |
| Singh, P | 1 |
| Kunhammad, S | 1 |
| Huang, G | 1 |
| Sidoti, PA | 4 |
| Wang, BZ | 1 |
| Meagher, P | 1 |
| Liu, X | 2 |
| Du, L | 1 |
| Li, N | 1 |
| Kashiwagi, K | 1 |
| Kogure, S | 1 |
| Mabuchi, F | 1 |
| Chiba, T | 1 |
| Issa de Fendi, L | 1 |
| Cena de Oliveira, T | 1 |
| Bigheti Pereira, C | 1 |
| Pereira Bigheti, C | 1 |
| Viani, GA | 1 |
| Cui, QN | 1 |
| Hsia, YC | 1 |
| Rose-Nussbaumer, J | 1 |
| Mehta, N | 1 |
| Naseri, A | 1 |
| Yang, K | 1 |
| Jin, L | 1 |
| Li, L | 1 |
| Zeng, S | 3 |
| Wei, R | 1 |
| Li, G | 2 |
| Man, P | 1 |
| Congdon, N | 2 |
| Jonckx, B | 1 |
| Feyen, JH | 1 |
| Schultheiss, M | 1 |
| Schnichels, S | 1 |
| Konrad, EM | 1 |
| Bartz-Schmidt, KU | 1 |
| Zahn, G | 1 |
| Caldirola, P | 1 |
| Fsadni, MG | 1 |
| Caram-Lelham, N | 1 |
| Spitzer, MS | 1 |
| Ding, C | 1 |
| Tanna, AP | 1 |
| Rademaker, AW | 1 |
| Godfrey, DG | 1 |
| Vold, SD | 1 |
| Rosentreter, A | 1 |
| Bula, AM | 1 |
| Alnawaiseh, M | 1 |
| Rodriguez-Una, I | 1 |
| Rotchford, AP | 1 |
| Nash, DL | 1 |
| Crouch, ER | 3 |
| Suh, W | 2 |
| Han, KE | 1 |
| Han, JR | 1 |
| Minckler, DS | 5 |
| Francis, BA | 3 |
| Hodapp, EA | 1 |
| Jampel, HD | 4 |
| Samples, JR | 1 |
| Smith, SD | 1 |
| Singh, K | 7 |
| Alvarado, JA | 1 |
| Hollander, DA | 1 |
| Juster, RP | 1 |
| Lee, LC | 1 |
| Al Obeidan, SA | 1 |
| Osman, EA | 1 |
| Al-Muammar, AM | 1 |
| Abu El-Asrar, AM | 1 |
| Onol, M | 3 |
| Aktaş, Z | 1 |
| Hasanreisoğlu, B | 3 |
| Giampani, J | 1 |
| Borges-Giampani, AS | 1 |
| Carani, JC | 1 |
| Oltrogge, EW | 1 |
| Siriwardena, D | 2 |
| Georgoulas, S | 1 |
| Dahlmann-Noor, A | 1 |
| Brocchini, S | 1 |
| Palanca-Capistrano, AM | 2 |
| Hall, J | 1 |
| Cantor, LB | 2 |
| Morgan, L | 1 |
| Hoop, J | 3 |
| WuDunn, D | 3 |
| Lim, LA | 1 |
| Chindasub, P | 1 |
| Kitnarong, N | 1 |
| Kashkouli, MB | 1 |
| Parvaresh, MM | 1 |
| Mirzajani, H | 1 |
| Astaraki, A | 1 |
| Falavarjani, KG | 1 |
| Ahadian, A | 1 |
| Takagishi, M | 1 |
| Baba, T | 1 |
| Takenaka, H | 1 |
| Shiraga, F | 1 |
| Rauscher, FM | 1 |
| Lee, RK | 1 |
| Saricaoglu, MS | 2 |
| Kalayci, D | 1 |
| Guven, D | 1 |
| Karakurt, A | 2 |
| Hasiripi, H | 1 |
| Shahabi, C | 1 |
| Chin, S | 1 |
| Yoshida, K | 1 |
| Shinmei, Y | 1 |
| Aoyagi, M | 1 |
| Saito, A | 1 |
| Ohno, S | 1 |
| Lee, E | 1 |
| Doyle, E | 1 |
| Jenkins, C | 1 |
| Palmiero, PM | 2 |
| Tello, C | 3 |
| Liebmann, J | 2 |
| Khan, A | 1 |
| Hau, S | 1 |
| Okuda, T | 1 |
| Fukuhira, Y | 1 |
| Sumi, Y | 1 |
| Shimomura, M | 1 |
| Budenz, DL | 10 |
| Radcliffe, N | 1 |
| Blumenthal, EZ | 1 |
| Liang, SY | 1 |
| Whitehead, K | 1 |
| Macdonald, E | 1 |
| Mukherjee, S | 1 |
| Jay, J | 1 |
| Koshino, T | 1 |
| Kawashima, H | 1 |
| Numaga, J | 1 |
| Tomidokoro, A | 1 |
| Shirato, S | 1 |
| Al-Mobarak, F | 1 |
| Khan, AO | 1 |
| Singh, M | 1 |
| See, JL | 1 |
| Aquino, MC | 1 |
| Thean, LS | 1 |
| Elner, VM | 2 |
| Newman-Casey, PA | 1 |
| Patil, AJ | 1 |
| Flint, A | 1 |
| Moroi, SE | 2 |
| Pushparaj, V | 1 |
| Edward, DP | 1 |
| Sbeity, Z | 1 |
| Goodkin, ML | 1 |
| Grewal, DS | 1 |
| Greenfield, DS | 9 |
| Carpineto, P | 1 |
| Agnifili, L | 1 |
| Nubile, M | 1 |
| Fasanella, V | 1 |
| Doronzo, E | 1 |
| Mastropasqua, A | 1 |
| Ciancaglini, M | 1 |
| Srinivasan, G | 1 |
| Heuer, DK | 4 |
| Parrish, RK | 5 |
| Folgar, FA | 1 |
| Teng, CC | 1 |
| Nakano, N | 1 |
| Hangai, M | 2 |
| Nakanishi, H | 1 |
| Inoue, R | 1 |
| Unoki, N | 1 |
| Hirose, F | 1 |
| Ojima, T | 1 |
| Yoshimura, N | 1 |
| Breusegem, C | 1 |
| Spielberg, L | 1 |
| Van Ginderdeuren, R | 1 |
| Renier, C | 1 |
| Van de Veire, S | 1 |
| Fieuws, S | 1 |
| Zeyen, T | 2 |
| Mahdy, RA | 1 |
| Nada, WM | 1 |
| Almasalamy, SM | 1 |
| Anany, HA | 1 |
| Almasary, AM | 1 |
| Coppens, G | 1 |
| Maudgal, P | 1 |
| Crowston, JG | 1 |
| Wells, AP | 3 |
| Bissig, A | 1 |
| Feusier, M | 1 |
| Roy, S | 2 |
| Lusthaus, JA | 1 |
| Kubay, O | 1 |
| Karim, R | 1 |
| Wechsler, D | 3 |
| Booth, F | 1 |
| Razeghinejad, MR | 1 |
| Nowroozzadeh, MH | 1 |
| Emarah, AM | 1 |
| El-Helw, MA | 1 |
| Kim, TH | 2 |
| Oh, HC | 1 |
| Yoo, YH | 2 |
| Rho, JH | 2 |
| Park, WC | 2 |
| Jeung, WJ | 1 |
| Rho, SH | 2 |
| Balikoglu-Yilmaz, M | 1 |
| Bozdag-Pehlivan, S | 1 |
| Sungu, N | 1 |
| Aksakal, FN | 1 |
| Altinok, A | 1 |
| Tuna, T | 1 |
| Unlu, N | 1 |
| Ustun, H | 1 |
| Koklu, G | 1 |
| Öztürk, F | 1 |
| Maestrini, HA | 1 |
| Matoso, HD | 1 |
| Reis, JR | 1 |
| Mérula, RV | 1 |
| Filho, AD | 1 |
| Diniz, AF | 1 |
| Sakurai, E | 1 |
| Ferreira, GA | 1 |
| Ye, H | 1 |
| Qian, Y | 1 |
| Lin, M | 1 |
| Duan, Y | 1 |
| Sun, X | 1 |
| Zhuo, Y | 1 |
| Chakrabarti, D | 1 |
| Stead, RE | 1 |
| Knape, RM | 1 |
| Smith, MF | 6 |
| Bochmann, F | 1 |
| Kaufmann, C | 1 |
| Becht, CN | 1 |
| Guber, I | 1 |
| Kaiser, M | 1 |
| Bachmann, LM | 1 |
| Thiel, MA | 1 |
| Swinnen, S | 1 |
| Stalmans, A | 1 |
| Zhong, H | 1 |
| Sun, G | 1 |
| Lin, X | 1 |
| Wu, K | 1 |
| Yu, M | 1 |
| Supawavej, C | 1 |
| Ziakas, NG | 1 |
| Kanonidou, ED | 1 |
| Boboridis, KG | 1 |
| Hong, B | 1 |
| Winarko, J | 1 |
| Kawji, S | 1 |
| Dustin, L | 1 |
| Chopra, V | 1 |
| Cillino, S | 2 |
| Di Pace, F | 2 |
| Cillino, G | 1 |
| Casuccio, A | 2 |
| Beattie, AR | 2 |
| Stoller, G | 1 |
| Samuelson, DA | 2 |
| Levkovitch-Verbin, H | 3 |
| Katz, G | 1 |
| Kalev-Landoi, M | 1 |
| Goldenfeld, M | 2 |
| Cankaya, AB | 1 |
| Rai, P | 1 |
| Kotecha, A | 1 |
| Kaltsos, K | 1 |
| Ruddle, JB | 1 |
| Murdoch, IE | 2 |
| Arslan, S | 1 |
| Aydemir, O | 1 |
| Güler, M | 1 |
| Dağlı, AF | 1 |
| Boey, PY | 1 |
| Mehta, JS | 2 |
| Tan, DT | 1 |
| SooHoo, JR | 1 |
| Seibold, LK | 1 |
| Laing, AE | 1 |
| Kahook, MY | 1 |
| Stahnke, T | 1 |
| Löbler, M | 1 |
| Kastner, C | 1 |
| Stachs, O | 1 |
| Wree, A | 1 |
| Sternberg, K | 1 |
| Schmitz, KP | 1 |
| Guthoff, R | 1 |
| Bae, K | 1 |
| Yang, J | 1 |
| Sun, P | 1 |
| Zhang, Y | 1 |
| Sun, N | 1 |
| Marey, HM | 1 |
| Ellakwa, AF | 1 |
| Sponsel, WE | 1 |
| Groth, SL | 1 |
| de Klerk, TA | 1 |
| Moriarty, AP | 1 |
| Min, JK | 1 |
| Kee, CW | 1 |
| Sohn, SW | 1 |
| Lee, HJ | 1 |
| Woo, JM | 2 |
| Yim, JH | 1 |
| Narayanaswamy, A | 1 |
| Hoh, ST | 1 |
| Seah, SK | 2 |
| Aung, T | 1 |
| Biteli, LG | 1 |
| Ceballos, EM | 1 |
| Beck, AD | 4 |
| Lynn, MJ | 2 |
| Taglia, DP | 1 |
| Perkins, TW | 5 |
| Gangnon, R | 3 |
| Heatley, GA | 3 |
| Kaufman, PL | 5 |
| Jiang, B | 1 |
| Jiang, YQ | 1 |
| Celis Sánchez, J | 1 |
| López Ferrando, N | 1 |
| García Largacha, M | 1 |
| González del Valle, F | 1 |
| Ortiz de la Torre, MJ | 1 |
| Ravinet, E | 1 |
| Krommes, G | 1 |
| Lieb, W | 1 |
| Grehn, F | 2 |
| Price, FW | 1 |
| Nguyen, QH | 2 |
| Feuer, W | 1 |
| Nicolela, MT | 4 |
| Bueche, M | 1 |
| Palmberg, PF | 7 |
| Alvi, NP | 1 |
| Finley, C | 1 |
| Lakhani, V | 1 |
| Burnstein, A | 1 |
| Knotts, SL | 1 |
| Lubomski, LH | 1 |
| Kempen, JH | 1 |
| Quigley, H | 1 |
| Robinson, KA | 1 |
| Bass, EB | 1 |
| Kim, C | 2 |
| Kim, Y | 1 |
| Choi, S | 1 |
| Lee, S | 1 |
| Ahn, B | 1 |
| Bagga, H | 1 |
| Nutheti, R | 1 |
| Nanda, AK | 1 |
| Peng, D | 1 |
| Zheng, J | 1 |
| Beckers, HJ | 1 |
| Kinders, KC | 1 |
| Webers, CA | 2 |
| Ng, PW | 2 |
| Yeung, BY | 2 |
| Yick, DW | 2 |
| Tsang, CW | 1 |
| Lam, DS | 3 |
| Georgopoulos, M | 3 |
| Vass, C | 4 |
| Vatanparast, Z | 2 |
| Jordan, JF | 1 |
| Mac, I | 1 |
| Soltau, JB | 1 |
| Hill, R | 1 |
| Ohanesian, R | 1 |
| Voskanyan, L | 1 |
| Malayan, A | 1 |
| Akarsu, C | 2 |
| Ellingham, RB | 1 |
| Morgan, WH | 1 |
| Westlake, W | 1 |
| House, PH | 1 |
| Feng, Y | 1 |
| Duan, X | 1 |
| Jiang, Y | 2 |
| Qing, G | 1 |
| Fu, P | 1 |
| Li, M | 1 |
| Akyol, N | 1 |
| Kükner, A | 1 |
| Colakoğlu, N | 1 |
| Laube, T | 1 |
| Ritters, B | 1 |
| Selbach, M | 1 |
| Hudde, T | 1 |
| Cordeiro, MF | 2 |
| Fagerli, M | 1 |
| Løfors, KT | 1 |
| Elsås, T | 1 |
| Willoch, CM | 1 |
| Nicolaissen, B | 1 |
| Hirata, A | 1 |
| Kimura, A | 1 |
| Sonoda, S | 1 |
| Freedman, S | 2 |
| Kammer, J | 1 |
| Jin, J | 1 |
| Shin, DB | 1 |
| Lee, SB | 1 |
| Kim, CS | 1 |
| Higginbotham, EJ | 5 |
| Yoon, KC | 2 |
| Yang, KJ | 2 |
| Seo, JS | 1 |
| Lee, SE | 1 |
| Heo, T | 1 |
| Chun, BJ | 1 |
| Jung, S | 1 |
| Kim, KK | 1 |
| Ahn, KY | 1 |
| Heatley, G | 2 |
| Kiland, J | 1 |
| Faha, B | 1 |
| Seeman, J | 1 |
| Schlamp, CL | 1 |
| Dawson, DG | 1 |
| Gleiser, J | 1 |
| Maneval, D | 1 |
| Nickells, RW | 1 |
| Yoon, PS | 1 |
| Seo, MS | 1 |
| Park, YG | 1 |
| Rodrigues, AM | 1 |
| Júnior, AP | 1 |
| Montezano, FT | 1 |
| de Arruda Melo, PA | 1 |
| Prata, J | 1 |
| Oyakhire, JO | 1 |
| Azuara-Blanco, A | 5 |
| Lesk, MR | 2 |
| Arcieri, ES | 1 |
| Oguz, H | 2 |
| Hooi, ST | 1 |
| Hooi, SH | 1 |
| Fraser, S | 1 |
| Edmunds, B | 1 |
| Wormald, RP | 1 |
| Muckley, ED | 1 |
| Lehrer, RA | 1 |
| Alwitry, A | 1 |
| Patel, V | 1 |
| King, AW | 1 |
| Zaleska-Zmijewska, A | 2 |
| Szaflik, J | 2 |
| Klimczak-Slaczka, D | 1 |
| Grałek, M | 1 |
| Chipczyńska, B | 1 |
| Kanigowska, K | 1 |
| Grigorian, AP | 1 |
| Spaeth, G | 1 |
| Yalvac, IS | 2 |
| Sungur, G | 1 |
| Turhan, E | 1 |
| Eksioglu, U | 1 |
| Duman, S | 3 |
| Alzafiri, Y | 1 |
| Harasymowycz, P | 1 |
| Shetty, RK | 1 |
| Wartluft, L | 1 |
| Ehrlich, R | 1 |
| Snir, M | 1 |
| Lusky, M | 1 |
| Weinberger, D | 1 |
| Friling, R | 1 |
| Gaton, DD | 1 |
| Du, LT | 1 |
| Najafi, K | 1 |
| Murthy, R | 1 |
| Kurumety, U | 1 |
| Rao, N | 1 |
| Joshi, AB | 1 |
| Feuer, WF | 1 |
| Atherley, C | 1 |
| Kano, K | 2 |
| Mizunoya, H | 1 |
| Al-Hazmi, A | 1 |
| Awad, A | 1 |
| Zwaan, J | 2 |
| Al-Mesfer, SA | 1 |
| Al-Jadaan, I | 1 |
| Al-Mohammed, A | 1 |
| Sony, P | 1 |
| Maquet, JA | 1 |
| Dios, E | 1 |
| Aragón, J | 1 |
| Bailez, C | 1 |
| Ussa, F | 1 |
| Laguna, N | 1 |
| Collignon, NJ | 1 |
| Watson, JC | 1 |
| Kadri, OA | 1 |
| Wilcox, MJ | 1 |
| Agarwal, HC | 4 |
| Saigal, D | 1 |
| Mead, AL | 1 |
| Funnell, CL | 1 |
| Clowes, M | 2 |
| Mietz, H | 11 |
| Roters, S | 1 |
| Krieglstein, GK | 12 |
| Vysniauskiene, I | 1 |
| Shaarawy, T | 3 |
| Flammer, J | 4 |
| Haefliger, IO | 1 |
| Mansury, AM | 1 |
| Vasudev, D | 1 |
| Detry-Morel, M | 1 |
| Pourjavan, S | 1 |
| Teoh, SC | 1 |
| Lee, JJ | 2 |
| Fam, HB | 1 |
| Sengun, A | 1 |
| Colluoglu, Z | 1 |
| Novak-Laus, K | 1 |
| Mandić, Z | 1 |
| Iveković, R | 1 |
| Korsić, J | 1 |
| Tedeschi-Reiner, E | 1 |
| Masnec-Paskvalin, S | 1 |
| Bojić, L | 1 |
| Modjtahedi, SP | 1 |
| Mansury, A | 1 |
| Wilkins, M | 2 |
| Indar, A | 2 |
| Wormald, R | 3 |
| Lattanzio, FA | 1 |
| Mitrev, PV | 1 |
| Williams, PB | 1 |
| Allen, RC | 1 |
| Polikoff, LA | 1 |
| Taglienti, A | 1 |
| Chanis, RA | 1 |
| Ramos-Esteban, JC | 1 |
| Donas, N | 1 |
| Tsong, J | 1 |
| Gagliuso, DJ | 1 |
| Danias, J | 1 |
| Serle, JB | 1 |
| Ashraff, NN | 1 |
| Hall, RC | 1 |
| Purdie, G | 1 |
| Arora, S | 2 |
| Lin, YC | 1 |
| Kau, HC | 1 |
| Kao, SC | 1 |
| Hsu, WM | 1 |
| Tsai, CC | 1 |
| Leung, DY | 1 |
| Kwong, YY | 1 |
| Yuen, HK | 1 |
| Murthy, SK | 1 |
| Damji, KF | 1 |
| Pan, Y | 1 |
| Hodge, WG | 1 |
| Abraham, LM | 1 |
| Selva, D | 1 |
| Casson, R | 2 |
| Leibovitch, I | 1 |
| Kessing, SV | 1 |
| Flesner, P | 1 |
| Jensen, PK | 1 |
| Cabarga, C | 1 |
| Shingleton, BJ | 3 |
| Price, RS | 1 |
| O'Donoghue, MW | 2 |
| Anis, S | 1 |
| Shihadeh, W | 1 |
| Mansouri, K | 1 |
| Wedrich, A | 1 |
| Blake, DA | 1 |
| Sahiner, N | 1 |
| John, VT | 1 |
| Clinton, AD | 1 |
| Galler, KE | 1 |
| Walsh, M | 1 |
| Arosemena, A | 1 |
| Johnson, PY | 1 |
| Kasner, O | 1 |
| Park, UC | 1 |
| Ahn, JK | 1 |
| Yu, HG | 1 |
| Ben Simon, GJ | 1 |
| Glovinsky, Y | 1 |
| Maurino, V | 2 |
| Patel, H | 1 |
| Kirwin, J | 1 |
| Adjadj, E | 1 |
| Zimmermann, C | 1 |
| Drewe, J | 1 |
| Zheng, K | 1 |
| Huang, Z | 1 |
| Zou, H | 1 |
| Li, H | 1 |
| Huang, Y | 1 |
| Xie, M | 1 |
| Wang, L | 1 |
| Zhang, P | 1 |
| Lin, J | 1 |
| Jamil, AL | 1 |
| Mills, RP | 1 |
| Cabarga del Nozal, C | 1 |
| Batman, A | 1 |
| Soykan, E | 1 |
| Chakraborty, D | 1 |
| Dutta Choudhury, B | 1 |
| Goldberg, I | 1 |
| Noble, J | 1 |
| Derzko-Dzulynsky, L | 1 |
| Rabinovitch, T | 1 |
| Birt, C | 1 |
| Ramamurthi, S | 1 |
| Girma, T | 1 |
| Courtright, P | 1 |
| Mengistu, F | 1 |
| Tamirat, T | 1 |
| Birhanu, Z | 1 |
| Anand, S | 1 |
| Dubey, S | 1 |
| Agarwal, M | 1 |
| Sathyan, P | 2 |
| Singh, G | 2 |
| Eong, KG | 1 |
| Raman, GV | 1 |
| Prashanth, S | 1 |
| Kyprianou, I | 1 |
| Nessim, M | 1 |
| Kumar, V | 1 |
| O'Neill, E | 1 |
| Labbé, A | 1 |
| Khammari, C | 1 |
| Baudouin, C | 1 |
| Ehongo, A | 1 |
| Bremer, F | 1 |
| Herndon, L | 1 |
| Smiddy, W | 1 |
| Zeppa, L | 1 |
| Morreale, D | 1 |
| Bocchetta, F | 1 |
| Lodato, G | 1 |
| Mohammadpour, M | 1 |
| Jabbarvand, M | 1 |
| Javadi, MA | 1 |
| Leszczyński, R | 1 |
| Gierek-Ciaciura, S | 1 |
| Forminśka-Kapuścik, M | 1 |
| Mrukwa-Kominek, E | 1 |
| Rokita-Wala, I | 1 |
| Wishart, PK | 1 |
| Kim, SW | 1 |
| Lee, DJ | 1 |
| Park, JM | 1 |
| Jeong, WJ | 1 |
| Singh, J | 1 |
| O'Brien, C | 1 |
| Chawla, HB | 1 |
| Diestelhorst, M | 5 |
| Glover, TL | 1 |
| Nasisse, MP | 1 |
| Davidson, MG | 1 |
| Annen, DJ | 1 |
| Stürmer, J | 1 |
| Dreyer, EB | 2 |
| Chaturvedi, N | 1 |
| Bazin, S | 1 |
| Williamson, W | 1 |
| Poirier, L | 1 |
| Ducousso, F | 1 |
| Ballion, JC | 1 |
| Verin, P | 1 |
| Magauran, RG | 1 |
| Betchkal, J | 1 |
| Doyle, JW | 6 |
| Gray, TB | 1 |
| Munden, PM | 1 |
| Alward, WL | 4 |
| Joos, KM | 2 |
| Bueche, MJ | 1 |
| Grajewski, AL | 1 |
| Mégevand, GS | 1 |
| Salmon, JF | 5 |
| Scholtz, RP | 1 |
| Murray, AD | 4 |
| Cardakli, UF | 1 |
| Eisele, JR | 1 |
| Nuyts, RM | 2 |
| Van Diemen, HA | 1 |
| Greve, EL | 2 |
| Lee, DA | 3 |
| Takahashi, WY | 1 |
| Duker, JS | 1 |
| Shin, DH | 2 |
| Tsai, CS | 1 |
| Kupin, TH | 2 |
| Olivier, MM | 2 |
| Ichien, M | 1 |
| Suemori-Matsushita, H | 1 |
| Kitazawa, Y | 6 |
| Gaspar, AZ | 2 |
| Orgül, S | 1 |
| Felten, PC | 1 |
| Pels, E | 1 |
| Langerhorst, CT | 1 |
| Geijssen, HC | 1 |
| Grossniklaus, HE | 1 |
| Rozsíval, P | 1 |
| Liehneová, I | 1 |
| Karp, CL | 1 |
| Griffin, EO | 1 |
| Choi, WS | 1 |
| Park, SJ | 1 |
| Kim, DM | 2 |
| Haynes, WL | 2 |
| McKinney, JK | 1 |
| Collignon-Brach, J | 1 |
| Hong, C | 1 |
| Hyung, SM | 4 |
| Song, KY | 1 |
| Youn, DH | 3 |
| Ramakrishnan, R | 1 |
| Michon, J | 1 |
| Robin, AL | 2 |
| Krishnadas, R | 1 |
| Shields, MB | 2 |
| Scroggs, MW | 1 |
| Sloop, CM | 1 |
| Simmons, RB | 2 |
| Skuta, GL | 4 |
| Wand, M | 2 |
| Sood, NN | 2 |
| Kaur, J | 1 |
| Dogra, A | 1 |
| Wilson, RP | 6 |
| Schmidt, CM | 5 |
| Gandham, S | 1 |
| Prata, JA | 2 |
| Koda, RT | 1 |
| Baerveldt, G | 3 |
| Lee, PP | 2 |
| Wise, JB | 1 |
| Pappa, KS | 1 |
| Derick, RJ | 2 |
| Weber, PA | 1 |
| Kapetansky, FM | 1 |
| Baker, ND | 2 |
| Lehmann, DM | 1 |
| Zacharia, PT | 3 |
| Deppermann, SR | 1 |
| Bank, A | 1 |
| Allingham, RR | 2 |
| Sarraf, D | 1 |
| Eezzuduemhoi, RD | 1 |
| Cheng, Q | 2 |
| Wilson, MR | 1 |
| Grierson, I | 2 |
| Schultz, G | 1 |
| McGorray, S | 3 |
| Kawase, K | 1 |
| Nishimura, K | 1 |
| Jikihara, S | 1 |
| Keller, C | 1 |
| To, K | 1 |
| Spaeth, GL | 5 |
| Eiferman, RA | 1 |
| Barron, A | 2 |
| Straker, C | 1 |
| Hung, PT | 1 |
| Lin, LL | 1 |
| Hsieh, JW | 1 |
| Wang, TH | 1 |
| Morinelli, EN | 1 |
| LaBree, L | 1 |
| Rump, AF | 2 |
| Biederbick, W | 1 |
| Botvinik-Helling, S | 1 |
| Stemmler, M | 1 |
| Schierholz, J | 1 |
| Conrady, S | 1 |
| Matthey, B | 1 |
| Theisohn, M | 2 |
| Gelber, EC | 1 |
| Caronia, RM | 1 |
| Friedman, R | 1 |
| Cohen, H | 1 |
| Stevens, RK | 1 |
| Musch, DC | 3 |
| Karp, KO | 1 |
| Lichter, PR | 2 |
| Bergstrom, TJ | 3 |
| Katz, LJ | 2 |
| Miller, MP | 3 |
| Suner, IJ | 3 |
| Kangas, TA | 1 |
| Flynn, HW | 2 |
| Merkli, A | 1 |
| Heller, J | 1 |
| Tabatabay, C | 1 |
| Gurny, R | 1 |
| Arnold, G | 1 |
| Kirchhof, B | 1 |
| Choi, MY | 2 |
| Wu, L | 1 |
| Yin, J | 1 |
| Zhang, M | 1 |
| Wei, H | 1 |
| Mai, C | 1 |
| Fan, Z | 1 |
| Hu, Y | 2 |
| Comegno, PE | 1 |
| Vasconcelos, JP | 1 |
| Malta, RF | 1 |
| José, NK | 1 |
| Taniguchi, T | 1 |
| Haque, MS | 1 |
| Yokoi, N | 2 |
| Komuro, A | 2 |
| Kinoshita, S | 2 |
| Kiremitçi-Gümüşderelioglu, M | 1 |
| Gökçe, M | 1 |
| Akata, RF | 1 |
| Hendrickson, P | 1 |
| Gebhardt, DO | 1 |
| Figueiredo, RS | 1 |
| Araujo, SV | 1 |
| Cohen, EJ | 1 |
| Rapuano, CJ | 1 |
| Cohen, JS | 2 |
| Greff, LJ | 1 |
| Novack, GD | 1 |
| Wind, BE | 1 |
| Mardelli, PG | 1 |
| Lederer, CM | 1 |
| Murray, PL | 1 |
| Pastor, SA | 1 |
| Hassanein, KM | 1 |
| Hagiwara, Y | 1 |
| Cheung, JC | 1 |
| Wright, MM | 2 |
| Murali, S | 1 |
| Pederson, JE | 2 |
| Masuda, K | 1 |
| Berestka, JS | 1 |
| Brown, SV | 1 |
| Bair, JS | 2 |
| Chen, CW | 2 |
| Katz, GJ | 1 |
| Johnson, AT | 1 |
| Fourman, S | 1 |
| Sakuma, T | 1 |
| Belyea, DA | 2 |
| Dan, JA | 2 |
| Lieberman, MF | 2 |
| Mehel, E | 2 |
| Weber, M | 2 |
| Stork Vabres, L | 1 |
| Pechereau, A | 2 |
| Carlson, DW | 1 |
| Barad, JP | 1 |
| Zimmerman, MB | 1 |
| Carney, BL | 1 |
| Vijaya, L | 1 |
| Madhavan, HN | 1 |
| Honda, Y | 3 |
| Matsuda, T | 1 |
| Chihara, E | 1 |
| McGehee, RF | 1 |
| Walton, DS | 1 |
| John, T | 1 |
| Jayagandan, A | 1 |
| Spencer, WH | 1 |
| Constable, PH | 1 |
| Alexander, RA | 1 |
| Bhattacharya, SS | 1 |
| Tezel, G | 2 |
| Kolker, AE | 2 |
| Kass, MA | 2 |
| Wax, MB | 2 |
| Gupta, N | 1 |
| Kang, SW | 1 |
| Iliev, ME | 1 |
| van der Zypen, E | 1 |
| Frankhauser, F | 1 |
| England, C | 1 |
| Nuijts, RM | 1 |
| Vernimmen, RC | 1 |
| Buffenn, AN | 1 |
| Saetre, SB | 1 |
| Kincaid, MC | 1 |
| Bond, JB | 1 |
| Melamed, S | 1 |
| Ram, J | 1 |
| Mizoguchi, T | 1 |
| Matsumura, M | 1 |
| Kadowaki, H | 1 |
| Kuroda, S | 1 |
| Terauchi, H | 1 |
| Nagata, M | 1 |
| Lee, D | 1 |
| Birt, CM | 1 |
| Khatana, AK | 1 |
| Reed, SY | 1 |
| Waheed, S | 1 |
| Ritterband, DC | 1 |
| Sanga, L | 1 |
| Honavar, SG | 2 |
| Kasahara, N | 1 |
| Smith, TJ | 1 |
| Sibayan, SA | 1 |
| Montenegro, MH | 1 |
| Simmons, RJ | 1 |
| Klaus, W | 1 |
| Wallace, DK | 1 |
| Plager, DA | 1 |
| Snyder, SK | 1 |
| Raiesdana, A | 1 |
| Helveston, EM | 1 |
| Ellis, FD | 1 |
| Khoury, JM | 1 |
| Shen, JH | 1 |
| Davis, D | 1 |
| O'Day, DM | 1 |
| Stone, RT | 1 |
| Chang, MR | 1 |
| Schiffman, J | 1 |
| Rueda, JC | 1 |
| Tsai, JC | 2 |
| Sharma, T | 1 |
| Ladd, W | 2 |
| Libby, CM | 1 |
| Jee, J | 1 |
| Harrison, DA | 1 |
| Wheeler, DT | 1 |
| Colotto, A | 1 |
| Falsini, B | 1 |
| Cesari, L | 1 |
| Cermola, S | 1 |
| Iarossi, G | 1 |
| Scullica, L | 1 |
| Good, D | 1 |
| Moon, JI | 1 |
| Beatty, S | 1 |
| Potamitis, T | 1 |
| Kheterpal, S | 1 |
| O'Neill, EC | 1 |
| Sano, T | 1 |
| Fukuchi, T | 1 |
| Sawaguchi, S | 1 |
| Hara, H | 1 |
| Watanabe, J | 1 |
| Oota, A | 1 |
| Shirakashi, M | 1 |
| Abe, H | 1 |
| Lai, JS | 1 |
| Chua, JK | 1 |
| Fan, DS | 1 |
| Pieroth, L | 1 |
| Vinals, AF | 1 |
| Goldstein, MH | 1 |
| Cooper, ML | 1 |
| Mattox, C | 1 |
| Frangie, JP | 1 |
| Wu, HK | 1 |
| Katz, SE | 1 |
| Edelman, RE | 1 |
| Lubow, M | 1 |
| Cantor, L | 1 |
| Burgoyne, J | 1 |
| Sanders, S | 1 |
| Bhavnani, V | 1 |
| Brizendine, E | 1 |
| Evans, J | 1 |
| Menapace, R | 1 |
| Strenn, K | 1 |
| Rainer, G | 1 |
| Jacobi, PC | 2 |
| Chen, PP | 2 |
| Basich, FM | 1 |
| Khadem, E | 1 |
| Nurözler, A | 1 |
| Kahraman, C | 1 |
| Kasim, R | 1 |
| Ustundag, C | 1 |
| Wilson, WR | 1 |
| Lynch, MG | 1 |
| Noe, R | 1 |
| Gammon, RR | 1 |
| Avery, N | 1 |
| Mintz, PD | 1 |
| Trible, JR | 1 |
| Brown, DB | 1 |
| Honjo, M | 1 |
| Stork, L | 1 |
| Xia, X | 1 |
| Huang, P | 1 |
| Wu, Z | 1 |
| Cheng, B | 1 |
| Xia, L | 1 |
| Goyal, M | 1 |
| Majji, AB | 1 |
| Sen, PK | 1 |
| Naduvilath, T | 1 |
| Dandona, L | 1 |
| Alfonso, E | 1 |
| Augsburger, JJ | 3 |
| Akova, YA | 1 |
| Bulut, S | 1 |
| Dabil, H | 1 |
| Larrosa, JM | 1 |
| Polo, V | 1 |
| Pinilla, I | 1 |
| Pablo, LE | 1 |
| Martinez, MR | 1 |
| Abecia, E | 1 |
| Honrubia, FM | 1 |
| Gandolfi, S | 1 |
| Vása, M | 1 |
| Samuelson, TW | 4 |
| Migdal, CS | 1 |
| Mullaney, PB | 1 |
| Selleck, C | 1 |
| Al-Awad, A | 1 |
| Al-Mesfer, S | 1 |
| Ozdemir, Y | 1 |
| Onder, F | 1 |
| Coşar, CB | 1 |
| Usubütün, A | 1 |
| Kural, G | 1 |
| Pyfer, M | 1 |
| Gordon, J | 1 |
| Piltz-Seymour, J | 1 |
| Keates, EU | 1 |
| Hardten, DR | 1 |
| Oshima, Y | 1 |
| Sakamoto, T | 1 |
| Nakamura, T | 1 |
| Tahara, Y | 1 |
| Goto, Y | 1 |
| Ishibashi, T | 1 |
| Inomata, H | 1 |
| Chowers, I | 1 |
| Ticho, U | 2 |
| Naduvilath, TJ | 1 |
| Loon, SC | 1 |
| Yan, L | 1 |
| Zhang, S | 1 |
| Dong, Q | 1 |
| Solomon, A | 1 |
| Frucht-Pery, J | 1 |
| Francoeur, AM | 1 |
| Assalian, A | 1 |
| Morin, I | 1 |
| Tétreault, F | 1 |
| Calleja, K | 1 |
| Guttman, A | 1 |
| Rauth, M | 1 |
| Pan, SS | 1 |
| Gayton, JL | 1 |
| Van Der Karr, M | 1 |
| Sanders, V | 1 |
| Yücel, I | 1 |
| Bagci, G | 1 |
| Duranoglu, Y | 1 |
| Aksu, G | 1 |
| Lüleci, G | 1 |
| Donohue, EK | 1 |
| Stefan, C | 1 |
| Cucea, R | 1 |
| Nevyas, JY | 1 |
| Nevyas-Wallace, A | 1 |
| Choe, R | 1 |
| Lanzl, IM | 1 |
| Dudley, D | 1 |
| Aslanides, IM | 1 |
| El Sayyad, F | 1 |
| Belmekki, M | 1 |
| Helal, M | 1 |
| Khalil, M | 1 |
| El-Hamzawey, H | 1 |
| Hisham, M | 1 |
| Gross, RL | 1 |
| Belmonte, SJ | 1 |
| Nakaizumi, T | 1 |
| Tsuji, H | 1 |
| Ahn, DG | 1 |
| el Menyawi, I | 1 |
| Radda, S | 1 |
| Nimmerrichter, P | 1 |
| Ishioka, M | 1 |
| Shimazaki, J | 1 |
| Yamagami, J | 1 |
| Fujishima, H | 1 |
| Shimmura, S | 1 |
| Quigley, HA | 2 |
| Buhrmann, RR | 1 |
| West, SK | 1 |
| Isseme, I | 1 |
| Scudder, M | 1 |
| Oliva, MS | 1 |
| Dunn, D | 1 |
| Gupta, SD | 1 |
| Arora, R | 1 |
| Lehmann, OJ | 1 |
| Matheson, MM | 1 |
| Mehta, K | 1 |
| Shaikh, NM | 1 |
| Baerveldt, GS | 1 |
| Shaikh, S | 1 |
| Yu, CB | 1 |
| Rockwood, EJ | 1 |
| Larive, B | 1 |
| Hahn, J | 1 |
| Mutsch, YA | 1 |
| Rodríguez-Bermejo Guijó , C | 1 |
| Manners, T | 1 |
| Willies, C | 1 |
| Ophir, A | 1 |
| Pikkel, J | 1 |
| Paciuc, M | 1 |
| Velasco, CF | 1 |
| Freedman, SF | 1 |
| Alm, A | 1 |
| Rahman, R | 1 |
| Xiong, X | 1 |
| Lim, BA | 1 |
| Lat-Luna, M | 1 |
| Chew, P | 1 |
| Tan, D | 1 |
| Mutlukan, E | 1 |
| Doe, EA | 1 |
| Imami, NR | 1 |
| Johnstone, MA | 1 |
| Crandall, AS | 1 |
| Brown, RH | 1 |
| Wolfsberger, A | 1 |
| Georgopoulos, A | 1 |
| Li, J | 1 |
| Pang, L | 1 |
| DeBry, PW | 1 |
| Kaufman, P | 1 |
| Brumback, LC | 1 |
| You, YA | 1 |
| Gu, YS | 1 |
| Fang, CT | 1 |
| Ma, XQ | 1 |
| Yamin, M | 1 |
| Quentin, CD | 1 |
| Macken, PL | 1 |
| Boyd, SR | 1 |
| Campbell, I | 1 |
| Chang, D | 1 |
| Rootman, DS | 1 |
| Trope, GE | 1 |
| Song, A | 1 |
| Chaudhry, IM | 1 |
| Hwang, JM | 1 |
| Michalíková, L | 1 |
| Ferková, S | 1 |
| Jakabovicová, E | 1 |
| Strmen, P | 1 |
| Pasquale, LR | 1 |
| Thibault, D | 1 |
| Dorman-Pease, ME | 1 |
| Wilkinson, WS | 1 |
| Watnick, RL | 1 |
| Huang, HT | 1 |
| Lee, CC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Primary Tube Versus Trabeculectomy Study[NCT00666237] | Phase 4 | 242 participants (Actual) | Interventional | 2008-04-01 | Completed | ||
| Effectiveness and Safety of Trabeculectomy and Peripheral Iridectomy Plus Goniotomy in Advanced Primary Angle-closure Glaucoma: a Multicenter Non-inferiority Randomized Controlled Trial[NCT05163951] | 88 participants (Anticipated) | Interventional | 2022-01-05 | Recruiting | |||
| Ab Interno Gelatin Stent With Mitomycin C Using Targeted Supra-tenon's Placement[NCT04454138] | 142 participants (Actual) | Observational | 2019-06-25 | Completed | |||
| Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C[NCT04750447] | 30 participants (Anticipated) | Observational [Patient Registry] | 2020-11-09 | Recruiting | |||
| The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device[NCT02016898] | Phase 2 | 100 participants (Actual) | Interventional | 2014-03-31 | Completed | ||
| Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for the Treatment of Open Angle Glaucoma in Patients With Cataract - a Randomised Controlled Trial[NCT04295122] | Phase 4 | 160 participants (Anticipated) | Interventional | 2020-03-15 | Not yet recruiting | ||
| Glycerin-Preserved, Human-Donor, Corneoscleral Patch Grafts for Glaucoma Drainage Devices[NCT04949347] | 100 participants (Actual) | Observational | 2017-02-22 | Completed | |||
| Evaluation of Macular Thickness in Patients With Glaucoma in Use of Topical Prostaglandin Analogue Undergoing Trabeculectomy With Mitomycin C[NCT06000280] | 37 participants (Actual) | Interventional | 2021-01-04 | Completed | |||
| [NCT02665884] | 40 participants (Anticipated) | Observational | 2016-02-29 | Not yet recruiting | |||
| A Multi Center Study Comparing the Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma[NCT00444080] | 120 participants (Actual) | Interventional | 2006-10-31 | Completed | |||
| Prospective Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma[NCT03323138] | 40 participants (Anticipated) | Interventional | 2012-07-01 | Recruiting | |||
| Combined Phacoemulsification and Viscocanalostomy With Ologen Implant Versus Combined Phacoemulsification and Viscocanalostomy[NCT03782051] | 81 participants (Actual) | Interventional | 2013-08-01 | Completed | |||
| Comparison of Conjunctival Vascularity Changes Using Optical Coherence Tomography Angiography After Trabeculectomy With Mitomycin and Ologen Implants[NCT04493073] | Early Phase 1 | 100 participants (Anticipated) | Interventional | 2020-12-01 | Not yet recruiting | ||
| Tube Versus Trabeculectomy (TVT) Study[NCT00306852] | 212 participants (Actual) | Interventional | 1999-10-31 | Completed | |||
| Comparison of Surgical Treatment Options for Primary Congenital and Developmental Glaucomas[NCT04647929] | 0 participants (Actual) | Interventional | 2020-12-01 | Withdrawn (stopped due to Funding for the study could not be found.) | |||
| Phaco-UCP; Combined Phacoemulsification and Ultrasound Ciliary Plasty Versus Phacoemulsification Alone for Management of Coexisting Cataract and Open Angle Glaucoma[NCT04430647] | 61 participants (Actual) | Interventional | 2018-03-01 | Completed | |||
| Effect of WeChat Application Combined Phone Reminder on Follow-up Adherence Improvement in Congenital Ectopia Lentis Patients : A Randomized Controlled Trial[NCT05628129] | 104 participants (Anticipated) | Interventional | 2022-12-05 | Recruiting | |||
| A Randomized Controlled Trail to Determine the Impact of a SMS Reminder Associated With Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China[NCT02328456] | 209 participants (Actual) | Interventional | 2014-12-31 | Completed | |||
| Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery[NCT01440751] | Phase 4 | 99 participants (Actual) | Interventional | 2011-09-30 | Completed | ||
| Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Chinese Primary Angle Closure Glaucoma[NCT02964676] | 246 participants (Anticipated) | Interventional | 2017-01-31 | Not yet recruiting | |||
| Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Primary Open Angle Glaucoma: a Three-year Comparative Study[NCT01633775] | 100 participants (Actual) | Observational | 2007-12-31 | Completed | |||
| Comparison of ExPress Implantation Versus Partial Deep Sclerectomy Combined With ExPress Implantation With Simultaneously Phacoemulsification[NCT03800589] | 186 participants (Actual) | Interventional | 2010-12-01 | Completed | |||
| Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation - a Prospective Cohort Study at the Ophthalmology Department Klinikum Klagenfurt[NCT06174324] | 100 participants (Anticipated) | Observational | 2021-10-12 | Recruiting | |||
| The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study[NCT02691455] | 50 participants (Actual) | Interventional | 2016-02-29 | Terminated (stopped due to Difficulty in recruiting participants) | |||
| Intermediate Term Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin c in Trabeculectomy Surgery.[NCT00346489] | Phase 4 | 70 participants | Interventional | 2004-09-30 | Completed | ||
| IOP Reduction and Complications of Polymethyl Methacrylate Glaucoma Drainage Device on Glaucoma Patient[NCT04052165] | 150 participants (Actual) | Interventional | 2015-07-01 | Completed | |||
| The Ahmed Versus Baerveldt (AVB) Study: Prospective, Multicenter Trial Comparing the Ahmed-FP7 Valve With the Baerveldt-350 Implant in Treating Refractory Glaucoma[NCT00940823] | 238 participants (Actual) | Interventional | 2005-07-31 | Completed | |||
| Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients[NCT00665756] | 40 participants (Actual) | Interventional | 2006-01-31 | Active, not recruiting | |||
| Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy[NCT00695747] | 95 participants (Actual) | Interventional | 1998-01-31 | Completed | |||
| Modified Trabeculectomy With an Extended Subscleral Tunnel Versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma (POAG)[NCT03480711] | 40 participants (Actual) | Interventional | 2018-07-10 | Completed | |||
| The Influence of Silicone Oil on Nerve Fiber Layer Thickness After Pars Plana Vitrectomy[NCT01255306] | 60 participants (Actual) | Observational | 2010-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The number of participants requiring reoperation for glaucoma will be reported (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Tube Shunt Surgery Group | 21 |
| Trabeculectomy With Mitomycin C | 12 |
Intraocular pressure will be reported in mmHg and measured using Goldmann applanation tonometry or a Tono-Pen. (NCT00666237)
Timeframe: At baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years
| Intervention | mmHg (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Intraocular Pressure: Baseline | Intraocular Pressure: 1 year | Intraocular Pressure: 18 months | Intraocular Pressure: 2 years | Intraocular Pressure: 3 years | Intraocular Pressure: 4 years | Intraocular Pressure: 5 years | |
| Trabeculectomy With Mitomycin C | 23.9 | 12.4 | 12.8 | 12.9 | 12.1 | 13.5 | 13.0 |
| Tube Shunt Surgery Group | 23.3 | 13.8 | 13.5 | 13.6 | 13.9 | 13.5 | 13.4 |
The need for supplemental glaucoma medications will be reported as the number of glaucoma medications used (NCT00666237)
Timeframe: At Baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years
| Intervention | glaucoma medications used (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | 1 year | 18 months | 2 years | 3 years | 4 years | 5 years | |
| Trabeculectomy With Mitomycin C | 3.2 | 0.9 | 0.8 | 1.0 | 1.2 | 1.3 | 1.3 |
| Tube Shunt Surgery Group | 3.1 | 2.1 | 2.1 | 2.2 | 2.1 | 2.3 | 2.2 |
Number of participants with early and late postoperative complications will be reported as per treating physician assessment (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Early Postoperative Complications | Late Postoperative Complications | |
| Trabeculectomy With Mitomycin C | 40 | 32 |
| Tube Shunt Surgery Group | 24 | 27 |
"Surgical failure is defined as:~Inadequate Intraocular Pressure (IOP) Reduction (IOP > 21 mmHg or reduced < 20% below baseline on 2 consecutive follow-up visits after 3 months)~Reoperation for glaucoma~Persistent hypotony (IOP ≤ 5 mmHg on 2 consecutive visits after 3 months)~Loss of light perception vision" (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| Inadequate IOP reduction | Reoperation for Glaucoma | Loss of light perception vision | Persistent Hypotony | |
| Trabeculectomy With Mitomycin C | 23 | 9 | 1 | 5 |
| Tube Shunt Surgery Group | 31 | 18 | 0 | 0 |
Visual acuity will be reported as the number of correctly identified letters on the Early Treatment Diabetic Retinopathy Study (EDTRS) chart. Total score ranges from 0-100 with the higher score indicating better visual acuity. (NCT00666237)
Timeframe: At baseline, At 5 years
| Intervention | letters (Mean) | |
|---|---|---|
| Baseline | 5 years | |
| Trabeculectomy With Mitomycin C | 73 | 66 |
| Tube Shunt Surgery Group | 73 | 69 |
Visual acuity will be measured using a Snellen chart on logMAR (Logarithm of Minimal Angle of Resolution) scale. Letter-by letter results calculated the visual performance score for each chart read. logMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20. (NCT00666237)
Timeframe: At Baseline, At 5 years
| Intervention | logMAR (Mean) | |
|---|---|---|
| Baseline | 5 years | |
| Trabeculectomy With Mitomycin C | 0.25 | 0.42 |
| Tube Shunt Surgery Group | 0.20 | 0.30 |
"Presence or absence of the following complications:~i. Starting after POM1: shallow AC w/ iridocorneal touch, any hyphema, corneal edema, wound leak/dehiscience, choroidal effusion, malignant glaucoma, dellen/non-healing epithelial defect, ptosis, diplopia.~ii. At any point: additional glaucoma surgery, loss of light perception vision, vitreous hemorrhage, ≥2mm hyphema, hypotony maculopathy, implant migration/blockage/exposure/extrusion, macular edema, choroidal effusion/hemorrhage requiring drainage, suprachoroidal hemorrhage, retinal detachment, suture abscess/blebitis/endophthalmitis" (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 35 |
| Targeted Supratenon's Placement of XEN 45 | 48 |
Presence or absence of the following management interventions (not considered complications): bleb needling, AC reformation, suture release, digital ocular compression, use of glaucoma medications, or laser/tpa to blocked ostomy or lumen. (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 32 |
| Targeted Supratenon's Placement of XEN 45 | 40 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) +/- Medications (NCT04454138)
Timeframe: Post op Year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 33 |
| Targeted Supratenon's Placement of XEN 45 | 22 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤17 (mmHg) on no medications (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 28 |
| Targeted Supratenon's Placement of XEN 45 | 18 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤17 (mmHg) +/- medication (NCT04454138)
Timeframe: Post op Year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 41 |
| Targeted Supratenon's Placement of XEN 45 | 26 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤21 (mmHg) on no medications (NCT04454138)
Timeframe: Post op Year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 31 |
| Targeted Supratenon's Placement of XEN 45 | 19 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) +/- medications (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 47 |
| Targeted Supratenon's Placement of XEN 45 | 28 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) on no medications (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 20 |
| Targeted Supratenon's Placement of XEN 45 | 15 |
To assess final intraocular pressure lowering between patients who receive mitomycin-C using a sponge versus irrigation (NCT02016898)
Timeframe: post-operative day 1 to month 6
| Intervention | mmHg (millimeters of mercury) (Mean) |
|---|---|
| Sponge Placement of Mitomycin-C | -8.4 |
| Irrigation Placement of MMC | -8.2 |
To assess complication rates between patients who receive mitomycin-C using a sponge versus irrigation (NCT02016898)
Timeframe: post-operative day 1 to month 6
| Intervention | Participants (Count of Participants) |
|---|---|
| Sponge Placement of Mitomycin-C | 29 |
| Irrigation Placement of MMC | 28 |
The secondary effectiveness measure will be qualified and complete success rate defined as IOP≤18mmHg with or without medications in the test group as compared to qualified and complete success rate in the concurrent control group at 24 month (NCT00444080)
Timeframe: 24 months
| Intervention | participants (Number) |
|---|---|
| Control Arm | 48 |
| Treatment Arm | 49 |
(NCT00444080)
Timeframe: assessed at 1d, 1w, 1m, 3m, 6m, 12m, 18m, 24m; 24 months reported
| Intervention | number of medications (Mean) |
|---|---|
| Control Arm | 0.7 |
| Treatment Arm | 0.9 |
Mean postoperative intraocular pressure (NCT00444080)
Timeframe: assessed at 1d, 1w, 1m, 3m, 6m, 12m, 18m, 24m. 24 months reported
| Intervention | mmHg (Mean) |
|---|---|
| Control Arm | 14.6 |
| Treatment Arm | 14.7 |
Comparison of the incidence of all adverse events that occur during the intra-operative and postoperative periods between the two study arms. More than 1 complication may have occurred in the same subject. (NCT00444080)
Timeframe: 24 months
| Intervention | complications (Number) |
|---|---|
| Control Arm | 25 |
| Treatment Arm | 11 |
The data value from the Baseline visit and 5 year follow-up visit were combined. Specifically, values were calculated by subtracting the 5 Year Intraocular Pressure from the Baseline Intraocular Pressure. (NCT00306852)
Timeframe: Baseline to 5 years
| Intervention | mm Hg (Mean) |
|---|---|
| Trabeculectomy | 12.6 |
| Implant | 14.4 |
Failure was prospectively defined as IOP greater than 21 mm Hg or less than 20 percent reduction below baseline on 2 consecutive follow-up visits after 3 months, IOP less than or equal to 5 mm Hg on 2 consecutive follow-up visits after 3 months, re-operation for glaucoma, or loss of light perception vision. (NCT00306852)
Timeframe: 5 years
| Intervention | percentage of participants (Number) |
|---|---|
| Trabeculectomy | 46.9 |
| Implant | 29.8 |
The number of supplemental glaucoma medications required in the Implant Group and Trabeculectomy Group at 5 years (NCT00306852)
Timeframe: 5 years
| Intervention | number of medications (Mean) |
|---|---|
| Trabeculectomy | 1.2 |
| Implant | 1.4 |
Reoperations for glaucoma was defined as additional glaucoma surgery requiring a return to the operating room. (NCT00306852)
Timeframe: 5 years
| Intervention | participants (Number) |
|---|---|
| Trabeculectomy | 15 |
| Implant | 20 |
Complications associated with both surgical procedures (NCT00306852)
Timeframe: 5 years
| Intervention | participants (Number) | |
|---|---|---|
| EARLY POSTOPERATIVE COMPLICATIONS | LATE POSTOPERATIVE COMPLICATIONS | |
| Implant | 33 | 36 |
| Trabeculectomy | 39 | 38 |
Visual acuity was measured by the total number of letters read (correctly) using a ETDRS eye chart (NCT00306852)
Timeframe: 5 years
| Intervention | Letters (Mean) | |
|---|---|---|
| PATIENTS WITH COMPLICATIONS | PATIENTS WITHOUT COMPLICATIONS | |
| Implant | 33 | 46 |
| Trabeculectomy | 56 | 44 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 1 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 1
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.03 |
| Transscleral Cyclophotocoagulation | 0.12 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 12 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 12
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.06 |
| Transscleral Cyclophotocoagulation | 0.09 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 3 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 3
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.10 |
| Transscleral Cyclophotocoagulation | 0.08 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 6 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 6
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.03 |
| Transscleral Cyclophotocoagulation | 0.05 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The week 1 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, week 1
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | 0.16 |
| Transscleral Cyclophotocoagulation | 0.14 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The year 2 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, year 2
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.28 |
| Transscleral Cyclophotocoagulation | 0.24 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The year 3 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, year 3
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.23 |
| Transscleral Cyclophotocoagulation | 0.49 |
Number of participants who reported pain. (NCT02691455)
Timeframe: 1 month
| Intervention | Participants (Count of Participants) |
|---|---|
| Second Aqueous Shunt | 10 |
| Transscleral Cyclophotocoagulation | 10 |
Number of participants who reported pain. (NCT02691455)
Timeframe: 1 week
| Intervention | Participants (Count of Participants) |
|---|---|
| Second Aqueous Shunt | 12 |
| Transscleral Cyclophotocoagulation | 11 |
"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from month 12 to year 3
| Intervention | eyes (Number) |
|---|---|
| Second Aqueous Shunt | 0 |
| Transscleral Cyclophotocoagulation | 0 |
"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from month 6 to month 12
| Intervention | eyes (Number) |
|---|---|
| Second Aqueous Shunt | 3 |
| Transscleral Cyclophotocoagulation | 2 |
"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from time of intervention to month 6
| Intervention | eyes (Number) |
|---|---|
| Second Aqueous Shunt | 0 |
| Transscleral Cyclophotocoagulation | 0 |
The Snellen visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). Loss of lines of vision indicates worsening visual acuity. (NCT02691455)
Timeframe: from time of intervention to year 3
| Intervention | eyes (Number) |
|---|---|
| Second Aqueous Shunt | 3 |
| Transscleral Cyclophotocoagulation | 8 |
(NCT02691455)
Timeframe: from baseline to 3 months
| Intervention | office visits per participant (Mean) |
|---|---|
| Second Aqueous Shunt | 3.73 |
| Transscleral Cyclophotocoagulation | 0.95 |
(NCT02691455)
Timeframe: from month 4 to year 3
| Intervention | office visits per participant per month (Mean) |
|---|---|
| Second Aqueous Shunt | 0.35 |
| Transscleral Cyclophotocoagulation | 0.13 |
Severity of pain was assessed by the Universal Pain Assessment Tool, and the score ranges from 0 to 10, with a higher score indicating greater pain. (NCT02691455)
Timeframe: 1 month
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 1.40 |
| Transscleral Cyclophotocoagulation | 1.28 |
Severity of pain was assessed by the Universal Pain Assessment Tool, and the score ranges from 0 to 10, with a higher score indicating greater pain. (NCT02691455)
Timeframe: 1 week
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 1.57 |
| Transscleral Cyclophotocoagulation | 1.44 |
The score on the National Eye Institute (NEI) Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 62.5 |
| Transscleral Cyclophotocoagulation | 48.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 86.4 |
| Transscleral Cyclophotocoagulation | 77.6 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 91.1 |
| Transscleral Cyclophotocoagulation | 76.9 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 50.2 |
| Transscleral Cyclophotocoagulation | 46.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 49.3 |
| Transscleral Cyclophotocoagulation | 54.9 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 65.8 |
| Transscleral Cyclophotocoagulation | 63.5 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 75.8 |
| Transscleral Cyclophotocoagulation | 63.9 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 63.1 |
| Transscleral Cyclophotocoagulation | 55.4 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 56.5 |
| Transscleral Cyclophotocoagulation | 65.8 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 58.9 |
| Transscleral Cyclophotocoagulation | 53.8 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 64.5 |
| Transscleral Cyclophotocoagulation | 63.2 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 64.3 |
| Transscleral Cyclophotocoagulation | 70.8 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 55.4 |
| Transscleral Cyclophotocoagulation | 56.9 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 57.6 |
| Transscleral Cyclophotocoagulation | 68.3 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 66.3 |
| Transscleral Cyclophotocoagulation | 62.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 71.2 |
| Transscleral Cyclophotocoagulation | 59.0 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 76.2 |
| Transscleral Cyclophotocoagulation | 70.4 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 83.0 |
| Transscleral Cyclophotocoagulation | 81.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 60.2 |
| Transscleral Cyclophotocoagulation | 59.2 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 62.5 |
| Transscleral Cyclophotocoagulation | 63.5 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 54.8 |
| Transscleral Cyclophotocoagulation | 61.8 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 63.4 |
| Transscleral Cyclophotocoagulation | 70.2 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 83.1 |
| Transscleral Cyclophotocoagulation | 82.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 83.3 |
| Transscleral Cyclophotocoagulation | 76.0 |
(NCT02691455)
Timeframe: from the time of intervention to year 3
| Intervention | eyes (Number) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hyphema | Hypotony persistent | Choroidal Effusion | Cystoid/Diabetic Macular Edema Progression | Primary Tube Complications | Cataract Progression | Macular Hole | Herpes Simplex Keratitis | Ectropion | Second Tube Migration Anteriorly | Vitreous Clogging Second glaucoma drainage device | Intraocular Lens Dislocation | Phacodonesis | |
| Second Aqueous Shunt | 2 | 2 | 1 | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Transscleral Cyclophotocoagulation | 0 | 0 | 0 | 3 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
(NCT00940823)
Timeframe: 5 years
| Intervention | glaucoma medications (Mean) |
|---|---|
| Ahmed Group | 1.8 |
| Baerveldt Group | 1.2 |
(NCT00940823)
Timeframe: 5 years
| Intervention | mmHg (Mean) |
|---|---|
| Ahmed Group | 16.6 |
| Baerveldt Group | 13.6 |
Visual acuity (VA) was tested monocularly (one eye at a time) using the manifest refraction adjusted for optical infinity using a standard Snellen Visual Acuity chart at 20 feet. Normal vision, or 20/20 vision, means that the participant can see at 20 feet what a healthy control can also see at 20 feet. Legal blindness, or 20/200 vision, means the participant can see at 20 feet what a healthy control can see at 200 feet. Hence, an increasing denominator implies visual impairment. Counting fingers was designated as 20/2000 vision, hand motions was 20/16000, light perception was 20/32000 and no light perception was 20/64000. To allow for appropriate statistical analysis, logMAR Snellen Visual Acuity was calculated using the formula: -logMAR (Snellen Acuity). This means that normal vision (20/20) would correspond to a value of 0, legal blindness (20/200) would correspond to a value of 1, and no light perception (20/64000) would correspond to 3.5. (NCT00940823)
Timeframe: 5 years
| Intervention | logMAR units on a scale (Mean) |
|---|---|
| Ahmed Group | 1.6 |
| Baerveldt Group | 1.6 |
(NCT00940823)
Timeframe: 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Ahmed Group | 78 |
| Baerveldt Group | 79 |
(NCT00940823)
Timeframe: 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Ahmed Group | 64 |
| Baerveldt Group | 58 |
"IOP out of target range (5-18 mmHg inclusive) or <20% reduction from baseline for 2 consecutive visits after 3 months.~De novo glaucoma surgery required (e.g., cyclodestructive procedure, additional tube shunt).~Removal of the implant.~Severe vision loss related to the surgery (endophthalmitis, suprachoroidal hemorrhage with vision loss, enucleation, evisceration, or phthisis bulbi) or progression to no light perception for any reason." (NCT00940823)
Timeframe: 5 years
| Intervention | participants (Number) |
|---|---|
| Ahmed Group | 63 |
| Baerveldt Group | 40 |
Retinal nerve fiber layer thickness change measured by optical coherence tomography might be an additional parameter that could provide new insights into clinical decision making in patients with silicone oil tamponade. (NCT01255306)
Timeframe: 6 months
| Intervention | micrometer (Mean) | |||
|---|---|---|---|---|
| RNFL thickness at 7th postop. day | RNFL thickness at 30th postop. day | RNFL thickness at 90th postop. day | RNFL thickness at 180th postop. day | |
| CONTROL EYES | 87.07 | 87.93 | 87.37 | 88.93 |
| STUDY EYES | 96.23 | 96.09 | 97.56 | 100.40 |
To assess whether retinal nerve fiber layer thickness changes in patients with raised intraocular pressure secondary to silicone oil endotamponade. (NCT01255306)
Timeframe: 6 months
| Intervention | micrometer (Mean) | |||
|---|---|---|---|---|
| RNFL thickness at 7th postop. day | RNFL thickness at 30th postop. day | RNFL thickness at 90th postop. day | RNFL thickness at 180th postop. day | |
| CONTROL | 87.07 | 87.93 | 87.37 | 88.93 |
| NO IOP | 96.08 | 93.76 | 96.44 | 101.76 |
| RAISED IOP | 96.34 | 97.91 | 98.44 | 99.34 |
65 reviews available for mitomycin and Glaucoma
| Article | Year |
|---|---|
[Surgical advancement in glaucoma in the past 10 years. German version].
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outcome | 2021 |
Animal models and drug candidates for use in glaucoma filtration surgery: A systematic review.
Topics: Animals; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pressure; Mice; Mitomycin; Models, Anima | 2022 |
[Pharmacological modulation of wound healing in glaucoma surgery].
Topics: Filtering Surgery; Glaucoma; Humans; Mitomycin; Trabeculectomy; Wound Healing | 2022 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
[The "Three Cherries Technique" for glaucoma drainage devices].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin | 2023 |
The developments in amniotic membrane transplantation in glaucoma and vitreoretinal procedures.
Topics: Amnion; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2023 |
Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice.
Topics: Adolescent; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; M | 2023 |
[Revision of the PRESERFLO® MicroShunt with ologen and mitomycin C].
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy | 2023 |
Comparative efficacies of 13 surgical interventions for primary congenital glaucoma in children: a network meta-analysis of randomized clinical trials.
Topics: Child; Glaucoma; Humans; Mitomycin; Network Meta-Analysis; Randomized Controlled Trials as Topic; Re | 2023 |
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Topics: Alkylating Agents; Female; Filtering Surgery; Glaucoma; History, 20th Century; History, 21st Century | 2020 |
Needling after trabeculectomy - does augmentation by anti-metabolites provide better outcomes and is Mitomycin C better than 5-Fluoruracil? A systematic review with network meta-analyses.
Topics: Fluorouracil; Glaucoma; Humans; Immunosuppressive Agents; Intraocular Pressure; Mitomycin; Network M | 2020 |
Overview of cicatricial modulators in glaucoma fistulizing surgery.
Topics: Cicatrix; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Wound Healing | 2020 |
[Glaucoma surgery today].
Topics: Germany; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Quality of Life; Retrospective Studies; | 2021 |
Surgical interventions for primary congenital glaucoma.
Topics: Child, Preschool; Glaucoma; Glaucoma Drainage Implants; Humans; Hyphema; Infant; Infant, Newborn; In | 2020 |
History, presence, and future of mitomycin C in glaucoma filtration surgery.
Topics: Alkylating Agents; Drug Delivery Systems; Fibrosis; Filtering Surgery; Glaucoma; History, 20th Centu | 2021 |
Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma?
Topics: Antimetabolites; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Randomiz | 2018 |
Efficacy and Safety of Bevacizumab Combined with Mitomycin C or 5-Fluorouracil in Primary Trabeculectomy: A Meta-Analysis of Randomized Clinical Trials.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Bevacizumab; Glaucoma | 2018 |
Trabeculectomy: A Brief History and Review of Current Trends.
Topics: Angiogenesis Inhibitors; Fluorouracil; Glaucoma; History, 20th Century; History, 21st Century; Human | 2018 |
Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma.
Topics: Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin; Randomized Controlled Trials as Topic; Trea | 2019 |
Mitomycin C versus 5-fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials.
Topics: Alkylating Agents; Antimetabolites; Chemotherapy, Adjuvant; Epithelium, Corneal; Fluorouracil; Glauc | 2013 |
Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis.
Topics: Collagen; Glaucoma; Glycosaminoglycans; Humans; Mitomycin; Prostheses and Implants; Trabeculectomy; | 2014 |
The optimal trabeculectomy: patient and procedure.
Topics: Alkylating Agents; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Patient Selection; Trabecular | 2014 |
Surgical interventions for primary congenital glaucoma.
Topics: Child, Preschool; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; Infant, Newborn; Mitomycin; | 2015 |
Pediatric Glaucoma: A Literature's Review and Analysis of Surgical Results.
Topics: Adolescent; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Male; Mitomycin; Trabeculecto | 2015 |
Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.
Topics: Antimetabolites; Chemotherapy, Adjuvant; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Press | 2015 |
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.
Topics: Antihypertensive Agents; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Limbus Corneae; Mitom | 2015 |
Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
Topics: Angiogenesis Inhibitors; Bevacizumab; Cicatrix; Glaucoma; Humans; Intraocular Pressure; Mitomycin; R | 2016 |
The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Angiogenesis Inhibitors; Antimetabolites; Bevacizumab; Drug Therapy, Combination; Glaucoma; Humans; | 2016 |
Modulation of wound healing during and after glaucoma surgery.
Topics: Antibiotics, Antineoplastic; Cicatrix; Dendrimers; Fibroblasts; Filtering Surgery; Glaucoma; Humans; | 2008 |
Corneal complications of glaucoma surgery.
Topics: Corneal Diseases; Corneal Transplantation; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Graft | 2009 |
Review of results from the Tube Versus Trabeculectomy Study.
Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocu | 2010 |
Interpretation and misinterpretation of results from the tube versus trabeculectomy study.
Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Incidence; Intraocular Pressure; In | 2011 |
Current variations of glaucoma filtration surgery.
Topics: Alkylating Agents; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Surgical Flaps; | 2012 |
The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice.
Topics: Antihypertensive Agents; Cataract Extraction; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocu | 2012 |
Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review.
Topics: Antimetabolites, Antineoplastic; Cataract; Cataract Extraction; Evidence-Based Medicine; Fluorouraci | 2002 |
[Modulation of wound healing in filtration surgery for glaucoma].
Topics: Adolescent; Adult; Age Factors; Alkylating Agents; Animals; Antimetabolites; Child; Filtering Surger | 2003 |
Glaucoma-filtering bleb infections.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Endophthalmitis; Fibrosis; Filtering Surgery; F | 2003 |
Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery.
Topics: Antimetabolites, Antineoplastic; Cataract Extraction; Fibrosis; Fluorouracil; Glaucoma; Glaucoma Dra | 2004 |
[Pharmacological methods improving the effectiveness of filtering procedures].
Topics: Antibiotics, Antineoplastic; Antibodies; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cy | 2004 |
Wound healing after glaucoma surgery: how to manage it?
Topics: Adult; Aged; Antimetabolites; Filtering Surgery; Fluorouracil; Glaucoma; Guidelines as Topic; Humans | 2005 |
Intra-operative mitomycin C for glaucoma surgery.
Topics: Antimetabolites; Cicatrix; Glaucoma; Humans; Intraoperative Period; Mitomycin; Randomized Controlled | 2005 |
Mitomycin: clinical applications in ophthalmic practice.
Topics: Antibiotics, Antineoplastic; Cicatrix; Conjunctival Neoplasms; Glaucoma; Humans; Melanoma; Mitomycin | 2006 |
[Wound healing modulation in glaucoma surgery].
Topics: Adult; Animals; Cataract Extraction; Child; Cicatrix; Eye Diseases; Filtering Surgery; Fluorouracil; | 2007 |
[Ocular side effects of glaucoma treatment agents].
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Eye Diseases; Ginkg | 2007 |
[Trabeculectomy with mitomycin C. Study apropos of 30 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorouracil; Follow-Up | 1995 |
Antifibrosis agents and glaucoma surgery.
Topics: Animals; Conjunctiva; Fibrosis; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Mitomycin | 1994 |
[Mitomycin C in glaucoma surgery].
Topics: Adult; Aged; Aged, 80 and over; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Midd | 1993 |
Antifibrotic agents in glaucoma filtering surgery.
Topics: Animals; Cataract Extraction; Fluorouracil; Glaucoma; Humans; Mitomycin; Rabbits; Sclerostomy; Wound | 1993 |
Wound healing modulation in glaucoma filtration surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Fluorouracil; Glaucoma; Humans; Intraocular | 1993 |
[Current topics in glaucoma].
Topics: Adult; Animals; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; M | 1996 |
[Filtering glaucoma operations. Can growth factor blockers replace antimetabolites?].
Topics: Antimetabolites, Antineoplastic; Cell Division; Combined Modality Therapy; Filtering Surgery; Fluoro | 1997 |
Mitomycin C primary trabeculectomy in primary glaucoma of white patients.
Topics: Antimetabolites; Cataract; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Intraoperati | 1997 |
Basic science and clinical aspects of wound healing in glaucoma filtering surgery.
Topics: Culture Techniques; Fibroblasts; Fibrosis; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Mitomy | 1998 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Exfoliation Syndrome; Fluorouracil; Glaucoma; Humans; Lenses, Intraoc | 1995 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Glaucoma; Humans; Mitomycin; Trabeculectomy | 1996 |
Current techniques in wound healing modulation in glaucoma surgery.
Topics: Animals; Antimetabolites; Cataract Extraction; Cicatrix; Filtering Surgery; Fluorouracil; Glaucoma; | 1996 |
The toxicology of mitomycin C on the ciliary body.
Topics: Animals; Antibiotics, Antineoplastic; Aqueous Humor; Ciliary Body; Conjunctiva; Filtering Surgery; G | 1996 |
Ocular toxicity of mitomycin-C.
Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Eye; Eye Diseases; Filtering Surgery; Glaucoma; | 1999 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin; | 1999 |
A major review of antimetabolites in glaucoma therapy.
Topics: Antimetabolites; Cytarabine; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Mitomycin; Ophthalmi | 1999 |
Glaucoma surgery: are there new perspectives in perioperative pharmacology?
Topics: Antimetabolites; Chemotherapy, Adjuvant; Fibrinolytic Agents; Filtering Surgery; Fluorouracil; Glauc | 1999 |
[The use of antimetabolites in the treatment of glaucoma].
Topics: Antimetabolites; Chemotherapy, Adjuvant; Fluorouracil; Glaucoma; Humans; Intraoperative Care; Mitomy | 1999 |
Intra-operative mitomycin C for glaucoma surgery.
Topics: Antimetabolites; Cataract Extraction; Cicatrix; Glaucoma; Humans; Intraoperative Period; Mitomycin; | 2001 |
The use of antimetabolites with trabeculectomy: a critical appraisal.
Topics: Antimetabolites; Combined Modality Therapy; Delivery of Health Care; Fluorouracil; Glaucoma; Humans; | 2001 |
Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy.
Topics: Antimetabolites; Chemotherapy, Adjuvant; Fluorouracil; Glaucoma; Humans; Intraoperative Period; Mito | 2001 |
Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Bacteria; Endophthalmitis; Eye Infections, Bacteri | 2002 |
84 trials available for mitomycin and Glaucoma
| Article | Year |
|---|---|
Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outc | 2022 |
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up.
Topics: Alkylating Agents; Blindness; Cataract; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Hum | 2022 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.
Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Tr | 2022 |
Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial.
Topics: Antiglaucoma Agents; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Prospecti | 2023 |
Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision - A pilot study.
Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Ocular Hypotension; Pilot Projects; Surgical Wound; Trabec | 2022 |
Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision - A pilot study.
Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Ocular Hypotension; Pilot Projects; Surgical Wound; Trabec | 2022 |
Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision - A pilot study.
Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Ocular Hypotension; Pilot Projects; Surgical Wound; Trabec | 2022 |
Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision - A pilot study.
Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Ocular Hypotension; Pilot Projects; Surgical Wound; Trabec | 2022 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra | 2020 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra | 2020 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra | 2020 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra | 2020 |
The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.
Topics: Adult; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Conjunctiva; Drug Therapy, Combinati | 2020 |
Baerveldt implant versus trabeculectomy as the first filtering surgery for uncontrolled primary congenital glaucoma: a randomized clinical trial.
Topics: Adolescent; Child; Child, Preschool; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans | 2020 |
Combined Trabeculotomy-Trabeculectomy Versus Trabeculectomy for Treatment of Silicone Oil-induced Ocular Hypertension.
Topics: Adolescent; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Silicone Oils; Ton | 2021 |
The Short-term Effect of Subtenon Sponge Application Versus Subtenon Irrigation of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device: A Randomized Trial.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Glaucoma; Glaucoma Drainage | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh.
Topics: Adult; Antibiotics, Antineoplastic; Bangladesh; Collagen; Female; Glaucoma; Glycosaminoglycans; Huma | 2019 |
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma | 2018 |
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma | 2018 |
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma | 2018 |
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma | 2018 |
Bleb Morphology After Mitomycin-C Augmented Trabeculectomy: Comparison Between Clinical Evaluation and Anterior Segment Optical Coherence Tomography.
Topics: Aged; Anterior Eye Segment; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitom | 2019 |
Phacotrabeculectomy using collagen matrix implant (Ologen
Topics: Aged; Alkylating Agents; Cataract; Collagen; Drug Implants; Female; Follow-Up Studies; Glaucoma; Gly | 2019 |
Augmented Subscleral Trabeculectomy With Beta Radiation and Mitomycin C in Egyptian Glaucoma Patients.
Topics: Adult; Beta Particles; Combined Modality Therapy; Egypt; Female; Follow-Up Studies; Glaucoma; Humans | 2019 |
[Trabeculectomy in uveitis associated with juvenile idiopathic arthritis: long-term results in pediatric secondary glaucoma].
Topics: Adolescent; Anti-Bacterial Agents; Arthritis, Juvenile; Child; Child, Preschool; Combined Modality T | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cohort Studies; Female; | 2014 |
[Comparison study on the efficacy and safety of bevacizumab versus mitomycin C as adjuvants in trabeculectomy].
Topics: Aged; Bevacizumab; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Glaucoma; Humans; Male | 2015 |
Excision of Tenon Capsule in Pediatric Trabeculectomy: A Controlled Study.
Topics: Alkylating Agents; Child, Preschool; Female; Glaucoma; Humans; Infant; Intraocular Pressure; Male; M | 2016 |
Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial.
Topics: Adult; Aged; Alkylating Agents; Amnion; Double-Blind Method; Female; Glaucoma; Glaucoma Drainage Imp | 2016 |
Intraocular Pressure Outcomes and Risk Factors for Failure in the Collaborative Bleb-Related Infection Incidence and Treatment Study.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Conjunctival Diseases; | 2015 |
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure | 2016 |
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure | 2016 |
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure | 2016 |
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure | 2016 |
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Antihypertensive Agents; Collagen; Combined Modality Therapy; Female; | 2016 |
[Glaucoma Drainage Devices: Tube versus Trabeculectomy Study].
Topics: Biocompatible Materials; Combined Modality Therapy; Follow-Up Studies; Glaucoma; Glaucoma Drainage I | 2018 |
Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
Topics: Administration, Topical; Alkylating Agents; Antihypertensive Agents; Antimetabolites; Combined Modal | 2009 |
Motility disturbances in the tube versus trabeculectomy study during the first year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Diplopia; Female; Follow-Up Studies; | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antihyper | 2010 |
A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma.
Topics: Amnion; Child; Child, Preschool; Conjunctiva; Freeze Drying; Glaucoma; Humans; Infant; Intraocular P | 2010 |
Anterior lens capsule versus mitomycin-C as an adjunct to trabeculectomy in combined phacotrabeculectomy.
Topics: Aged; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Lens Capsule, Cry | 2011 |
Effect of doxycycline on postoperative scarring after trabeculectomy in an experimental rabbit model.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blister; Cicatrix; Conjunctiva; Doxycyc | 2010 |
ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Conjunctiva; Drug Administration Schedule | 2011 |
Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.
Topics: Absorbable Implants; Aged; Collagen; Cross-Linking Reagents; Female; Glaucoma; Glycosaminoglycans; H | 2011 |
Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C.
Topics: Administration, Topical; Aged; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract; | 2013 |
Comparison of the outcome of repeat trabeculectomy with adjunctive mitomycin C and initial trabeculectomy.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Int | 2011 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma.
Topics: Adult; Alkylating Agents; Collagen; Female; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans; | 2013 |
Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctiva; Filtering Surgery; Follow-Up Stud | 2002 |
A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy.
Topics: Antimetabolites; Double-Blind Method; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Intraope | 2002 |
[Trabeculectomy combined with mitomycin C and removed suture in glaucoma].
Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Postopera | 2003 |
[Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma].
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Hum | 2003 |
Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery.
Topics: Aged; Chemotherapy, Adjuvant; Connective Tissue; Female; Follow-Up Studies; Glaucoma; Glaucoma Drain | 2003 |
Effects of viscoelastic material on the corneal endothelial cells in trabeculectomy with adjunctive mitomycin-C.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Antimetabolites; Drug Therapy, Combina | 2003 |
Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up St | 2004 |
[Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Endothelium, Corneal; F | 2004 |
Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Child, Preschool; Female; Glaucoma; Humans; Infan | 2001 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Fibrosis; Follow-Up Studies; Glaucoma; Hu | 2006 |
Prospective evaluation of preoperative factors associated with successful mitomycin C needling of failed filtration blebs.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Female; Follow-Up Studies; Glaucoma; Humans; Inject | 2006 |
Comparison of 1-site versus 2-site phacotrabeculectomy.
Topics: Antihypertensive Agents; Case-Control Studies; Cataract; Fluorouracil; Follow-Up Studies; Glaucoma; | 2006 |
Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial.
Topics: Aged; Alkylating Agents; Collagen; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular | 2006 |
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female | 2007 |
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female | 2007 |
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female | 2007 |
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female | 2007 |
[The comparison study of glaucoma trabeculectomy applying amniotic membrane or mitomycin C].
Topics: Aged; Amnion; Antimetabolites; Female; Follow-Up Studies; Glaucoma; Humans; Male; Middle Aged; Mitom | 2005 |
A placebo controlled double blind clinical trial of mitomycin C in primary trabeculectomy in Ethiopian patients.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Case-Control Studies; Double-Blind Method; Ethiopia; | 2006 |
E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial.
Topics: Aged; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Female; Glaucoma; Humans; Intraocula | 2008 |
Nonpenetrating very deep sclerectomy with reticulated hyaluronic acid implant in glaucoma treatment.
Topics: Aged; Drug Implants; Female; Glaucoma; Humans; Hyaluronic Acid; Intraocular Pressure; Male; Middle A | 2008 |
[Effect of mitomycin C on aqueous humor flow after trabeculectomy].
Topics: Adult; Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Female; Follow-Up Stud | 1995 |
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
Topics: Adult; Aged; Case-Control Studies; Filtering Surgery; Follow-Up Studies; Glaucoma; Humans; Intraocul | 1995 |
Adjunctive mitomycin C in Molteno implant surgery.
Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Life Tables; Male; | 1995 |
Intraoperative mitomycin C in complicated glaucomas.
Topics: Adult; Age Factors; Aged; Aphakia; Drug Evaluation; Female; Fluorouracil; Glaucoma; Glaucoma, Open-A | 1993 |
Short-term clinical results and complications of trabeculectomies performed with mitomycin C using different concentrations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Fem | 1995 |
Mitomycin-C concentration in human ocular aqueous humor after topical administration during trabeculectomy.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Aqueous Humor; Chromatography, High Pressure L | 1995 |
The effect of low-and high-dose adjunctive mitomycin C in trabeculectomy.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Dose-Response R | 1996 |
[The effect of mitomycin C on filtration surgery of glaucoma with poor prognosis].
Topics: Adolescent; Adult; Child; Child, Preschool; Cicatrix; Female; Filtering Surgery; Follow-Up Studies; | 1996 |
Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma.
Topics: Aged; Alkylating Agents; Dose-Response Relationship, Drug; Female; Glaucoma; Humans; Intraocular Pre | 1996 |
A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures.
Topics: Aged; Aged, 80 and over; Cell Count; Chemotherapy, Adjuvant; Double-Blind Method; Endothelium, Corne | 1996 |
Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Female; Filter | 1995 |
A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Double-Blind Method; Female; Glaucoma; Humans; Intraoc | 1997 |
Mitomycin-C in congenital glaucoma.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschoo | 1997 |
Intraoperative mitomycin C and the corneal endothelium.
Topics: Adult; Aged; Aged, 80 and over; Cell Count; Chemotherapy, Adjuvant; Endothelium, Corneal; Female; Gl | 1998 |
The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Glaucoma; Humans; Incidence; Intraocula | 1998 |
Combined phacoemulsification and trabeculectomy versus trabeculectomy alone: a comparison study using mitomycin-C.
Topics: Aged; Aged, 80 and over; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure | 1998 |
Oral prednisone in guarded filtration procedures supplemented with antimetabolites.
Topics: Administration, Oral; Aged; Chemotherapy, Adjuvant; Double-Blind Method; Female; Filtering Surgery; | 1999 |
Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Corneal Diseases; Female; Glaucoma; Graft Survival; | 1999 |
Combined cataract and glaucoma surgery: trabeculectomy versus endoscopic laser cycloablation.
Topics: Cataract; Ciliary Body; Endoscopy; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intrao | 1999 |
Simultaneous subconjunctival and subscleral mitomycin-C application in trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; | 2000 |
Postoperative application of mitomycin for trabeculectomies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Evaluation; Female; Follow-Up Studies; Glaucoma; Hu | 2000 |
Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Evaluation; Female; Fluorouracil | 2000 |
Mini-trabeculectomy in eyes with high risk of scarring: midterm follow-up.
Topics: Aged; Aged, 80 and over; Cicatrix; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure | 2001 |
Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Female; Follow-Up | 2002 |
Amniotic membrane graft for late-onset glaucoma filtering leaks.
Topics: Adult; Amnion; Biological Dressings; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Ag | 2002 |
540 other studies available for mitomycin and Glaucoma
| Article | Year |
|---|---|
Longitudinal changes in complete avascular area assessed using anterior segmental optical coherence tomography angiography in filtering trabeculectomy bleb.
Topics: Adult; Aged; Computed Tomography Angiography; Female; Glaucoma; Humans; Intraocular Pressure; Longit | 2021 |
Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery.
Topics: Animals; Collagen Type I, alpha 1 Chain; Glaucoma; Intraocular Pressure; Mitomycin; Rabbits; Valproi | 2022 |
Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study.
Topics: Adolescent; Child; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci | 2022 |
Surgical trends in glaucoma management: The current Indian scenario.
Topics: Cataract; Child; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Trab | 2022 |
Long-term outcomes and risk factors for failure of glaucoma filtering surgery in eyes with vernal keratoconjunctivitis and steroid-induced glaucoma.
Topics: Adolescent; Child; Conjunctivitis, Allergic; Female; Glaucoma; Humans; Intraocular Pressure; Male; M | 2022 |
Survey of glaucoma surgical preferences among glaucoma specialists in Spain.
Topics: Collagen; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Spain | 2022 |
Efficacy of ab-interno gelatin microstent implantation in primary and refractory glaucoma.
Topics: Adult; Gelatin; Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pres | 2023 |
One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis.
Topics: Cohort Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Trabeculec | 2023 |
Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma?
Topics: Choroidal Effusions; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Myopia | 2022 |
Current practice of trabeculectomy in a cohort of experienced glaucoma surgeons in Australia and New Zealand.
Topics: Australia; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; New Zealand; Retrospecti | 2023 |
The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy.
Topics: Cataract; Exfoliation Syndrome; Glaucoma; Humans; Intraocular Pressure; Lens Implantation, Intraocul | 2022 |
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.
Topics: Antihypertensive Agents; Cataract; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mit | 2022 |
The Norwich trabeculectomy study: risk factor analysis for the development of adverse, thin cystic blebs.
Topics: Antimetabolites; Conjunctiva; Factor Analysis, Statistical; Fluorouracil; Glaucoma; Humans; Intraocu | 2022 |
Glaucoma management in congenital ectropion uveae: Surgical outcomes from a large tertiary referral center in South India.
Topics: Ectropion; Follow-Up Studies; Glaucoma; Humans; Infant, Newborn; Intraocular Pressure; Mitomycin; Re | 2023 |
Early Complications and Results of Preserflo MicroShunt in the Management of Uncontrolled Open-Angle Glaucoma: A Case Series.
Topics: Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomycin; Tonometry, Oc | 2022 |
Two Year Outcomes of Trabeculectomy in Cytomegalovirus Anterior Uveitis with Uncontrolled Intraocular Pressure.
Topics: Cytomegalovirus; Cytomegalovirus Infections; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retr | 2023 |
Effects of topical docosahexaenoic acid on postoperative fibrosis in an animal model of glaucoma filtration surgery.
Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Fibrosis; Filtering Surgery; Glaucoma; Intra | 2023 |
Same-site trabeculectomy with mitomycin and Ologen™ following failed non-penetrating deep sclerectomy.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Scleros | 2023 |
[Trabeculectomy with mitomycin C and Ologen® implant in comparison to classical trabeculectomy].
Topics: Glaucoma; Humans; Mitomycin; Retrospective Studies; Trabeculectomy; Treatment Outcome | 2023 |
Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Mouse Model of Glaucoma Filtration Surgery and TGFβ1-Induced Responses in Human Tenon's Fibroblasts.
Topics: Animals; Collagen; Disease Models, Animal; Fibroblasts; Filtering Surgery; Flavonols; Glaucoma; Huma | 2022 |
Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome.
Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocorneal | 2023 |
Subconjunctival Lymphatics Respond to VEGFC and Anti-Metabolites in Rabbit and Mouse Eyes.
Topics: Animals; Antimetabolites; Conjunctiva; Dextrans; Fluorouracil; Glaucoma; Intraocular Pressure; Mice; | 2022 |
Trabeculectomy Tenon Advancement Technique May Reduce Bleb-Related Infections.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Postoperative Complications; | 2023 |
Differential effects of acetylsalicylic acid and mitomycin C on cytokine-induced Tenon's capsule myofibroblast transdifferentiation and activity: Implications for glaucoma surgery.
Topics: Aspirin; Cell Transdifferentiation; Cells, Cultured; Chromatography, Liquid; Cicatrix; Collagen; Cyt | 2022 |
Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C.
Topics: Cohort Studies; Endophthalmitis; Glaucoma; Humans; Mitomycin; Retrospective Studies; Trabeculectomy | 2023 |
Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study.
Topics: Cross-Sectional Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Protein Kinase Inhibitor | 2022 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
A comparative analysis of surgical outcome in uveitic and non-uveitic steroid-induced glaucoma in children.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Glaucoma; Humans; Male; Mitomycin; Retros | 2022 |
A comparative analysis of surgical outcome in uveitic and non-uveitic steroid-induced glaucoma in children.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Glaucoma; Humans; Male; Mitomycin; Retros | 2022 |
A comparative analysis of surgical outcome in uveitic and non-uveitic steroid-induced glaucoma in children.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Glaucoma; Humans; Male; Mitomycin; Retros | 2022 |
A comparative analysis of surgical outcome in uveitic and non-uveitic steroid-induced glaucoma in children.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Glaucoma; Humans; Male; Mitomycin; Retros | 2022 |
Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries.
Topics: Adolescent; Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Male; | 2023 |
Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma.
Topics: Glaucoma; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ph | 2023 |
One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma.
Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Prospective Studies; Treatm | 2023 |
Inadvertent filtering bleb due to extracapsular cataract extraction wound reopening after mitomycin C use: a case report.
Topics: Aged, 80 and over; Cataract Extraction; Female; Glaucoma; Humans; Mitomycin; Postoperative Complicat | 2023 |
ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts.
Topics: Cicatrix; Collagen; Fibroblasts; Glaucoma; Humans; Matrix Metalloproteinase 9; Mitomycin; Tenon Caps | 2023 |
The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits.
Topics: Animals; Cicatrix; Conjunctiva; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pressure; Matrix | 2023 |
Analysis of the Systemic Exposure of Mitomycin C Used in Glaucoma Filtering Surgery Among Women in the Reproductive Age Group.
Topics: Adolescent; Adult; Chromatography, Liquid; Female; Filtering Surgery; Glaucoma; Humans; Intraocular | 2023 |
Impact of postoperative choroidal detachment on trabeculectomy outcomes: a four-year comparative study.
Topics: Aged; Eye; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Retros | 2023 |
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 5 years of follow-up (Ophthalmology. 2022;129:1344-1356).
Topics: Eye; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomyci | 2023 |
A retrospective study to assess visual field improvement following augmented trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; M | 2023 |
Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement.
Topics: Eye; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Treatment Outcome | 2023 |
Augmented trabeculectomy - The surgical journey and road trip forward.
Topics: Eye; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outcome | 2023 |
Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.
Topics: Fibrosis; Glaucoma; Humans; Infant; Intraocular Pressure; Mitomycin; Retrospective Studies; Tonometr | 2023 |
Tube Versus Trabeculectomy IRIS Registry Study: 1-Year Secondary Treatment Outcomes.
Topics: Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies | 2023 |
Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand.
Topics: Adolescent; Adult; Child; Child, Preschool; Cornea; Female; Follow-Up Studies; Glaucoma; Glaucoma, O | 2023 |
Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma.
Topics: Exfoliation Syndrome; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospe | 2023 |
A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient.
Topics: Adult; Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mal | 2023 |
Surgical outcomes of trabeculectomy augmented with sub-Tenon injected mitomycin C.
Topics: Follow-Up Studies; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Trabecul | 2023 |
Change in visual acuity 12 and 24 months after transscleral ab interno glaucoma gel stent implantation with adjunctive Mitomycin C.
Topics: Aged; Female; Follow-Up Studies; Gels; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pre | 2019 |
Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
Topics: Adult; Aged; Alkylating Agents; Collagen; Female; Fibrosis; Follow-Up Studies; Glaucoma; Glaucoma Dr | 2019 |
Trabeculectomy followed by phacoemulsification versus trabeculectomy alone: The Collaborative Bleb-Related Infection Incidence and Treatment Study.
Topics: Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Ma | 2019 |
Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C.
Topics: Animals; Antimetabolites; Conjunctiva; Disease Models, Animal; Dogs; Filtering Surgery; Glaucoma; In | 2019 |
Chronic chorioretinal detachment under normal intraocular pressure in eye with uveitic glaucoma after trabeculectomy: A case report.
Topics: Antibiotics, Antineoplastic; Choroidal Effusions; Chronic Disease; Glaucoma; Humans; Intraocular Pre | 2020 |
The Tenons' Layer Reposition Approach of Trabeculectomy: A Longitudinal Case Series of a Mixed Group of Glaucoma Patients.
Topics: Adult; Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula | 2020 |
Reoperations for Complications Within 90 Days After Glaucoma Surgery.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Ciliary Body; Female; Glaucoma; Glaucoma Drainage | 2020 |
A Comparison of Trabeculectomy Surgery Outcomes With Mitomycin-C Applied by Intra-Tenon Injection Versus Sponge.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma; Humans; Injections, Intraocula | 2020 |
Bleb-related tuberculous endophthalmitis following combined phacoemulsification and trabeculectomy with mitomycin C.
Topics: Aged; Antitubercular Agents; Endophthalmitis; Glaucoma; Humans; Male; Mitomycin; Mycobacterium tuber | 2020 |
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin | 2020 |
Response to: Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin | 2020 |
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin | 2020 |
Response to letter to the Editor Regarding MMC and pH.
Topics: Blister; Filtering Surgery; Glaucoma; Humans; Hydrogen-Ion Concentration; Intraocular Pressure; Mito | 2020 |
Glaucoma Drainage Device Technique in a Cohort of Experienced Glaucoma Surgeons in Australia and New Zealand.
Topics: Adult; Aged; Alkylating Agents; Australia; Cohort Studies; Female; Glaucoma; Glaucoma Drainage Impla | 2020 |
Alteration of gene expression in mice after glaucoma filtration surgery.
Topics: Animals; Anti-Bacterial Agents; Conjunctiva; Filtering Surgery; Glaucoma; Mice; Mice, Inbred BALB C; | 2020 |
Outcomes and risk factors for failure after trabeculectomy in Taiwanese patients: medical chart reviews from 2006 to 2017.
Topics: Adult; Aged; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Retr | 2022 |
[Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C].
Topics: Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2021 |
A PVDF electrospun antifibrotic composite for use as a glaucoma drainage implant.
Topics: Aqueous Humor; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin | 2021 |
Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort.
Topics: Child; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; | 2021 |
National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK.
Topics: Glaucoma; Humans; Intraocular Pressure; Ireland; Mitomycin; Trabeculectomy; United Kingdom | 2021 |
Novel combination therapy reduces subconjunctival fibrosis after glaucoma filtration surgery in the rabbit model.
Topics: Animals; Conjunctiva; Disease Models, Animal; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pre | 2021 |
Common and rare complications following filtering surgery for children with congenital glaucoma; a5 years study.
Topics: Child; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complicat | 2021 |
Effect of oral statin use on mitomycin-C augmented trabeculectomy outcomes.
Topics: Administration, Oral; Adult; Aged; Antimetabolites; Female; Fluorouracil; Follow-Up Studies; Glaucom | 2021 |
Evaluating CO
Topics: Adult; Carbon Dioxide; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lasers; Mitomyc | 2021 |
The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery.
Topics: Animals; Filtering Surgery; Glaucoma; Intraocular Pressure; Male; Mitomycin; Pyridones; Rabbits; Tra | 2021 |
Long-term treatment outcomes for congenital ectropion uveae with ptosis and glaucoma.
Topics: Ectropion; Glaucoma; Humans; Intraocular Pressure; Iris Diseases; Mitomycin; Trabeculectomy; Treatme | 2020 |
Augmented trabeculectomy-outcomes of first hundred versus second hundred surgeries of a fellowship-trained glaucoma surgeon.
Topics: Fellowships and Scholarships; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; | 2022 |
Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma.
Topics: Child; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomy | 2021 |
Long-term outcomes of initial trabeculectomy in glaucoma associated with granulomatous and non-granulomatous uveitis.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; R | 2021 |
Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention.
Topics: Adolescent; Adult; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci | 2022 |
Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma.
Topics: Collagen; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans; Intraocular Pressure; Mitomycin; | 2022 |
Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique.
Topics: Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2022 |
RETINAL TOXICITY FOLLOWING PRESUMED INADVERTENT INTRAOCULAR INJECTION OF MITOMYCIN C DURING TRABECULECTOMY.
Topics: Glaucoma; Humans; Injections, Intraocular; Intraocular Pressure; Mitomycin; Retina; Trabeculectomy | 2023 |
Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Trabecu | 2021 |
Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients.
Topics: Adult; Alkylating Agents; Behcet Syndrome; Combined Modality Therapy; Conjunctiva; Female; Glaucoma; | 2017 |
Outcomes for Ab Interno Bleb Revision With a Novel Translimbal Sclerostomy Spatula.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; F | 2017 |
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag | 2017 |
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag | 2017 |
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag | 2017 |
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag | 2017 |
Regular Versus Releasable Sutures in Surgery for Primary Congenital Glaucoma.
Topics: Administration, Topical; Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Eq | 2017 |
Inhibition of Monocyte Chemoattractant Protein 1 Prevents Conjunctival Fibrosis in an Experimental Model of Glaucoma Filtration Surgery.
Topics: Animals; Antifibrinolytic Agents; Cell Survival; Chemokine CCL2; Collagen; Conjunctiva; Disease Mode | 2017 |
Intermediate Term Outcomes of Early Posttrabeculectomy Bleb Leaks Managed by Large Diameter Soft Bandage Contact Lens.
Topics: Adult; Alkylating Agents; Bandages; Contact Lenses, Hydrophilic; Female; Glaucoma; Humans; Intraocul | 2017 |
Posterior Surgical Revision of Failed Fornix-based Trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antihypertensive Agents; Conjunctiva; F | 2017 |
Primary Trabeculectomy Outcomes by Glaucoma Fellows in a Tertiary Hospital in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Blister; Brazil; Education, Medical, Graduate; Fe | 2017 |
Same-site surgical revision of failed trabeculectomy blebs with mitomycin C augmentation: long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2018 |
Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M | 2017 |
Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Collagen; Female; Follow-Up Studies; Glaucoma; Glycosami | 2018 |
Trabeculectomy bleb needling and antimetabolite administration practices in the UK: a glaucoma specialist national survey.
Topics: Antimetabolites; Cross-Sectional Studies; Dose-Response Relationship, Drug; Fluorouracil; Glaucoma; | 2018 |
Trabeculectomy Outcomes After Glaucoma Drainage Device Surgery.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma; Glaucoma Drainage Implants; Hum | 2018 |
Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations.
Topics: Aged; Alkylating Agents; Female; Filtering Surgery; Follow-Up Studies; Glaucoma; Humans; Intraocular | 2018 |
Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery.
Topics: Adult; Combined Modality Therapy; Glaucoma; Humans; Hydrophthalmos; Intraocular Pressure; Male; Mito | 2018 |
Results of an Adaptive Surgical Approach for Managing Late Onset Hypotony After Trabeculectomy With Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Blister; Combined Modality Therapy; Female; Glaucoma; Humans; Intrao | 2018 |
Ab Interno Gel Implant-associated Bleb-related Infection.
Topics: Aged; Alkylating Agents; Anti-Bacterial Agents; Endophthalmitis; Female; Follow-Up Studies; Gelatin; | 2018 |
Combined trabeculotomy-trabeculectomy using the modified Safer Surgery System augmented with MMC: its long-term outcomes of glaucoma treatment in Asian children.
Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Equipment Design; Female; Follow-U | 2018 |
Comment on: Viscoelastic-augmented trabeculectomy - A newer concept.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Sclera; Trabeculecto | 2018 |
[Long-Term Results after Trabeculectomy Combined with Mitomycin C and Ologen Implant].
Topics: Collagen; Combined Modality Therapy; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans; Intrao | 2019 |
Observational Outcomes of Initial Trabeculectomy With Mitomycin C in Patients of African Descent vs Patients of European Descent: Five-Year Results.
Topics: Aged; Alkylating Agents; Black or African American; Combined Modality Therapy; Female; Follow-Up Stu | 2018 |
Determining If Race Should Be Considered Within the Choice of Glaucoma Surgery.
Topics: Glaucoma; Humans; Mitomycin; Sclera; Trabeculectomy | 2018 |
Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study.
Topics: Animals; Anti-Inflammatory Agents; Blister; Conjunctiva; Disease Models, Animal; Drug Therapy, Combi | 2018 |
Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure.
Topics: Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Male | 2018 |
Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: A case report.
Topics: Alkylating Agents; Anterior Chamber; Chronic Disease; Filtering Surgery; Glaucoma; Humans; Intraocul | 2019 |
Outcomes of Laser Goniopuncture Following Nonpenetrating Deep Sclerectomy With Mitomycin C: A Large Retrospective Cohort Study.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-Up Studies; Glaucoma | 2019 |
Determinants of Corneal Endothelial Cell Loss After Trabeculectomy With Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Cell Count; Combined Modality Therapy; Corneal En | 2019 |
Ex-PRESS glaucoma shunt implantation and trabeculectomy combined with mitomycin C in the treatment of uveitic glaucoma.
Topics: Adult; Combined Modality Therapy; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Male; Middle | 2019 |
Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Child; Child, Preschool; Do | 2019 |
The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series.
Topics: Adult; Alkylating Agents; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomyc | 2019 |
Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis.
Topics: Adsorption; Cell-Derived Microparticles; Coated Materials, Biocompatible; Drug Liberation; Fibrosis; | 2019 |
[Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety].
Topics: Aged; Bevacizumab; Collagen; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Trabecu | 2020 |
Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model.
Topics: Absorbable Implants; Animals; Drug Delivery Systems; Drug Implants; Drug Liberation; Endophthalmitis | 2019 |
Phacotrabeculectomy in Eyes With Uveitic Glaucoma: A Retrospective Case-Control Study.
Topics: Adult; Aged; Case-Control Studies; Combined Modality Therapy; Female; Glaucoma; Glaucoma, Open-Angle | 2019 |
Comparison of 2-year-results of mitomycin C-augmented trabeculectomy with or without cataract extraction in glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma; | 2019 |
Outcomes of Wider Area Bleb Revision Using Bleb Knife With Adjunctive Mitomycin C.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Filtering Surgery; Glaucoma; | 2019 |
[Ocular decompression retinopathy with pre-retinal hemorrhage after trabeculectomy: A case report].
Topics: Child; Female; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Mitomycin; Postoperative Hemorr | 2019 |
Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops.
Topics: Female; Follow-Up Studies; Glaucoma; Humans; Incidence; Intraocular Pressure; Japan; Male; Middle Ag | 2020 |
Deep sclerectomy with bevacizumab and mitomycin C: a comparative study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ca | 2015 |
Mitomycin solution (Mitosol) for glaucoma surgery.
Topics: Cicatrix; Glaucoma; Humans; Mitomycin; Solutions | 2013 |
Polypropylene vs silicone Ahmed valve with adjunctive mitomycin C in paediatric age group: a prospective controlled study.
Topics: Alkylating Agents; Analysis of Variance; Child; Child, Preschool; Female; Glaucoma; Glaucoma Drainag | 2013 |
Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Endotamponade; Female; Follow-Up Studies; Glaucom | 2014 |
Comparison of trabeculectomy with mitomycin-C versus medical treatment in moderate stage of steroid induced glaucoma.
Topics: Administration, Topical; Adolescent; Adult; Alkylating Agents; Child; Combined Modality Therapy; Fem | 2013 |
Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery.
Topics: Administration, Topical; Analysis of Variance; Animals; Anti-Infective Agents, Local; Antibiotics, A | 2013 |
Ocular surface complications after trabeculectomy: incidence, risk factors, time course and prognosis.
Topics: Alkylating Agents; Corneal Diseases; Female; Glaucoma; Humans; Incidence; Male; Middle Aged; Mitomyc | 2013 |
Combination therapy to reduce conjunctival scarring after glaucoma surgery.
Topics: Alkylating Agents; Apoptosis; Calcium Channel Blockers; Cicatrix; Conjunctival Diseases; Cyclosporin | 2013 |
Anterior lens capsule application in phacotrabeculectomy.
Topics: Alkylating Agents; Female; Glaucoma; Humans; Lens Capsule, Crystalline; Male; Mitomycin; Phacoemulsi | 2013 |
Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery.
Topics: Cell Proliferation; Cicatrix; Drug Delivery Systems; Filtering Surgery; Glaucoma; Humans; Mitomycin; | 2013 |
Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Child; Child, Preschool; Female; Glau | 2013 |
Outcomes of same-site re-operation with minimal use of mitomycin in failed trabeculectomy.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Female; Glaucom | 2014 |
Epiconjunctival mitomycin-C application for early failing filtering blebs.
Topics: Alkylating Agents; Conjunctiva; Female; Fibrosis; Glaucoma; Humans; Intraocular Pressure; Male; Midd | 2014 |
Postoperative flat anterior chamber: incidence, risk factors, and effect on the long-term success of trabeculectomy.
Topics: Alkylating Agents; Anterior Chamber; Female; Glaucoma; Humans; Incidence; Intraocular Pressure; Male | 2013 |
Fornix-based Trabeculectomy With Mitomycin C Using the Horizontal Conjunctival Suture Technique.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma; Humans; Intraocula | 2015 |
Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Collagen; Combined Modality Therapy; Female; Glaucoma; G | 2014 |
Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Anterior Eye Segment; Combined Modality Therapy; Cross-S | 2014 |
Nd:YAG laser goniopuncture for late bleb failure after trabeculectomy with adjunctive mitomycin C.
Topics: Aged; Alkylating Agents; Female; Fluorouracil; Glaucoma; Gonioscopy; Humans; Intraocular Pressure; L | 2014 |
Reply to Kivelä et al.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2014 |
Interval censoring and competing risks when reporting results of glaucoma surgery.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2014 |
The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Anti-Bacterial Agents; Cohort Studies | 2014 |
Long-term outcomes of resident- versus attending-performed primary trabeculectomy with mitomycin C in a United States residency program.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Clinical Competence; Cohort Studies; Combined Mod | 2014 |
Novel technique for posterior placement of mitomycin-soaked sponges in glaucoma surgery.
Topics: Alkylating Agents; Glaucoma; Humans; Mitomycin; Sclera; Surgical Sponges; Tenon Capsule; Trabeculect | 2014 |
Traumatic aniridia after trabeculectomy.
Topics: Aniridia; Eye Injuries; Glaucoma; Humans; Intraocular Pressure; Iris; Male; Middle Aged; Mitomycin; | 2014 |
Efficacy and safety of mitomycin C--augmented revisions of non-functioning filtering blebs after trabeculectomy--7 year results.
Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure; Male; M | 2013 |
Qualitative and quantitative analysis of filtering blebs with optical coherence tomography.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma; Humans; Intraocula | 2014 |
CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.
Topics: Alkylating Agents; Animals; Chitosan; Conjunctiva; Disease Models, Animal; Drug Carriers; Fibrosis; | 2014 |
Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy.
Topics: Adult; Aged; Blister; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Male; M | 2014 |
Topical infliximab for the suppression of wound healing following experimental glaucoma filtration surgery.
Topics: Animals; Antibodies, Monoclonal; Fibroblast Growth Factors; Filtering Surgery; Glaucoma; Infliximab; | 2014 |
Meibomian gland loss due to trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Blister; Conjunctiva; Cross-Sectional Studies; Ey | 2014 |
Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil.
Topics: Aged; Alkylating Agents; Anthracenes; Antihypertensive Agents; Collagen; Combined Modality Therapy; | 2015 |
Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery.
Topics: Animals; Apoptosis; Biocompatible Materials; Drug Delivery Systems; Drug Implants; Filtering Surgery | 2014 |
Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique.
Topics: Administration, Topical; Adult; Cysts; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implan | 2014 |
Conjunctival Advancement With Subconjunctival Amniotic Membrane Draping Technique for Leaking Cystic Blebs.
Topics: Adult; Aged; Alkylating Agents; Amnion; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure; | 2016 |
Long-term outcomes of needle revision of failing deep sclerectomy blebs.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans | 2015 |
Incidence of Postoperative Ptosis Following Trabeculectomy With Mitomycin C.
Topics: Adult; Aged; Alkylating Agents; Blepharoptosis; Female; Glaucoma; Humans; Incidence; Intraocular Pre | 2015 |
The Long-term Outcomes of Glaucoma Drainage Device in Pediatric Glaucoma.
Topics: Adolescent; Alkylating Agents; Child; Child, Preschool; Female; Follow-Up Studies; Glaucoma; Glaucom | 2016 |
Reply to "Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use".
Topics: Alkylating Agents; Anterior Eye Segment; Female; Glaucoma; Humans; Male; Mitomycin; Sclera; Sclerost | 2015 |
Combined deep sclerectomy and descemet stripping automated endothelial keratoplasty.
Topics: Aged; Aged, 80 and over; Cell Count; Cornea; Corneal Edema; Descemet Stripping Endothelial Keratopla | 2014 |
Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use.
Topics: Alkylating Agents; Anterior Eye Segment; Female; Glaucoma; Humans; Male; Mitomycin; Sclera; Sclerost | 2015 |
Risk Factors for a Severe Bleb Leak Following Trabeculectomy: A Retrospective Case-Control Study.
Topics: Age Factors; Aged; Alkylating Agents; Case-Control Studies; Female; Glaucoma; Humans; Intraocular Pr | 2015 |
Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography.
Topics: Aged; Alkylating Agents; Aqueous Humor; Conjunctiva; Cross-Sectional Studies; Female; Fistula; Glauc | 2015 |
Outcomes of chronic hypotony following trabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Chronic Disease; Female; Glaucoma; Humans; Intraocular P | 2015 |
Nonpenetrating deep sclerectomy for glaucoma after descemet stripping automated endothelial keratoplasty: three consecutive case reports.
Topics: Administration, Topical; Aged; Descemet Stripping Endothelial Keratoplasty; Female; Glaucoma; Humans | 2015 |
Trabeculectomy-related complications in Olmsted County, Minnesota, 1985 through 2010.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Child; Child, Preschool; Female; Foll | 2015 |
Surgical results of trabeculectomy and Ahmed valve implantation following a previous failed trabeculectomy in primary congenital glaucoma patients.
Topics: Child, Preschool; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; I | 2015 |
Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome.
Topics: Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoperative Period; Iridocorne | 2016 |
Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Animals; Bevacizumab; Chemotherapy, Adjuvant; Disease Mo | 2015 |
The effect of adjustable suture (Khaw) trabeculectomy on intraocular pressure: a retrospective case series.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mi | 2016 |
Fluctuation of Bacteria on Bleb Surface After Trabeculectomy With Adjunctive Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Bacteria; Combined Modality Therapy; Conjunctiva; | 2016 |
Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-U | 2015 |
Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure | 2015 |
[One-year results on the safety and efficacy of the InnFocus MicroShunt™ depending on placement and concentration of mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Filtering Surgery; Glaucoma; Humans; Intr | 2015 |
A Novel Method for the Delivery of Antimetabolites During Glaucoma Surgery.
Topics: Antimetabolites; Drug Delivery Systems; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postopera | 2016 |
Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Bevacizumab; Bl | 2015 |
Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens.
Topics: Adolescent; Adult; Aged; Child; Female; Glaucoma; Humans; Intraocular Pressure; Lens Subluxation; Le | 2016 |
Concentration Accuracy of Compounded Mitomycin C for Ophthalmic Surgery.
Topics: Alkylating Agents; Chromatography, High Pressure Liquid; Drug Compounding; Drug Storage; Fibrosis; G | 2016 |
A role for antimetabolites in glaucoma tube surgery: current evidence and future directions.
Topics: Animals; Antimetabolites; Fibrosis; Fluorouracil; Glaucoma; Humans; Mitomycin; Trabeculectomy | 2016 |
A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Exfoliation Syndrome; F | 2016 |
Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification.
Topics: Aged; Alkylating Agents; Blepharoptosis; Cataract; Combined Modality Therapy; Female; Glaucoma; Huma | 2015 |
Intraoperative transconjunctival mitomycin-C application for needle revision of trabeculectomy.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-Up Studies; Glaucoma | 2016 |
Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease.
Topics: Adult; Alkylating Agents; Cohort Studies; Combined Modality Therapy; Conjunctiva; Female; Glaucoma; | 2016 |
Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Cataract Extraction; Female; Glaucoma; Humans; Intraocular Pressure; | 2014 |
Transconjunctival Revision With Mitomycin-C Following Failed Trabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Fluorour | 2016 |
Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Female; Glaucoma; Glaucoma, Open-Angle; Human | 2016 |
Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliatio | 2016 |
Tube Fenestration in the Tube Versus Trabeculectomy Study.
Topics: Aged; Alkylating Agents; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; | 2016 |
Additive Effect of Risk Factors for Trabeculectomy Failure in Glaucoma Patients: A Risk-group From a Cohort Study.
Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Predictiv | 2016 |
Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Drug T | 2017 |
The Combination of PlGF Inhibition and MMC as a Novel Anti-Scarring Strategy for Glaucoma Filtration Surgery.
Topics: Animals; Anterior Chamber; Blood Proteins; Cicatrix; Disease Models, Animal; Filtering Surgery; Glau | 2016 |
α5β1-Integrin inhibitor (CLT-28643) effective in rabbit trabeculectomy model.
Topics: Administration, Topical; Alkylating Agents; Aminoquinolines; Animals; Collagen; Conjunctiva; Disease | 2017 |
Re: Panarelli et al.: A retrospective comparison of primary Baerveldt implantation versus trabeculectomy with mitomycin C (Ophthalmology 2016;123:789-95).
Topics: Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Postoperative Complic | 2016 |
Revision of trabeculectomy filtering blebs with mitomycin C: Long term results.
Topics: Aged; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Nucleic Ac | 2016 |
Outcome of repeat trabeculectomies: long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Stud | 2017 |
Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma.
Topics: Adolescent; Alkylating Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Glaucoma; | 2017 |
Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma.
Topics: Adult; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studies; Glaucoma; Humans; Intr | 2017 |
Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery.
Topics: Animals; Ciliary Body; Conjunctiva; Cornea; Glaucoma; Hydroxamic Acids; Indoles; Matrix Metalloprote | 2017 |
Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; | 2008 |
Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Cataract Extraction; Combined Modalit | 2008 |
Efficacy and safety of deep sclerectomy in uveitic glaucoma.
Topics: Adolescent; Adult; Child; Drug Delivery Systems; Female; Glaucoma; Glaucoma Drainage Implants; Human | 2009 |
A modified technique of Ahmed glaucoma valve implantation with adjunctive use of antifibrotic agents.
Topics: Alkylating Agents; Combined Modality Therapy; Fibrosis; Fluorouracil; Glaucoma; Glaucoma Drainage Im | 2008 |
Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application.
Topics: Aged; Blister; Glaucoma; Humans; Incidence; Intraocular Pressure; Intraoperative Care; Middle Aged; | 2008 |
Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up.
Topics: Adolescent; Age Distribution; Antibiotics, Antineoplastic; Child; Child, Preschool; Combined Modalit | 2008 |
Australia and New Zealand survey of antimetabolite and steroid use in trabeculectomy surgery.
Topics: Antimetabolites; Australia; Cross-Sectional Studies; Fluorouracil; Glaucoma; Glucocorticoids; Health | 2008 |
The surgical outcome of primary trabeculectomy with mitomycin C and A fornix-based conjunctival flap technique in Thailand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Child; Female; Glaucoma; Humans; Male | 2008 |
Intraoperative mitomycin C use during filtration surgery and lacrimal drainage system obstruction.
Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Dacryocystorhinostomy; Female | 2009 |
Stratus optical coherence tomography study of filtering blebs after primary trabeculectomy with a fornix-based conjunctival flap.
Topics: Adult; Aged; Aged, 80 and over; Blister; Conjunctiva; Exfoliation Syndrome; Female; Glaucoma; Glauco | 2010 |
Decompression retinopathy and possible risk factors.
Topics: Child; Decompression, Surgical; Eye Diseases; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci | 2009 |
Superior versus inferior Ahmed glaucoma valve implantation.
Topics: Adult; Antihypertensive Agents; Equipment Safety; Female; Follow-Up Studies; Glaucoma; Glaucoma Drai | 2009 |
Block suture for trabeculectomy using only 2 anchors.
Topics: Alkylating Agents; Conjunctiva; Glaucoma; Humans; Intraocular Pressure; Intraoperative Complications | 2008 |
Trabeculectomy surgery augmented with intra-Tenon injection of mitomycin C.
Topics: Aged; Blister; Choroid Diseases; Cysts; Eye Diseases; Glaucoma; Humans; Hyphema; Injections; Intraoc | 2008 |
Slit-lamp-adapted optical coherence tomography for assessment of an overhanging filtering bleb.
Topics: Aged; Alkylating Agents; Blister; Combined Modality Therapy; Conjunctival Diseases; Diagnostic Techn | 2010 |
Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Female; Fluorouracil; F | 2009 |
A thin honeycomb-patterned film as an adhesion barrier in an animal model of glaucoma filtration surgery.
Topics: Absorbable Implants; Animals; Blister; Conjunctival Diseases; Disease Models, Animal; Filtering Surg | 2009 |
Late-onset bleb leakage.
Topics: Aged; Blister; Fluorescein; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Ocular Hypotens | 2009 |
Histopathology of a functioning mitomycin-C trabeculectomy.
Topics: Anterior Eye Segment; Blister; Eye Enucleation; Glaucoma; Humans; Iris Neoplasms; Male; Melanoma; Mi | 2009 |
The increasingly iatrogenic indications for mitomycin C trabeculectomy over 10 years.
Topics: Alkylating Agents; Combined Modality Therapy; Corneal Transplantation; Female; Glaucoma; Humans; Iat | 2009 |
Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Education, Medical, Co | 2009 |
Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C.
Topics: Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage | 2009 |
High-definition imaging of trabeculectomy blebs using spectral domain optical coherence tomography adapted for the anterior segment.
Topics: Aged; Anterior Eye Segment; Blister; Combined Modality Therapy; Cross-Sectional Studies; Female; Gla | 2009 |
Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study.
Topics: Antibiotics, Antineoplastic; Conjunctival Diseases; Female; Fibroblasts; Fibrosis; Glaucoma; Humans; | 2009 |
Noncontact in vivo scanning laser microscopy of filtering blebs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aqueous Humor; Blister; Combined Modality Therapy; Conju | 2009 |
Three-dimensional high-speed optical coherence tomography for diagnosis of hypotony maculopathy after glaucoma filtration surgery.
Topics: Aged; Alkylating Agents; Female; Glaucoma; Humans; Imaging, Three-Dimensional; Intraocular Pressure; | 2010 |
Conjunctival and corneal findings in bleb-associated endophthalmitis: an in vivo confocal microscopy study.
Topics: Aged; Aged, 80 and over; Blister; Case-Control Studies; Conjunctivitis; Endophthalmitis; Female; Gla | 2011 |
Ab-externo cyclodialysis enhanced trabeculectomy for intractable post-penetrating keratoplasty glaucoma.
Topics: Cornea; Female; Glaucoma; Graft Survival; Humans; Intraocular Pressure; Keratoplasty, Penetrating; M | 2010 |
Glaucoma surgery decreases the rates of localized and global visual field progression.
Topics: Algorithms; Disease Progression; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular P | 2010 |
Early trabeculectomy bleb walls on anterior-segment optical coherence tomography.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Blister; Conjunctiva; Cross-Sectional Studies; Fe | 2010 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Antihypertensive Agents; Cataract Extraction; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implant | 2010 |
Corneal complications of intraoperative Mitomycin C in glaucoma surgery.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antifibrinolytic Agents; Corneal Diseases; Epithelium, C | 2010 |
Pediatric Ahmed valves.
Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; | 2010 |
Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Equipment Design; Female; Follow-Up Studies; Glaucoma; Hu | 2010 |
Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years.
Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mi | 2010 |
Mitomycin-C and pediatric Ahmed valves.
Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; | 2010 |
An experimental study of rabbit conjunctival epithelial toxicity using co-treatment with mitomycin-C and a histone deacetylase inhibitor.
Topics: Alkylating Agents; Animals; Apoptosis; Cells, Cultured; Conjunctiva; Drug Therapy, Combination; Epit | 2010 |
Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Combined Modality Therapy; Eye In | 2011 |
Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Aqueous Humor; Cell Count; Child; Chi | 2011 |
Cationic nano-copolymers mediated IKKβ targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery.
Topics: Animals; Biological Assay; Cations; Cell Count; Cell Proliferation; Cell Survival; Disease Models, A | 2010 |
Update on congenital glaucoma.
Topics: Adrenergic Agents; Adrenergic Antagonists; Carbonic Anhydrase Inhibitors; Cryotherapy; Glaucoma; Gla | 2011 |
Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cross-Linking Reagents; Femal | 2011 |
Antimetabolite application technique in trabeculectomy surgery.
Topics: Antimetabolites; Drug Delivery Systems; Fibrosis; Fluorouracil; Glaucoma; Humans; Intraoperative Car | 2011 |
Reversal of optic disc cupping with improvement of visual field and stereometric parameters after trabeculectomy in young adult patients (two case reports).
Topics: Adolescent; Adult; Female; Follow-Up Studies; Glaucoma; Humans; Male; Mitomycin; Optic Disk; Trabecu | 2010 |
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.
Topics: Actins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Ce | 2011 |
Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Cornea; Female; Glaucoma; Humans; Intraocular Pr | 2013 |
Childhood orbitotemporal neurofibromatosis masked by congenital glaucoma and buphthalmos.
Topics: Alkylating Agents; Diagnosis, Differential; Glaucoma; Humans; Hydrophthalmos; Infant; Magnetic Reson | 2011 |
Vision loss and recovery after trabeculectomy: risk and associated risk factors.
Topics: Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Postoperative Complications; | 2011 |
Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.
Topics: Alkylating Agents; Animals; Antibodies, Monoclonal, Humanized; Cicatrix; Conjunctiva; Disease Models | 2013 |
Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia.
Topics: Aged; Analysis of Variance; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Mal | 2012 |
Changing trends in the incidence of bleb-related infection in trabeculectomy.
Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Endophthalmitis; Eye Infecti | 2012 |
Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery.
Topics: Administration, Topical; Alkylating Agents; Animals; Cicatrix; Conjunctival Diseases; Disease Models | 2012 |
Outcomes of trabeculectomy after descemet stripping automated endothelial keratoplasty: a comparison with penetrating keratoplasty.
Topics: Alkylating Agents; Case-Control Studies; Descemet Stripping Endothelial Keratoplasty; Female; Glauco | 2012 |
Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex® or mitomycin-C.
Topics: Animals; Anterior Chamber; Collagen; Conjunctiva; Delayed-Action Preparations; Dexamethasone; Filter | 2012 |
Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model.
Topics: Administration, Topical; Animals; Blood Platelets; Cicatrix; Disease Models, Animal; Eye; Fibrosis; | 2012 |
Different fibroblast subpopulations of the eye: a therapeutic target to prevent postoperative fibrosis in glaucoma therapy.
Topics: Adipose Tissue; Cell Culture Techniques; Cell Proliferation; Choroid; Extracellular Matrix Proteins; | 2012 |
Prognostic risk factors for failure of trabeculectomy with mitomycin C after vitrectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma; Huma | 2012 |
Comparative study of encapsulated blebs following Ahmed glaucoma valve implantation and trabeculectomy with mitomycin-C.
Topics: Adult; Blister; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; Male; Middle Aged; Mit | 2012 |
Histological and ultrastructural features for proliferation inhibition by delivery of exogenous p27Kip1 to rabbit models after glaucoma filtration surgery.
Topics: Adenoviridae; Animals; Cell Proliferation; Cicatrix; Conjunctiva; Cyclin-Dependent Kinase Inhibitor | 2012 |
Mitomycin-augmented non-penetrating deep sclerectomy: preoperative gonioscopy and postoperative perimetric, tonometric and medication trends.
Topics: Aged; Antibiotics, Antineoplastic; Female; Follow-Up Studies; Glaucoma; Gonioscopy; Humans; Intraocu | 2013 |
Interval censoring for survival curves when reporting the results of glaucoma surgery.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2013 |
Response to Dulku and de Klerk and Moriarty.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2013 |
Comment on 'deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia'.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2013 |
Surgical outcome of mitomycin C-soaked collagen matrix implant in trabeculectomy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Collagen; Cross-Linking Reagents; Female; Follow-U | 2013 |
Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year.
Topics: Absorbable Implants; Aged; Alkylating Agents; Cataract; Collagen; Female; Glaucoma; Glycosaminoglyca | 2013 |
Subconjunctival bevacizumab as an adjuvant in first-time filtration surgery for patients with primary glaucomas.
Topics: Aged; Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Bevac | 2013 |
[Where should we go in the post-mitomycin era of glaucoma surgery?].
Topics: Glaucoma; Humans; Mitomycin | 2002 |
Trabeculectomy with antiproliferative agents in uveitic glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineopla | 2002 |
Comparison of the Ahmed Glaucoma Valve, the Krupin Eye Valve with Disk, and the double-plate Molteno implant.
Topics: Adult; Aged; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Life Tables; Middle | 2002 |
[Long-term follow-up of mitomycin C in trabeculectomy].
Topics: Adolescent; Adult; Female; Follow-Up Studies; Glaucoma; Humans; Male; Microsurgery; Mitomycin; Nucle | 2000 |
[Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid].
Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Disease Progression; Drug Evaluation; Drug Therapy, Co | 2002 |
Standardization of the dose of intraoperative mitomycin C in trabeculectomy.
Topics: Antibiotics, Antineoplastic; Glaucoma; Humans; Intraoperative Period; Mitomycin; Trabecular Meshwork | 2002 |
Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata.
Topics: Corneal Diseases; Endothelium, Corneal; Glaucoma; Humans; Mitomycin; Trabeculectomy | 2002 |
Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glau | 2002 |
Clinical experience of e-PTFE membrane implant surgery for refractory glaucoma.
Topics: Adult; Aged; Equipment Design; Female; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Huma | 2003 |
Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
Topics: Adolescent; Aphakia, Postcataract; Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Child; Chi | 2003 |
[Interferon-alpha 2b inhibits proliferation of human tenon capsule fibroblasts].
Topics: Antimetabolites; Cell Division; Cells, Cultured; Conjunctiva; Fibroblasts; Filtering Surgery; Fluoro | 1998 |
Five-year results of trabeculectomy with mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocular Pre | 2003 |
Fornix-based trabeculectomy using the 'anchoring' corneal suture technique.
Topics: Adult; Antibiotics, Antineoplastic; Asian People; Combined Modality Therapy; Conjunctiva; Cornea; Fe | 2003 |
Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application.
Topics: Analysis of Variance; Diffusion; Dose-Response Relationship, Drug; Glaucoma; Humans; In Vitro Techni | 2002 |
The Armenian Eye Care Project: surgical outcomes of complicated paediatric glaucoma.
Topics: Adolescent; Anti-Bacterial Agents; Armenia; Child; Cohort Studies; Glaucoma; Humans; Intraocular Pre | 2003 |
Effects of thick Tenon's capsule on primary trabeculectomy with mitomycin-C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Connective Tissue; Female; Glaucom | 2003 |
Mitomycin C eliminates the short-term intraocular pressure rise found following Molteno tube implantation.
Topics: Adult; Aged; Glaucoma; Humans; Intraoperative Care; Male; Middle Aged; Mitomycin; Molteno Implants; | 2003 |
Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up.
Topics: Adult; Aged; Female; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Intrao | 2003 |
[Improve the quality of glaucoma surgery].
Topics: Filtering Surgery; Glaucoma; Humans; Mitomycin | 1998 |
Effects of systemic octreotide, local mytomycine-C and local corticosteroids on wound-healing reaction after glaucoma surgery.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Ciliary Body; Conjunctiva; Fibroblasts; F | 2001 |
[Clinical experiences and results of application of mitomycin C in trabeculectomy].
Topics: Aged; Choroid Diseases; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Intr | 2003 |
Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C.
Topics: Adult; Antibiotics, Antineoplastic; Child; Combined Modality Therapy; Conjunctival Diseases; Cysts; | 2003 |
Needling revision of failed filtering blebs after trabeculectomy: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Child, Preschool; Conjunctiva; Female; Fluorouracil; Follow-Up Studi | 2003 |
Amnion-shielded trabeculectomy.
Topics: Amnion; Aqueous Humor; Biological Dressings; Chronic Disease; Glaucoma; Humans; Intraocular Pressure | 2003 |
Mitomycin C trabeculectomy in an eye with cicatricial conjunctiva following amniotic membrane transplantation.
Topics: Adult; Amnion; Antibiotics, Antineoplastic; Biological Dressings; Cicatrix; Conjunctival Diseases; G | 2003 |
Aqueous shunt devices compared with trabeculectomy with Mitomycin-C for children in the first two years of life.
Topics: Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Glaucoma; Glaucoma Drainage I | 2003 |
The case against glaucoma drainage implant surgery in patients with a poor prognosis for standard filtering procedure.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Fibrosis; Fluorouracil; Glaucoma; Glau | 2004 |
Effect of human RAD50 gene therapy on glaucoma filtering surgery in rabbit eye.
Topics: Animals; Cell Division; Conjunctiva; DNA-Binding Proteins; Fibroblasts; Fibrosis; Genetic Therapy; G | 2004 |
Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension.
Topics: Adenoviridae; Animals; Antimetabolites; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; | 2004 |
Consultation section. Refractive surgical problem.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antihypertensive Agents; Astigmatism; Corneal | 2004 |
Recurrent retinal haemorrhages after glaucoma surgery.
Topics: Adolescent; Antibiotics, Antineoplastic; Combined Modality Therapy; Fluorescein Angiography; Glaucom | 2004 |
Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C.
Topics: Antibiotics, Antineoplastic; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; | 2004 |
Clinical and anatomical reversal of long-term hypotony maculopathy.
Topics: Antibiotics, Antineoplastic; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure; Middle Age | 2004 |
Aqueous shunt devices compared with trabeculectomy with mitomycin-C for children in the first two years of life.
Topics: Antibiotics, Antineoplastic; Aqueous Humor; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; In | 2004 |
Trabeculectomy outcomes in a Malaysian general hospital.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Chemotherapy, Adjuvant; Combined Modality Therapy; | 2003 |
Trabeculectomy and antimetabolites.
Topics: Antimetabolites; Cicatrix; Clinical Competence; Fluorouracil; Glaucoma; Humans; Mitomycin; Trabecule | 2004 |
National survey of antimetabolite use in glaucoma surgery in the United Kingdom.
Topics: Antimetabolites; Fluorouracil; Glaucoma; Health Care Surveys; Humans; Intraoperative Care; Mitomycin | 2004 |
Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Cataract Extraction | 2004 |
Fornix vs limbal-based trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chi-Square Distribution; Cornea; Female | 2005 |
[Surgical management of pathologic filtering blebs in pediatric glaucoma].
Topics: Adolescent; Anti-Bacterial Agents; Blister; Child; Endophthalmitis; Female; Glaucoma; Humans; Male; | 2004 |
An explanation of transient visual loss associated with leaking filtering bleb.
Topics: Aqueous Humor; Cornea; Female; Fluorophotometry; Glaucoma; Humans; Middle Aged; Mitomycin; Postopera | 2004 |
Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease.
Topics: Adolescent; Adult; Aged; Behcet Syndrome; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocu | 2004 |
Foldable acrylic versus rigid polymethylmethacrylate intraocular lens in combined phacoemulsification and trabeculectomy.
Topics: Aged; Antibiotics, Antineoplastic; Biocompatible Materials; Cataract; Glaucoma; Hospitals, Universit | 2004 |
Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Conjunct | 2005 |
Augmented trabeculectomy in paediatric glaucoma.
Topics: Antimetabolites; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorouracil; Glaucoma; | 2005 |
Histopathologic features of conjunctival filtering blebs.
Topics: Cell Count; Conjunctiva; Epithelial Cells; Fibrosis; Fluorouracil; Glaucoma; Goblet Cells; Humans; M | 2005 |
2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use.
Topics: Antineoplastic Agents; Drug Utilization; Fibrosis; Filtering Surgery; Fluorouracil; Glaucoma; Glauco | 2005 |
Deep sclerectomy augmented with mitomycin C.
Topics: Aged; Antihypertensive Agents; Blister; Cicatrix; Conjunctiva; Epidemiologic Methods; Exudates and T | 2005 |
[Clinical results of fornix-based trabeculectomy with a scleral tunnel].
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M | 2005 |
Correlation between surgical success rate and severity of congenital glaucoma.
Topics: Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Intraocular Press | 2005 |
Macular hole and sub-hyaloid hemorrhage following filtering surgery with mitomycin C.
Topics: Child; Combined Modality Therapy; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Retinal H | 2005 |
Protocol for mitomycin C use in glaucoma surgery.
Topics: Aged; Antibiotics, Antineoplastic; Clinical Protocols; Conjunctiva; Female; Glaucoma; Humans; Intrao | 2005 |
Effectiveness of octreotide, an antiproliferative agent, on wound healing reaction after glaucoma surgery in an experimental rabbit model.
Topics: Animals; Antineoplastic Agents, Hormonal; Ciliary Body; Glaucoma; Mitomycin; Octreotide; Uveal Disea | 2004 |
Effects of mitomycin C on glaucoma filtration capsules.
Topics: Animals; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Fibrosis; Glaucoma; Glaucoma Drainage | 2005 |
Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
Topics: Animals; Antibiotics, Antineoplastic; Cicatrix; Conjunctiva; Disease Models, Animal; Enzyme Inhibito | 2005 |
Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy.
Topics: Aged; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Intraoper | 2005 |
Bullous keratopathy as a complication of trabeculectomy with mitomycin C.
Topics: Adult; Corneal Diseases; Endothelium, Corneal; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; | 2005 |
[Characteristics of filtering blebs after fornix-based trabeculectomy with a scleral tunnel].
Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula | 2005 |
Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Glaucoma; | 2005 |
Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions.
Topics: Aged; Aged, 80 and over; Biometry; Cataract; Cornea; Eye; Female; Glaucoma; Humans; Intraocular Pres | 2005 |
Short term experience with "modern" trabeculectomy augmented with intraoperative antimetabolites.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Fluorouracil; Follow-Up Studies; Glauco | 2005 |
Corneal honeybee sting.
Topics: Aged; Animals; Bees; Corneal Diseases; Corneal Injuries; Eye Foreign Bodies; Glaucoma; Humans; Insec | 2005 |
Autosomal dominant Weill-Marchesani syndrome and glaucoma management.
Topics: Abnormalities, Multiple; Adolescent; Chromosome Disorders; Dwarfism; Eye Abnormalities; Follow-Up St | 2005 |
Trabeculectomy with mitomycin C in glaucoma associated with uveitis.
Topics: Adult; Antimetabolites; Croatia; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care | 2005 |
Intermediate-term comparison of trabeculectomy with intraoperative mitomycin-C between Asian American and Caucasian glaucoma patients: a case-controlled comparison.
Topics: Adult; Aged; Asian; Combined Modality Therapy; Epidemiologic Methods; Female; Glaucoma; Humans; Intr | 2007 |
Cyclosporin as an adjunct to glaucoma filtration surgery.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiv | 2005 |
Is intraocular pressure in the early postoperative period predictive of antimetabolite-augmented filtration surgery success?
Topics: Aged; Antimetabolites; Combined Modality Therapy; Female; Fluorouracil; Glaucoma; Humans; Intraocula | 2005 |
Deep sclerectomy with mitomycin C in failed trabeculectomy.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Chemotherapy, Adjuvant; Drug Administration Schedu | 2007 |
Comparison of two clinical Bleb grading systems.
Topics: Blister; Diagnostic Techniques, Ophthalmological; Fluorouracil; Glaucoma; Humans; Mitomycin; Prospec | 2006 |
Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks.
Topics: Aged; Blister; Conjunctiva; Conjunctival Diseases; Female; Fluorouracil; Glaucoma; Humans; Intraocul | 2006 |
Short and long term effect of combined cataract and glaucoma surgery with MMC on ocular dimensions.
Topics: Antihypertensive Agents; Cataract Extraction; Glaucoma; Humans; Intraocular Pressure; Mitomycin | 2006 |
Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
Topics: Antihypertensive Agents; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy | 2006 |
Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes.
Topics: Adult; Antibiotics, Antineoplastic; Cataract; Follow-Up Studies; Glaucoma; Humans; Intraocular Press | 2006 |
Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C.
Topics: Adolescent; Adult; Aged; Antimetabolites; Blister; Child; Combined Modality Therapy; Conjunctiva; Co | 2006 |
Surgical reduction of symptomatic, circumferential, filtering blebs.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Conjunctiv | 2006 |
Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels.
Topics: Adult; Cell Proliferation; Cells, Cultured; Conjunctiva; Dose-Response Relationship, Drug; Drug Deli | 2006 |
Review of consecutive phacotrabeculectomies supplemented with early needle revision and antimetabolites.
Topics: Aged; Aged, 80 and over; Antimetabolites; Cataract; Female; Fluorouracil; Glaucoma; Humans; Intraocu | 2006 |
Phacotrabeculectomy with mitomycin C in patients with uveitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Cataract; Co | 2006 |
Refractory glaucoma--here there be dragons.
Topics: Ciliary Body; Combined Modality Therapy; Glaucoma; Humans; Intraocular Pressure; Laser Coagulation; | 2006 |
Trabeculectomy with brief exposure to mitomycin C.
Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Female; Glaucoma; Humans; Int | 2006 |
Immediate postoperative intraocular pressure measurements after trabeculectomy with releasable sutures.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; False Negative Reactions; Female; Fluorou | 2006 |
[Dosage and kinetics of MMC release of a collagen implant used as a delivery device in glaucoma surgery in the rabbit eye].
Topics: Animals; Cicatrix; Collagen; Drug Delivery Systems; Filtering Surgery; Glaucoma; Mitomycin; Prosthes | 2006 |
[An experimental trial of glaucoma filtering surgery with amniotic membrane].
Topics: Amnion; Animals; Antimetabolites; Fibroblasts; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ra | 2005 |
Glaucoma tube or trabeculectomy? That is the question.
Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Glaucoma; Glaucoma Drainage Implants; Humans; | 2007 |
[Mitomycin C versus 5-FU in failing blebs needling].
Topics: Filtering Surgery; Fluorouracil; Glaucoma; Humans; Mitomycin; Punctures; Treatment Failure | 2006 |
Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antihypertensive Agents; Behcet Syndrome; Combined M | 2007 |
Phacotrabeculectomy study.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Fluorouracil; Glaucoma; Humans; Intraocular Pr | 2007 |
Mietz H, Krieglstein GK: Postoperative application of mitomycin C improves the complete success rate of primary trabeculectomy: a prospective, randomized trial. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1429-1436.
Topics: Alkylating Agents; Fibrosis; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; P | 2007 |
Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Combined Mod | 2007 |
The use of a "cheese-wire" suture in trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; | 2007 |
Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation.
Topics: Aged; Aged, 80 and over; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular | 2008 |
A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
Topics: Alkylating Agents; Animals; Antimetabolites; Blister; Conjunctiva; Connective Tissue; Connective Tis | 2006 |
A case of Sturge-Weber syndrome in association with phacomatosis pigmentovascularis and developmental glaucoma.
Topics: Adolescent; Female; Glaucoma; Humans; Mitomycin; Neurocutaneous Syndromes; Sturge-Weber Syndrome; Tr | 2007 |
Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy.
Topics: Aged; Alkylating Agents; Cataract; Choroid Hemorrhage; Combined Modality Therapy; Exfoliation Syndro | 2007 |
Long-term results of trabeculectomy with mitomycin C applied under the scleral flap.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Combined Modality Therapy; Female; Follow-Up Stud | 2007 |
Surgical revision of failed filtration surgery with mitomycin C augmentation.
Topics: Aged; Antihypertensive Agents; Antimetabolites, Antineoplastic; Combined Modality Therapy; Female; F | 2007 |
Management of suprachoroidal hemorrhage.
Topics: Aged, 80 and over; Choroid Hemorrhage; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocu | 2007 |
Focal corneal decompensation after filtering surgery with mitomycin C.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Edema; Glaucoma; Humans; Intraocular Pr | 2007 |
Trabeculectomy is not the best surgical option for glaucoma.
Topics: Glaucoma; Humans; Mitomycin; Trabeculectomy | 2008 |
Co-treatment of suberoylanilide hydroxamic acid and mitomycin-C induces the apoptosis of rabbit tenon's capsule fibroblast and improves the outcome of glaucoma filtration surgery.
Topics: Alkylating Agents; Animals; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Caspase 3; C | 2008 |
Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucom | 1995 |
Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs.
Topics: Animals; Collagen; Conjunctiva; Connective Tissue; Dogs; Drug Implants; Fibroblasts; Fibrosis; Filte | 1995 |
[Follow-up of a pilot study of trabeculectomy with low dosage mitomycin C (0.2 mg/ml for 1 minute). Independent evaluation of a retrospective nonrandomized study].
Topics: Aged; Aged, 80 and over; Cataract Extraction; Dose-Response Relationship, Drug; Female; Follow-Up St | 1995 |
Antiproliferative agents and the prevention of scarring after surgery: friend or foe?
Topics: Cicatrix; Filtering Surgery; Glaucoma; Humans; Mitomycin | 1995 |
Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment.
Topics: Aged; Anterior Eye Segment; Cataract; Cell Count; Chemotherapy, Adjuvant; Female; Fluorouracil; Glau | 1995 |
Treatment of postfiltration bleb leaks with autologous blood.
Topics: Aged; Anterior Chamber; Blood; Female; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Ma | 1995 |
Removable sutures in glaucoma surgery.
Topics: Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Suture Techniques; Time Factors; Tr | 1994 |
Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma; | 1995 |
One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction.
Topics: Adult; Aged; Astigmatism; Cataract; Cataract Extraction; Female; Fluorouracil; Follow-Up Studies; Gl | 1995 |
Occlusion of the retinal vasculature after trabeculectomy with mitomycin C.
Topics: Cataract Extraction; Glaucoma; Humans; Lenses, Intraocular; Male; Middle Aged; Mitomycin; Retinal Ar | 1994 |
Mitomycin C as adjunctive therapy with glaucoma implant surgery.
Topics: Adult; Aged; Biocompatible Materials; Chemotherapy, Adjuvant; Female; Fibrosis; Follow-Up Studies; G | 1994 |
Successful surgical treatment of hypotony maculopathy following trabeculectomy with topical mitomycin C.
Topics: Administration, Topical; Adult; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Male; Mitomyci | 1994 |
Retained cellulose sponge after trabeculectomy with adjunctive subconjunctival mitomycin C.
Topics: Cataract Extraction; Eye Foreign Bodies; Glaucoma; Humans; Lenses, Intraocular; Male; Middle Aged; M | 1994 |
[Trabeculectomy for normal-tension glaucoma].
Topics: Adult; Aged; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M | 1994 |
Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Int | 1994 |
[Experiences with mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Huma | 1994 |
Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony.
Topics: Adult; Aged; Ciliary Body; Combined Modality Therapy; Conjunctiva; Female; Fluorouracil; Glaucoma; H | 1994 |
[Initial experience with the use of mitomycin C in anti-glaucoma filtering surgery].
Topics: Adult; Aged; Female; Glaucoma; Humans; Male; Middle Aged; Mitomycin; Postoperative Complications; Wo | 1994 |
Adjunctive use of transconjunctival mitomycin-C in ab externo diode laser sclerostomy surgery in rabbits.
Topics: Animals; Chemotherapy, Adjuvant; Conjunctiva; Glaucoma; Intraocular Pressure; Laser Therapy; Mitomyc | 1994 |
Residual mitomycin C dosage in surgical sponges removed at the time of trabeculectomy.
Topics: Chromatography, High Pressure Liquid; Glaucoma; Humans; Mitomycin; Sclera; Surgical Sponges; Trabecu | 1994 |
Mitomycin C in anterior chamber tube shunt to a surgical membrane.
Topics: Animals; Anterior Chamber; Glaucoma; Intraocular Pressure; Mitomycin; Polytetrafluoroethylene; Prost | 1993 |
Low-energy argon laser suture lysis after trabeculectomy.
Topics: Cataract Extraction; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Mitomycin; Surgical Flap | 1994 |
Effects of topical mitomycin C on glaucoma filtration surgery.
Topics: Administration, Topical; Adolescent; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studi | 1993 |
Safety and efficacy of mitomycin C trabeculectomy in southern India. A short-term pilot study.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Child; Combined Modality Therap | 1993 |
Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Conjunctiva; Female; Fibrosis | 1993 |
Minimizing conjunctival wound leaks in filtration surgery with mitomycin C.
Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Surgical Flaps; Surgical Sponges; Surgical Wound Dehiscenc | 1993 |
Glaucoma surgery: new approaches.
Topics: Developing Countries; Glaucoma; Humans; India; Intraoperative Period; Mitomycin | 1993 |
Effects of topical mitomycin C on primary trabeculectomies and combined procedures.
Topics: Administration, Topical; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Post | 1993 |
Mitomycin-C concentration in human aqueous humour following trabeculectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aqueous Humor; Child; Child, Preschool; Chromatography, | 1993 |
Trabeculectomy with mitomycin C for refractory glaucoma in blacks.
Topics: Adult; Aged; Black People; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; I | 1993 |
Mitomycin-compatible suture technique for fornix-based conjunctival flaps in glaucoma filtration surgery.
Topics: Conjunctiva; Follow-Up Studies; Glaucoma; Humans; Mitomycin; Surgical Flaps; Suture Techniques; Trab | 1993 |
Late argon laser suture lysis after mitomycin C trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male; | 1993 |
Ocular hypotony after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Glaucoma; Humans; Intraoperative | 1993 |
Application of mitomycin C during filtering surgery.
Topics: Glaucoma; Humans; Mitomycin; Postoperative Complications; Surgical Sponges; Trabeculectomy | 1993 |
Aqueous and vitreous concentration of mitomycin C by topical administration after glaucoma filtration surgery in rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Glaucoma; Mit | 1993 |
Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C.
Topics: Animals; Biopsy; Conjunctiva; Disease Models, Animal; Drug Evaluation, Preclinical; Fibroblasts; Flu | 1993 |
Anterior chamber reaction after mitomycin and 5-fluorouracil trabeculectomy: a comparative study.
Topics: Anterior Chamber; Aqueous Humor; Biological Transport, Active; Blood; Chemotherapy, Adjuvant; Eye Pr | 1993 |
Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit.
Topics: Animals; Double-Blind Method; Drug Evaluation, Preclinical; Fluorouracil; Glaucoma; Intraocular Pres | 1993 |
Bleb leak with hypotony after laser suture lysis and trabeculectomy with mitomycin C.
Topics: Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Mitomycin; Ocular Hypotension; Postoperative | 1993 |
Surgical management of post-traumatic angle recession glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Child; Combined Modality Therapy; Drai | 1993 |
Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery.
Topics: Adolescent; Adult; Animals; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Conjunctiva; | 1995 |
Laser suture lysis after mitomycin C trabeculectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Chi | 1996 |
Mitomycin C in glaucoma triple procedure.
Topics: Animals; Cataract Extraction; Chemotherapy, Adjuvant; Glaucoma; Humans; Lenses, Intraocular; Mitomyc | 1996 |
Trabeculectomy at the inferior limbus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Chemotherapy, Adjuvant; Child; Chi | 1996 |
Bleb-related endophthalmitis after trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Aqueous Humor; Bacteria | 1996 |
Formula revealed.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Filtering Surgery; Glaucoma; Humans; Mitomycin; | 1996 |
Needle elevation of the scleral flap for failing filtration blebs after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Chemotherapy, Adju | 1996 |
Endophthalmitis after filtering surgery with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bact | 1996 |
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systems.
Topics: Argon; Biocompatible Materials; Drug Delivery Systems; Drug Stability; Drug Storage; Fluorouracil; G | 1996 |
Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C.
Topics: Actins; Adult; Aged; Antibiotics, Antineoplastic; Cell Division; Child; Connective Tissue; Female; F | 1996 |
Effects of postoperative mitomycin C eyedrop on trabeculectomy in refractory glaucoma patients.
Topics: Adult; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Hum | 1996 |
Intraoperative use of mitomycin in trabeculectomy.
Topics: Female; Glaucoma; Humans; Intraoperative Period; Male; Mitomycin; Trabeculectomy | 1996 |
Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Drainage; Filtering Surgery; Glaucoma; Intraocular | 1996 |
Epithelial barrier function of the filtering bleb conjunctiva and the cornea after trabeculectomy with mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Conjunctiva; Cornea; Epinephrine; Epithelium; Female; Fluorescein | 1996 |
Experimentally designed glaucoma implant surgery with mitomycin C in rabbit.
Topics: Animals; Anterior Eye Segment; Antibiotics, Antineoplastic; Aqueous Humor; Chemotherapy, Adjuvant; G | 1995 |
A novel MMC-loaded pHEMA drainage device for the treatment of glaucoma: in vitro and in vivo studies.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Conjunctiva; Cornea; Delayed-Action P | 1996 |
Regression of rubeosis iridis after trabeculectomy combined with mitomycin-C.
Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; H | 1996 |
Decrease of intraocular pressure after subconjunctival injection of mitomycin in human glaucoma.
Topics: Anti-Bacterial Agents; Blindness; Conjunctiva; Glaucoma; Humans; Injections; Intraocular Pressure; M | 1996 |
Bleb rupture following filtering surgery with mitomycin-C: clinicopathologic correlations.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Female | 1996 |
Combined phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative mitomycin-C: comparison between 3.2- and 6.0-mm incisions.
Topics: Aged; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Lenses, Intraocular; Male | 1996 |
Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C.
Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Child; Corneal Diseases; Female; Follow-Up Studies; | 1996 |
Slit-lamp needle revision of failed filtering blebs using mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Filtering Surgery; Follow-Up Studies | 1996 |
Use of a scleral shield for the application of mitomycin-C during trabeculectomy: preliminary clinical results.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cell Division; Drug Delivery Systems; Female; Glaucoma; Hu | 1996 |
Surgery for refractory glaucoma.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Humans; Intrao | 1996 |
Intermediate-term outcome of variable dose mitomycin C filtering surgery.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocular Pressu | 1997 |
Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery.
Topics: Aged; Cataract; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Lens | 1997 |
Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment.
Topics: Adult; Aged; Cataract Extraction; Chemotherapy, Adjuvant; Cornea; Female; Filtering Surgery; Follow- | 1997 |
Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma.
Topics: Animals; Autoradiography; Conjunctiva; Eye; Glaucoma; Intraocular Pressure; Intraoperative Period; M | 1997 |
Scleritis after glaucoma filtering surgery with mitomycin C.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Age | 1995 |
An ultrasound biomicroscopic study of filtering blebs after mitomycin C trabeculectomy.
Topics: Adolescent; Adult; Aged; Anterior Eye Segment; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; | 1995 |
Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula | 1997 |
Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites; Chemotherapy, Adjuvant | 1997 |
[Does the dosage of mitomycin-C applied during filtering surgery of glaucoma vary with the individual surgeon?].
Topics: Antimetabolites; Filtering Surgery; Glaucoma; Humans; Mitomycin; Surgical Sponges | 1997 |
In vitro effects of mitomycin C on human Tenon's capsule fibroblasts & correlation with surgical outcome in glaucoma patients.
Topics: Antibiotics, Antineoplastic; Cell Line; Connective Tissue; Connective Tissue Cells; Eye; Fibroblasts | 1997 |
Prolonged impairment of peripheral corneal epithelium barrier function after successful trabeculectomy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Biological Transport; Cell Membrane Permeability; Chemothe | 1997 |
Surgical results and complications of trabeculectomy with intraoperative application of mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Fem | 1996 |
Intraoperative mitomycin-C for glaucoma associated with ocular inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Chi | 1997 |
Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma.
Topics: Adolescent; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fo | 1997 |
Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites; Chemotherapy, Adjuvant; Conjunctiva; Female; Flu | 1997 |
Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit.
Topics: Animals; Cicatrix; Conjunctiva; Eye; Filtering Surgery; Glaucoma; Injections; Mitomycin; Rabbits; Wo | 1997 |
Comparative results of combined procedures for glaucoma and cataract: II. Limbus-based versus fornix-based conjunctival flaps.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Follow-Up | 1997 |
Filtering bleb infection as a complication of orthokeratology.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Contact Lenses; Drug Therapy, Combination | 1997 |
Management of chronic hypotony following trabeculectomy with mitomycin C.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Blood; Chronic Disease; Follow-Up Studies; Gla | 1997 |
Transconjunctival application of mitomycin C in combination with laser sclerostomy ab interno: a long-term morphological study of the postoperative healing process.
Topics: Administration, Topical; Animals; Collagen; Glaucoma; Intraoperative Care; Laser Therapy; Microscopy | 1997 |
Combined phacoemulsification and trabeculectomy with mitomycin-C.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Female; Foll | 1997 |
Transconjunctival mitomycin C as an adjunct to conventional glaucoma filtration surgery in rabbits.
Topics: Animals; Conjunctiva; Eye; Filtering Surgery; Glaucoma; Mitomycin; Postoperative Care; Preoperative | 1997 |
Encapsulated filtering blebs after trabeculectomy with mitomycin-C.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-U | 1997 |
Fornix-based trabeculectomy with mitomycin-C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow- | 1997 |
Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Follow-Up Studies; Glaucoma; Huma | 1997 |
[The long-term cystic bleb appearance and safety after trabeculectomy with mitomycin C].
Topics: Female; Glaucoma; Humans; Infections; Male; Mitomycin; Postoperative Complications; Retrospective St | 1997 |
The effect of adjunctive mitomycin C in Molteno implant surgery.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucom | 1997 |
Bleb-related ocular infection in children after trabeculectomy with mitomycin C.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; | 1997 |
Midterm reversible failure in trabeculectomies with adjunctive mitomycin-C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucom | 1997 |
Simultaneous use of mitomycin-C with Baerveldt implantation.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Filtering Surgery; Follow-Up Studies; G | 1997 |
Ocular concentrations of mitomycin C using different delivery devices.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; | 1998 |
Surgical results of secondary glaucomas in childhood.
Topics: Adolescent; Child; Child, Preschool; Ciliary Body; Cryotherapy; Eye Abnormalities; Follow-Up Studies | 1998 |
Half corneal light shield as a delivery system for standardized application of mitomycin C.
Topics: Absorption; Animals; Antibiotics, Antineoplastic; Cornea; Drug Delivery Systems; Filtering Surgery; | 1998 |
Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glau | 1998 |
Outcomes of primary trabeculectomy with the use of adjunctive mitomycin.
Topics: Administration, Topical; Aged; Chemotherapy, Adjuvant; Cohort Studies; Female; Glaucoma; Humans; Int | 1998 |
Late removal of releasable sutures after trabeculectomy or combined trabeculectomy with cataract extraction supplemented with antifibrotics.
Topics: Aged; Cataract Extraction; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intraocular Pr | 1998 |
Molteno implant with mitomycin C: intermediate-term results.
Topics: Adult; Chemotherapy, Adjuvant; Cohort Studies; Female; Filtering Surgery; Follow-Up Studies; Glaucom | 1998 |
Late-onset bleb leaks after glaucoma filtering surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aqueous Humor; Cataract Extraction; Chemotherapy, Adjuva | 1998 |
Penetrating keratoplasty with a valved glaucoma drainage implant for congenital glaucoma and corneal scarring secondary to hydrops.
Topics: Administration, Topical; Anterior Chamber; Antibiotics, Antineoplastic; Corneal Edema; Corneal Opaci | 1998 |
Antimetabolites in glaucoma surgery: our experiences and results.
Topics: Antimetabolites; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraopera | 1997 |
Permanent glaucomatous visual loss after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Cornea; Dexamethasone; Filtering Surgery; | 1998 |
The effect of paclitaxel powder on glaucoma filtration surgery in rabbits.
Topics: Animals; Antineoplastic Agents, Phytogenic; Conjunctiva; Filtering Surgery; Glaucoma; Intraocular Pr | 1998 |
Trabeculectomy augmented with mitomycin C application under the scleral flap.
Topics: Adult; Combined Modality Therapy; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Life Ta | 1998 |
[Influences of trabeculectomy combined with the use of mitomycin C on corneal endothelial cells].
Topics: Administration, Topical; Endothelium, Corneal; Female; Glaucoma; Humans; Male; Middle Aged; Mitomyci | 1998 |
Needling revision of glaucoma drainage device filtering blebs.
Topics: Chemotherapy, Adjuvant; Drainage; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pre | 1998 |
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ciliary Body; Drainage; Female; Follow-Up Studies; Glauc | 1998 |
The imposter of Seidel.
Topics: Aged; Antimetabolites; Aqueous Humor; Contrast Media; Diagnosis, Differential; Fluorescein; Glaucoma | 1998 |
Trabeculectomy with mitomycin C: intermediate-term results.
Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Postopera | 1998 |
Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glauc | 1998 |
Episcleral versus combined episcleral and intrascleral application of mitomycin-C in trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoper | 1998 |
Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of case-matched young patients.
Topics: Adolescent; Adult; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular | 1998 |
Trabeculectomy with long-term-stored mitomycin C in West Indian population.
Topics: Adult; Aged; Animals; Drug Storage; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Age | 1998 |
The results of trabeculectomy with and without mitomycin C in young patients.
Topics: Adolescent; Adult; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Nucleic Acid Synthesis Inhibit | 1998 |
Effect of mitomycin C on aqueous humor flow, flare and intraocular pressure in eyes with glaucoma 2 years after trabeculectomy.
Topics: Adolescent; Adult; Aged; Antimetabolites; Aqueous Humor; Female; Glaucoma; Humans; Intraocular Press | 1998 |
Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Follow-Up Studies; Glaucoma; Hu | 1998 |
Rapid preparation of small-volume autologous fibrinogen concentrate and its same day use in bleb leaks after glaucoma filtration surgery.
Topics: Administration, Topical; Adult; Aged; Female; Fibrin Tissue Adhesive; Follow-Up Studies; Glaucoma; H | 1998 |
Occlusive ligature and standardized fenestration of a Baerveldt tube with and without antimetabolites for early postoperative intraocular pressure control.
Topics: Aged; Antimetabolites; Aqueous Humor; Female; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Hu | 1998 |
Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Cicatrix; Conjunctival Diseases; Follow-Up S | 1998 |
A novel method for controlling the quantity of mitomycin-C applied during filtering surgery for glaucoma.
Topics: Antibiotics, Antineoplastic; Filtering Surgery; Glaucoma; Humans; Mitomycin; Surgical Sponges | 1998 |
[Mitomycin C concentrations in rabbit ocular tissues after topical administration during glaucoma filtration surgery].
Topics: Administration, Topical; Animals; Eye; Female; Filtering Surgery; Glaucoma; Intraoperative Period; M | 1997 |
Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciliary Body; Cryotherapy; Female; Follow-Up Stud | 1999 |
Combined penetrating keratoplasty and trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Corneal Diseases; Female; Glaucoma; Graft Survival; Humans; Intraocu | 1999 |
Late bleb-related endophthalmitis after trabeculectomy with mitomycin C.
Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; | 1999 |
Quantification of intraoperative administration of mitomycin-C in filtering surgery with surgical sponge material.
Topics: Absorption; Animals; Biological Assay; Conjunctiva; Delayed-Action Preparations; Fibrin Foam; Filter | 1999 |
Management of congenital glaucoma.
Topics: Adrenergic beta-Antagonists; Child, Preschool; Ciliary Body; Cryosurgery; Decision Making; Filtering | 1999 |
[Modulation of wound healing in glaucoma filtration surgery].
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Female; Filtering Surgery; Glau | 1998 |
Combined trabeculotomy and trabeculectomy as an initial procedure in uncomplicated congenital glaucoma.
Topics: Chemotherapy, Adjuvant; Child, Preschool; Corneal Opacity; Female; Glaucoma; Humans; Infant; Infant, | 1999 |
Results of medical management and mitomycin C-augmented excisional bleb revision for encapsulated filtering blebs.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ophthalmic Solutions; Postoper | 1999 |
Clinical and histopathologic findings of iris nevus (Cogan-Reese) syndrome.
Topics: Adult; Corneal Edema; Glaucoma; Humans; Intraocular Pressure; Iris Neoplasms; Male; Mitomycin; Nevus | 1999 |
Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Fibrosis; Fluorouracil; Glaucoma; Humans; Intraocular Pressu | 1999 |
The comparative benefits of glaucoma filtering surgery with an electric-pulse targeted drug delivery system demonstrated in an animal model.
Topics: Animals; Bleomycin; Chemotherapy, Adjuvant; Conjunctiva; Cornea; Drug Delivery Systems; Electroporat | 1999 |
Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Intra | 1999 |
Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma.
Topics: Adolescent; Child; Child, Preschool; Combined Modality Therapy; Female; Filtering Surgery; Follow-Up | 1999 |
[The effect of heterogeneous scleral transplantation on hypotony after filtration surgery of glaucoma with mitomycin C].
Topics: Adolescent; Adult; Cicatrix; Female; Filtering Surgery; Follow-Up Studies; Glaucoma; Humans; Male; M | 1997 |
Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Endophthalmitis; Female; Filtration; Fluoro | 1999 |
A comparative study of the chemical stability of various mitomycin C solutions used in glaucoma filtering surgery.
Topics: Buffers; Chemotherapy, Adjuvant; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; | 1999 |
The effect of hydroxyurea on rabbit subconjunctival fibroblast culture and use of hydroxyurea in rabbits after glaucoma filtration surgery.
Topics: Animals; Cell Adhesion; Cells, Cultured; Conjunctiva; Dose-Response Relationship, Drug; Fibroblasts; | 1999 |
Combination of autologous blood injection and bleb compression sutures to treat hypotony maculopathy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Blood; Combined Modality Therapy; Female; Glaucoma; Huma | 1999 |
Paired parallel locking forceps.
Topics: Alkylating Agents; Equipment Design; Filtering Surgery; Glaucoma; Humans; Mitomycin; Postoperative C | 2000 |
Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Corneal Diseases; Endothelium, | 2000 |
Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Ascorbic Acid; Cells, Cultured; Child; | 1999 |
Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas.
Topics: Adolescent; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fo | 2000 |
[Sinusotomy with intraoperative mitomycin C administration in selected eyes with advanced glaucomatous damage].
Topics: Adult; Aged; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle | 2000 |
Midterm follow-up of necrotic bleb excision and advancement of the fornical conjunctiva.
Topics: Adult; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraoperative P | 1999 |
Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery.
Topics: Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Chronic Disease; Female; Glaucoma; Humans | 2000 |
Intrascleral concentration vs depth profile of mitomycin-C after episcleral application: impact of applied concentration and volume of mitomycin-C solution.
Topics: Absorption; Administration, Topical; Chromatography, High Pressure Liquid; Dose-Response Relationshi | 2000 |
Trabeculectomy with mitomycin C for post-keratoplasty glaucoma.
Topics: Adult; Aged; Female; Glaucoma; Graft Rejection; Humans; Intraocular Pressure; Keratoplasty, Penetrat | 2000 |
Long term results of glaucoma surgery among participants in an east African population survey.
Topics: Africa, Eastern; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Iris; Male; Midd | 2000 |
Treating glaucoma.
Topics: Antibiotics, Antineoplastic; Glaucoma; Humans; Mitomycin | 2000 |
Conjunctival dysfunction and mitomycin C-induced hypotony.
Topics: Adolescent; Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Conjunctival Dise | 2000 |
Risk factors for development of post-trabeculectomy endophthalmitis.
Topics: Aged; Antimetabolites; Case-Control Studies; Diabetes Complications; Endophthalmitis; Female; Fluoro | 2000 |
Fornix-based trabeculectomy with Wise's suture technique in Chinese patients.
Topics: Antimetabolites, Antineoplastic; Asian People; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Gl | 2000 |
Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Cataract; Cataract Extraction; Female; | 2000 |
Success criteria and success rates in trabeculectomy with and without intraoperative antimetabolites using intensified postoperative care (IPC).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Female; Fluorouracil; Glaucoma; Humans; Intraocular | 2000 |
[Trabeculectomy with mitomycin C in aphakic glaucoma].
Topics: Aphakia; Glaucoma; Humans; Mitomycin; Postoperative Complications; Trabeculectomy | 2000 |
Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma.
Topics: Adolescent; Adult; Aged; Eye Injuries; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pres | 2001 |
Trabeculectomy with mitomycin-C in pediatric glaucomas.
Topics: Child; Endophthalmitis; Glaucoma; Humans; Male; Mitomycin; Patient Education as Topic; Surgical Woun | 2001 |
Trabeculectomy with mitomycin-C in pediatric glaucomas.
Topics: Endophthalmitis; Glaucoma; Humans; Incidence; Infant; Mitomycin; Risk Factors; Surgical Wound Infect | 2001 |
Should antiproliferatives be used in filtering surgery of normal tension glaucoma?
Topics: Antineoplastic Agents; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mito | 2001 |
Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure.
Topics: Aged; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Male; Middle Aged; Mit | 2001 |
Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography-photo-diode array detection.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Chromatography, High Pressure Liquid; Glaucoma; Human | 2001 |
Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.
Topics: Adult; Antihypertensive Agents; Corneal Diseases; Endothelium, Corneal; Fluorouracil; Follow-Up Stud | 2001 |
Glaucoma surgery treatment patterns of ASCRS members--2000 survey.
Topics: Cross-Sectional Studies; Filtering Surgery; Fluorouracil; Glaucoma; Health Surveys; Humans; Middle A | 2001 |
Activity of dissolved mitomycin C after different methods of long-term storage.
Topics: Antibiotics, Antineoplastic; Cold Temperature; Drug Stability; Drug Storage; Glaucoma; Microbial Sen | 2002 |
[Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Conjunctiva; Dry Eye Synd | 2001 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
[Results and complications after deep sclerectomy].
Topics: Cataract Extraction; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoperative Compl | 2002 |
Haemophilus aphrophilus bleb infection after a mitomycin trabeculectomy.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glaucoma; Gluco | 1995 |
Phacotrabeculectomy: peripheral iridectomy or no peripheral iridectomy?
Topics: Aged; Aged, 80 and over; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Iris; Lens Implan | 2002 |
[Antimetabolites in glaucoma surgery--long-term results].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Fluorouracil; Glaucoma; Humans; Intraocular Pressur | 2002 |
Intraoperative and post operative treatment with 5-fluorouracil and mitomycin-c: long term effects in vivo on subconjunctival and scleral fibroblasts.
Topics: Animals; Cell Division; Cells, Cultured; Conjunctiva; Fibroblasts; Fluorouracil; Glaucoma; Injection | 1992 |
Who should receive antimetabolites after filtering surgery?
Topics: Antimetabolites; Fluorouracil; Glaucoma; Humans; Mitomycin; Postoperative Care | 1992 |
Effect of topical mitomycin C on glaucoma filtration surgery in monkeys.
Topics: Administration, Topical; Animals; Anterior Eye Segment; Disease Models, Animal; Glaucoma; Intraocula | 1992 |
The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits.
Topics: Administration, Topical; Animals; Cicatrix; Combined Modality Therapy; Glaucoma; Intraocular Pressur | 1991 |
Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Follow-Up | 1990 |